,Seed query,Entry,Entry Name,Protein names,Gene Names,Organism,Length,Gene Ontology (biological process),Gene Ontology (cellular component),Gene Ontology (GO),Gene Ontology (molecular function),Topological domain,Transmembrane,Subcellular location [CC],Intramembrane
0,"(gene:""AADAC"")",P22760,AAAD_HUMAN,Arylacetamide deacetylase (EC 3.1.1.3),AADAC DAC,Homo sapiens (Human),399,lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; catalytic activity [GO:0003824]; deacetylase activity [GO:0019213]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride catabolic process [GO:0010898]; xenobiotic metabolic process [GO:0006805],catalytic activity [GO:0003824]; deacetylase activity [GO:0019213]; lipase activity [GO:0016298]; serine hydrolase activity [GO:0017171]; triglyceride lipase activity [GO:0004806],"TOPO_DOM 1..5; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 24..399; /note=""Lumenal""; /evidence=""ECO:0000255""","TRANSMEM 6..23; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass type II membrane protein. Microsome membrane; Single-pass type II membrane protein.,
1,,C9K0E9,C9K0E9_HUMAN,Arylacetamide deacetylase,AADAC,Homo sapiens (Human),204,,membrane [GO:0016020],membrane [GO:0016020]; hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""CYP4F3"")",Q08477,CP4F3_HUMAN,Cytochrome P450 4F3 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYPIVF3) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase CYP4F3) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2) (EC 1.14.14.94),CYP4F3 LTB4H,Homo sapiens (Human),520,arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; omega-hydroxylase P450 pathway [GO:0097267],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692]; arachidonic acid metabolic process [GO:0019369]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; lipoxin A4 metabolic process [GO:2001302]; lipoxin B4 metabolic process [GO:2001304]; omega-hydroxylase P450 pathway [GO:0097267],20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; very long-chain fatty acid omega-hydroxylase activity [GO:0140692],,"TRANSMEM 11..31; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:10409674}; Single-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000305|PubMed:10409674}; Single-pass membrane protein {ECO:0000255}.,
1,,K7EJZ8,K7EJZ8_HUMAN,Cytochrome P450 family 4 subfamily F member 3,CYP4F3,Homo sapiens (Human),79,,,,,,,,
2,,V9GYA1,V9GYA1_HUMAN,Cytochrome P450 family 4 subfamily F member 3,CYP4F3,Homo sapiens (Human),74,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""AKR1A1"")",P14550,AK1A1_HUMAN,Aldo-keto reductase family 1 member A1 (EC 1.1.1.2) (EC 1.1.1.372) (EC 1.1.1.54) (Alcohol dehydrogenase [NADP(+)]) (Aldehyde reductase) (Glucuronate reductase) (EC 1.1.1.19) (Glucuronolactone reductase) (EC 1.1.1.20) (S-nitroso-CoA reductase) (ScorR) (EC 1.6.-.-),AKR1A1 ALDR1 ALR,Homo sapiens (Human),325,aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; synapse [GO:0045202],apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; synapse [GO:0045202]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; glycerol dehydrogenase (NADP+) activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; methylglyoxal reductase (NADPH) (acetol producing) activity [GO:1990002]; S-nitrosoglutathione reductase (NADH) activity [GO:0080007]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163]; aldehyde catabolic process [GO:0046185]; cellular detoxification of aldehyde [GO:0110095]; D-glucuronate catabolic process [GO:0042840]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; glucuronate catabolic process to xylulose 5-phosphate [GO:0019640]; glutathione derivative biosynthetic process [GO:1901687]; L-ascorbic acid biosynthetic process [GO:0019853]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066],aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; allyl-alcohol dehydrogenase activity [GO:0047655]; glucuronolactone reductase activity [GO:0047941]; glycerol dehydrogenase (NADP+) activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; methylglyoxal reductase (NADPH) (acetol producing) activity [GO:1990002]; S-nitrosoglutathione reductase (NADH) activity [GO:0080007]; S-nitrosoglutathione reductase (NADPH) activity [GO:0160163],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9JII6}. Apical cell membrane {ECO:0000250|UniProtKB:Q9JII6}.",
1,,Q5T621,Q5T621_HUMAN,Aldo-keto reductase family 1 member A1,AKR1A1,Homo sapiens (Human),147,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
2,,V9GYG2,V9GYG2_HUMAN,Aldo-keto reductase family 1 member A1,AKR1A1,Homo sapiens (Human),119,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
3,,V9GYP9,V9GYP9_HUMAN,Aldo-keto reductase family 1 member A1,AKR1A1,Homo sapiens (Human),140,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""CYP4V2"")",Q6ZWL3,CP4V2_HUMAN,Cytochrome P450 4V2 (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),CYP4V2,Homo sapiens (Human),525,fatty acid omega-oxidation [GO:0010430]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; fatty acid omega-oxidation [GO:0010430]; retinoid metabolic process [GO:0001523]; sterol metabolic process [GO:0016125]; visual perception [GO:0007601],heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497],,"TRANSMEM 13..33; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:22772592}; Single-pass membrane protein {ECO:0000305}.,
1,,Q49AA5,Q49AA5_HUMAN,CYP4V2 protein,CYP4V2,Homo sapiens (Human),51,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""AKR1B1"")",P15121,ALDR_HUMAN,Aldo-keto reductase family 1 member B1 (EC 1.1.1.300) (EC 1.1.1.372) (EC 1.1.1.54) (Aldehyde reductase) (Aldose reductase) (AR) (EC 1.1.1.21),AKR1B1 ALDR1 ALR2,Homo sapiens (Human),316,C21-steroid hormone biosynthetic process [GO:0006700]; carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; fructose biosynthetic process [GO:0046370]; L-ascorbic acid biosynthetic process [GO:0019853]; metanephric collecting duct development [GO:0072205]; negative regulation of apoptotic process [GO:0043066]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; retinoid metabolic process [GO:0001523],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; aldose reductase (NADPH) activity [GO:0004032]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glyceraldehyde oxidoreductase activity [GO:0043795]; glycerol dehydrogenase (NADP+) activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758]; C21-steroid hormone biosynthetic process [GO:0006700]; carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; epithelial cell maturation [GO:0002070]; fructose biosynthetic process [GO:0046370]; L-ascorbic acid biosynthetic process [GO:0019853]; metanephric collecting duct development [GO:0072205]; negative regulation of apoptotic process [GO:0043066]; regulation of urine volume [GO:0035809]; renal water homeostasis [GO:0003091]; retinoid metabolic process [GO:0001523],aldose reductase (NADPH) activity [GO:0004032]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; allyl-alcohol dehydrogenase activity [GO:0047655]; electron transfer activity [GO:0009055]; glyceraldehyde oxidoreductase activity [GO:0043795]; glycerol dehydrogenase (NADP+) activity [GO:0047956]; L-glucuronate reductase activity [GO:0047939]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,E9PCX2,E9PCX2_HUMAN,Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase),AKR1B1,Homo sapiens (Human),263,,cytoplasm [GO:0005737],cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,E9PEF9,E9PEF9_HUMAN,Aldo-keto reductase family 1 member B1 (EC 1.1.1.21) (EC 1.1.1.300) (Aldose reductase),AKR1B1,Homo sapiens (Human),102,,cytoplasm [GO:0005737],cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
0,"(gene:""CYP4X1"")",Q8N118,CP4X1_HUMAN,Cytochrome P450 4X1 (EC 1.14.14.-) (CYPIVX1),CYP4X1 UNQ1929/PRO4404,Homo sapiens (Human),509,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; anandamide 14,15 epoxidase activity [GO:0062189]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lipid metabolic process [GO:0006629]","anandamide 14,15 epoxidase activity [GO:0062189]; heme binding [GO:0020037]; iron ion binding [GO:0005506]",,"TRANSMEM 14..34; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q6A152}; Single-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000250|UniProtKB:Q6A152}; Single-pass membrane protein {ECO:0000255}.,
0,"(gene:""AKR1B10"")",O60218,AK1BA_HUMAN,Aldo-keto reductase family 1 member B10 (EC 1.1.1.300) (EC 1.1.1.54) (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein) (ARP) (hARP) (Small intestine reductase) (SI reductase),AKR1B10 AKR1B11,Homo sapiens (Human),316,cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739],cytosol [GO:0005829]; extracellular region [GO:0005576]; lysosome [GO:0005764]; mitochondrion [GO:0005739]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; retinal dehydrogenase activity [GO:0001758]; cellular detoxification of aldehyde [GO:0110095]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; retinoid metabolic process [GO:0001523],alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; allyl-alcohol dehydrogenase activity [GO:0047655]; geranylgeranyl reductase activity [GO:0045550]; indanol dehydrogenase activity [GO:0047718]; retinal dehydrogenase activity [GO:0001758],,,SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:21585341}. Secreted {ECO:0000269|PubMed:21585341}. Note=Secreted through a lysosome-mediated non-classical pathway.,
0,"(gene:""CYP4Z1"")",Q86W10,CP4Z1_HUMAN,Cytochrome P450 4Z1 (EC 1.14.14.1) (CYPIVZ1) (Laurate 7-monooxygenase) (EC 1.14.14.130),CYP4Z1 UNQ3060/PRO9882,Homo sapiens (Human),505,arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; lauric acid metabolic process [GO:0048252]","arachidonic acid 14,15-epoxygenase activity [GO:0008404]; aromatase activity [GO:0070330]; fatty acid in-chain hydroxylase activity [GO:0052722]; heme binding [GO:0020037]; iron ion binding [GO:0005506]","TOPO_DOM 1..9; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 31..505; /note=""Lumenal""; /evidence=""ECO:0000255""","TRANSMEM 10..30; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:15059886}; Single-pass type II membrane protein {ECO:0000269|PubMed:15059886}. Microsome membrane {ECO:0000269|PubMed:15059886}; Single-pass type II membrane protein {ECO:0000269|PubMed:15059886}.,
0,"(gene:""AKR1C1"")",Q04828,AK1C1_HUMAN,Aldo-keto reductase family 1 member C1 (EC 1.1.1.-) (EC 1.1.1.112) (EC 1.1.1.209) (EC 1.1.1.210) (EC 1.1.1.357) (EC 1.1.1.51) (EC 1.1.1.53) (EC 1.1.1.62) (EC 1.3.1.20) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Chlordecone reductase homolog HAKRC) (Dihydrodiol dehydrogenase 1) (DD1) (High-affinity hepatic bile acid-binding protein) (HBAB),AKR1C1 DDH DDH1,Homo sapiens (Human),323,bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cellular response to jasmonic acid stimulus [GO:0071395]; cholesterol homeostasis [GO:0042632]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; intestinal cholesterol absorption [GO:0030299]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; response to organophosphorus [GO:0046683]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062],"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 3beta-hydroxy-5beta-steroid dehydrogenase activity [GO:0033703]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase (B-specific) activity [GO:0047042]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0033764]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase [NAD(P)+] activity [GO:0030283]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; bile acid and bile salt transport [GO:0015721]; bile acid metabolic process [GO:0008206]; cellular response to jasmonic acid stimulus [GO:0071395]; cholesterol homeostasis [GO:0042632]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; intestinal cholesterol absorption [GO:0030299]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; response to organophosphorus [GO:0046683]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; xenobiotic metabolic process [GO:0006805]","17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity [GO:0047006]; 3beta-hydroxy-5beta-steroid dehydrogenase activity [GO:0033703]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase (B-specific) activity [GO:0047042]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor [GO:0033764]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase [NAD(P)+] activity [GO:0030283]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]",,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:8486699}.",
1,,H0Y804,H0Y804_HUMAN,Aldo-keto reductase family 1 member C1,AKR1C1,Homo sapiens (Human),248,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
2,,A6NHU4,A6NHU4_HUMAN,Aldo-keto reductase family 1 member C1,AKR1C1,Homo sapiens (Human),205,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""CYP51A1"")",Q16850,CP51A_HUMAN,Lanosterol 14-alpha demethylase (LDM) (EC 1.14.14.154) (CYPLI) (Cytochrome P450 51A1) (CYP51A1) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase),CYP51A1 CYP51,Homo sapiens (Human),509,cholesterol biosynthetic process [GO:0006695]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol 14-demethylase activity [GO:0008398]; cholesterol biosynthetic process [GO:0006695]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125],heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; sterol 14-demethylase activity [GO:0008398],,"TRANSMEM 30..50; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q64654}; Single-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000250|UniProtKB:Q64654}; Single-pass membrane protein {ECO:0000255}.,
1,,A0A8I5KRT9,A0A8I5KRT9_HUMAN,Cytochrome P450 family 51 subfamily A member 1,CYP51A1,Homo sapiens (Human),458,organic hydroxy compound biosynthetic process [GO:1901617]; small molecule biosynthetic process [GO:0044283]; steroid biosynthetic process [GO:0006694],intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],"intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; organic hydroxy compound biosynthetic process [GO:1901617]; small molecule biosynthetic process [GO:0044283]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 31..50; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
2,,H7C0D0,H7C0D0_HUMAN,Cytochrome P450 family 51 subfamily A member 1,CYP51A1,Homo sapiens (Human),222,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,Q05D40,Q05D40_HUMAN,CYP51A1 protein,CYP51A1,Homo sapiens (Human),180,organic hydroxy compound biosynthetic process [GO:1901617]; small molecule biosynthetic process [GO:0044283]; steroid biosynthetic process [GO:0006694],intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],"intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; organic hydroxy compound biosynthetic process [GO:1901617]; small molecule biosynthetic process [GO:0044283]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 25..44; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""AKR1C2"")",P52895,AK1C2_HUMAN,Aldo-keto reductase family 1 member C2 (EC 1.-.-.-) (EC 1.1.1.112) (EC 1.1.1.209) (EC 1.1.1.53) (EC 1.1.1.62) (EC 1.3.1.20) (3-alpha-HSD3) (Chlordecone reductase homolog HAKRD) (Dihydrodiol dehydrogenase 2) (DD-2) (DD2) (Dihydrodiol dehydrogenase/bile acid-binding protein) (DD/BABP) (Type III 3-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.357),AKR1C2 DDH2,Homo sapiens (Human),323,cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202],cytosol [GO:0005829],"cytosol [GO:0005829]; aldose reductase (NADPH) activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; daunorubicin metabolic process [GO:0044597]; digestion [GO:0007586]; doxorubicin metabolic process [GO:0044598]; epithelial cell differentiation [GO:0030855]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; steroid metabolic process [GO:0008202]","aldose reductase (NADPH) activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; carboxylic acid binding [GO:0031406]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; indanol dehydrogenase activity [GO:0047718]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity [GO:0047115]",,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:8486699}.",
1,,B4DK69,B4DK69_HUMAN,Aldo-keto reductase family 1 member C2,AKR1C2,Homo sapiens (Human),297,,,estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303],estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303],,,,
2,,Q1KXY7,Q1KXY7_HUMAN,3 alpha hydroxysteroid dehydrogenase III (EC 1.1.1.213),AKR1C2,Homo sapiens (Human),9,,,androsterone dehydrogenase (A-specific) activity [GO:0047026],androsterone dehydrogenase (A-specific) activity [GO:0047026],,,,
3,,S4R3P0,S4R3P0_HUMAN,Aldo-keto reductase family 1 member C2,AKR1C2,Homo sapiens (Human),200,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""CYP7A1"")",P22680,CP7A1_HUMAN,Cytochrome P450 7A1 (24-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.26) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cholesterol 7-alpha-monooxygenase) (EC 1.14.14.23),CYP7A1 CYP7,Homo sapiens (Human),504,bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; cellular response to cholesterol [GO:0071397]; cellular response to glucose stimulus [GO:0071333]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fatty acid biosynthetic process [GO:0045717]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of bile acid biosynthetic process [GO:0070857]; response to ethanol [GO:0045471]; sterol metabolic process [GO:0016125],24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; cholesterol 7-alpha-monooxygenase activity [GO:0008123]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 4..24; /note=""Helical""; /evidence=""ECO:0000255""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:11013305, ECO:0000305|PubMed:2384150}; Single-pass membrane protein {ECO:0000305}. Microsome membrane {ECO:0000305|PubMed:11013305, ECO:0000305|PubMed:2384150}; Single-pass membrane protein {ECO:0000305}.",
0,"(gene:""AKR1C3"")",P42330,AK1C3_HUMAN,"Aldo-keto reductase family 1 member C3 (EC 1.1.1.-) (EC 1.1.1.210) (EC 1.1.1.53) (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239, EC 1.1.1.64)",AKR1C3 DDH1 HSD17B5 KIAA0119 PGFS,Homo sapiens (Human),323,cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; Delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; geranylgeranyl reductase activity [GO:0045550]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin F synthase activity [GO:0047017]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; cellular response to calcium ion [GO:0071277]; cellular response to corticosteroid stimulus [GO:0071384]; cellular response to jasmonic acid stimulus [GO:0071395]; cellular response to prostaglandin D stimulus [GO:0071799]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to starvation [GO:0009267]; cyclooxygenase pathway [GO:0019371]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; farnesol catabolic process [GO:0016488]; G protein-coupled receptor signaling pathway [GO:0007186]; keratinocyte differentiation [GO:0030216]; macromolecule metabolic process [GO:0043170]; male gonad development [GO:0008584]; negative regulation of retinoic acid biosynthetic process [GO:1900053]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; regulation of retinoic acid receptor signaling pathway [GO:0048385]; regulation of testosterone biosynthetic process [GO:2000224]; renal absorption [GO:0070293]; response to nutrient [GO:0007584]; retinal metabolic process [GO:0042574]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]; testosterone biosynthetic process [GO:0061370]","15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity [GO:0047020]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; all-trans-retinol dehydrogenase (NADP+) activity [GO:0052650]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; Delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; geranylgeranyl reductase activity [GO:0045550]; ketoreductase activity [GO:0045703]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; prostaglandin D2 11-ketoreductase activity [GO:0036131]; prostaglandin F synthase activity [GO:0047017]; prostaglandin H2 endoperoxidase reductase activity [GO:0036130]; retinal dehydrogenase activity [GO:0001758]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:10622721}.,
1,,A0A0A0MSS8,A0A0A0MSS8_HUMAN,Aldo-keto reductase family 1 member C3,AKR1C3,Homo sapiens (Human),323,,,estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303],estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303],,,,
2,,S4R3Z2,S4R3Z2_HUMAN,"Aldo-keto reductase family 1 member C3 (Aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II), isoform CRA_a)",AKR1C3 hCG_19343,Homo sapiens (Human),300,,,estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303],estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303],,,,
3,,S4R3D5,S4R3D5_HUMAN,Aldo-keto reductase family 1 member C3,AKR1C3,Homo sapiens (Human),155,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""CYP7B1"")",O75881,CP7B1_HUMAN,Cytochrome P450 7B1 (24-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.26) (25/26-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.29) (3-hydroxysteroid 7-alpha hydroxylase) (Oxysterol 7-alpha-hydroxylase),CYP7B1,Homo sapiens (Human),506,B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell proliferation [GO:0050673]; estrogen receptor signaling pathway [GO:0030520]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; B cell chemotaxis [GO:0035754]; bile acid biosynthetic process [GO:0006699]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell proliferation [GO:0050673]; estrogen receptor signaling pathway [GO:0030520]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; positive regulation of epithelial cell proliferation [GO:0050679]; prostate gland epithelium morphogenesis [GO:0060740]; sterol metabolic process [GO:0016125],24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; 25-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033783]; 27-hydroxycholesterol 7-alpha-monooxygenase activity [GO:0047092]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396],,"TRANSMEM 17..37; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 289..309; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:9802883}; Multi-pass membrane protein {ECO:0000305}. Microsome membrane {ECO:0000305|PubMed:9802883}; Multi-pass membrane protein {ECO:0000305}.,
1,,Q05C57,Q05C57_HUMAN,CYP7B1 protein,CYP7B1,Homo sapiens (Human),489,organic hydroxy compound metabolic process [GO:1901615]; steroid metabolic process [GO:0008202],membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; organic hydroxy compound metabolic process [GO:1901615]; steroid metabolic process [GO:0008202]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 17..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 289..309; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""AKR1C4"")",P17516,AK1C4_HUMAN,Aldo-keto reductase family 1 member C4 (EC 1.1.1.-) (EC 1.1.1.209) (EC 1.1.1.210) (EC 1.1.1.51) (EC 1.1.1.53) (EC 1.1.1.62) (3-alpha-hydroxysteroid dehydrogenase type I) (3-alpha-HSD1) (EC 1.1.1.357) (3alpha-hydroxysteroid 3-dehydrogenase) (Chlordecone reductase) (CDR) (EC 1.1.1.225) (Dihydrodiol dehydrogenase 4) (DD-4) (DD4) (HAKRA),AKR1C4 CHDR,Homo sapiens (Human),323,androgen metabolic process [GO:0008209]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; cellular response to jasmonic acid stimulus [GO:0071395]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; bile acid transmembrane transporter activity [GO:0015125]; chlordecone reductase activity [GO:0047743]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; electron transfer activity [GO:0009055]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; retinal dehydrogenase activity [GO:0001758]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; androgen metabolic process [GO:0008209]; bile acid and bile salt transport [GO:0015721]; bile acid biosynthetic process [GO:0006699]; cellular response to jasmonic acid stimulus [GO:0071395]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; progesterone metabolic process [GO:0042448]; prostaglandin metabolic process [GO:0006693]; retinoid metabolic process [GO:0001523]; steroid metabolic process [GO:0008202]","5alpha-androstane-3beta,17beta-diol dehydrogenase activity [GO:0047024]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; bile acid binding [GO:0032052]; bile acid transmembrane transporter activity [GO:0015125]; chlordecone reductase activity [GO:0047743]; dihydrotestosterone 17-beta-dehydrogenase activity [GO:0035410]; electron transfer activity [GO:0009055]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; ketosteroid monooxygenase activity [GO:0047086]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]; retinal dehydrogenase activity [GO:0001758]; testosterone 17-beta-dehydrogenase (NADP+) activity [GO:0047045]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q04828}.",
0,"(gene:""CYP8B1"")",Q9UNU6,CP8B1_HUMAN,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase (EC 1.14.14.139) (7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase) (CYPVIIIB1) (Cytochrome P450 8B1) (Sterol 12-alpha-hydroxylase),CYP8B1 CYP12,Homo sapiens (Human),501,bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; positive regulation of intestinal cholesterol absorption [GO:0045797]; response to cholesterol [GO:0070723]; response to nutrient levels [GO:0031667]; sterol metabolic process [GO:0016125],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; 5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity [GO:0033779]; 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity [GO:0033778]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; sterol 12-alpha-hydroxylase activity [GO:0008397]; bile acid biosynthetic process [GO:0006699]; bile acid signaling pathway [GO:0038183]; positive regulation of intestinal cholesterol absorption [GO:0045797]; response to cholesterol [GO:0070723]; response to nutrient levels [GO:0031667]; sterol metabolic process [GO:0016125]","5beta-cholestane-3alpha,7alpha-diol 12alpha-hydroxylase activity [GO:0033779]; 7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity [GO:0033778]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxygen binding [GO:0019825]; sterol 12-alpha-hydroxylase activity [GO:0008397]",,"TRANSMEM 1..21; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:O02766}; Single-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000250|UniProtKB:O02766}; Single-pass membrane protein {ECO:0000255}.,
1,,C9JFR9,C9JFR9_HUMAN,Cytochrome P450 family 8 subfamily B member 1,CYP8B1,Homo sapiens (Human),496,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 6..25; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}.,
0,"(gene:""AKR1D1"")",P51857,AK1D1_HUMAN,Aldo-keto reductase family 1 member D1 (EC 1.3.1.3) (3-oxo-5-beta-steroid 4-dehydrogenase) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase),AKR1D1 SRD5B1,Homo sapiens (Human),326,androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586],cytosol [GO:0005829],cytosol [GO:0005829]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; Delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229]; androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; bile acid catabolic process [GO:0030573]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol catabolic process [GO:0006707]; digestion [GO:0007586],aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; Delta4-3-oxosteroid 5beta-reductase activity [GO:0047787]; ketosteroid monooxygenase activity [GO:0047086]; steroid binding [GO:0005496]; steroid dehydrogenase activity [GO:0016229],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7508385}.,
1,,C4PL35,C4PL35_HUMAN,"Aldo-keto reductase family 1, member D1 (EC 1.3.99.6)",AKR1D1,Homo sapiens (Human),169,androgen metabolic process [GO:0008209],cytosol [GO:0005829],cytosol [GO:0005829]; 3-oxo-5-beta-steroid 4-dehydrogenase activity [GO:0047568]; aldose reductase (NADPH) activity [GO:0004032]; ketosteroid monooxygenase activity [GO:0047086]; androgen metabolic process [GO:0008209],3-oxo-5-beta-steroid 4-dehydrogenase activity [GO:0047568]; aldose reductase (NADPH) activity [GO:0004032]; ketosteroid monooxygenase activity [GO:0047086],,,,
2,,C4PL36,C4PL36_HUMAN,"Aldo-keto reductase family 1, member D1 (EC 1.3.99.6)",AKR1D1,Homo sapiens (Human),179,androgen metabolic process [GO:0008209],cytosol [GO:0005829],cytosol [GO:0005829]; 3-oxo-5-beta-steroid 4-dehydrogenase activity [GO:0047568]; aldose reductase (NADPH) activity [GO:0004032]; ketosteroid monooxygenase activity [GO:0047086]; androgen metabolic process [GO:0008209],3-oxo-5-beta-steroid 4-dehydrogenase activity [GO:0047568]; aldose reductase (NADPH) activity [GO:0004032]; ketosteroid monooxygenase activity [GO:0047086],,,,
3,,C4PL37,C4PL37_HUMAN,"Aldo-keto reductase family 1, member D1 (EC 1.3.99.6)",AKR1D1,Homo sapiens (Human),16,,,3-oxo-5-beta-steroid 4-dehydrogenase activity [GO:0047568],3-oxo-5-beta-steroid 4-dehydrogenase activity [GO:0047568],,,,
4,,C9J3U1,C9J3U1_HUMAN,Aldo-keto reductase family 1 member D1,AKR1D1,Homo sapiens (Human),96,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""DHFR"")",P00374,DYR_HUMAN,Dihydrofolate reductase (EC 1.5.1.3),DHFR,Homo sapiens (Human),187,axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825]; axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:P00375}. Cytoplasm {ECO:0000250|UniProtKB:P00375}.,
1,,B0YJ76,B0YJ76_HUMAN,Dihydrofolate reductase (EC 1.5.1.3),DYR DHFR,Homo sapiens (Human),187,dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654],dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661],,,,
2,,B4DM58,B4DM58_HUMAN,Dihydrofolate reductase (EC 1.5.1.3),DHFR,Homo sapiens (Human),129,one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661]; one-carbon metabolic process [GO:0006730]; response to methotrexate [GO:0031427]; tetrahydrofolate biosynthetic process [GO:0046654],dihydrofolate reductase activity [GO:0004146]; NADP binding [GO:0050661],,,,
0,"(gene:""AKR1E2"")",Q96JD6,AKCL2_HUMAN,"1,5-anhydro-D-fructose reductase (AF reductase) (EC 1.1.1.263) (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2) (LoopADR) (Testis aldo-keto reductase) (htAKR) (Testis-specific protein) (hTSP)",AKR1E2 AKR1CL2 AKRDC1,Homo sapiens (Human),320,,cytosol [GO:0005829],"cytosol [GO:0005829]; 1,5-anhydro-D-fructose reductase activity [GO:0050571]; aldose reductase (NADPH) activity [GO:0004032]; oxidoreductase activity [GO:0016491]","1,5-anhydro-D-fructose reductase activity [GO:0050571]; aldose reductase (NADPH) activity [GO:0004032]; oxidoreductase activity [GO:0016491]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.,
1,,E9PK93,E9PK93_HUMAN,"1,5-anhydro-D-fructose reductase (EC 1.1.1.263) (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2)",AKR1E2,Homo sapiens (Human),198,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
2,,G3V1C1,G3V1C1_HUMAN,"Aldo-keto reductase family 1 member E2 (Aldo-keto reductase family 1, member C-like 2, isoform CRA_c)",AKR1E2 AKR1CL2 hCG_22604,Homo sapiens (Human),203,small molecule metabolic process [GO:0044281],,oxidoreductase activity [GO:0016491]; small molecule metabolic process [GO:0044281],oxidoreductase activity [GO:0016491],,,,
3,,H0YCI2,H0YCI2_HUMAN,Aldo-keto reductase family 1 member E2,AKR1E2,Homo sapiens (Human),56,,,,,,,,
4,,H0YDE8,H0YDE8_HUMAN,Aldo-keto reductase family 1 member E2,AKR1E2,Homo sapiens (Human),37,,,,,,,,
0,"(gene:""DHFRL1"")",Q86XF0,DYR2_HUMAN,"Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial) (EC 1.5.1.3) (Dihydrofolate reductase-like protein 1)",DHFR2 DHFRL1 DHFRP4,Homo sapiens (Human),187,dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; dihydrofolate reductase activity [GO:0004146]; folate reductase activity [GO:0033560]; mRNA binding [GO:0003729]; NADP binding [GO:0050661]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105],dihydrofolate reductase activity [GO:0004146]; folate reductase activity [GO:0033560]; mRNA binding [GO:0003729]; NADP binding [GO:0050661],,,"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:21876188}. Mitochondrion matrix {ECO:0000269|PubMed:21876188}. Mitochondrion inner membrane {ECO:0000269|PubMed:21876188}.",
0,"(gene:""AKR7A2"")",O43488,ARK72_HUMAN,Aflatoxin B1 aldehyde reductase member 2 (EC 1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase),AKR7A2 AFAR AFAR1 AKR7,Homo sapiens (Human),359,carbohydrate metabolic process [GO:0005975]; cellular aldehyde metabolic process [GO:0006081]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; electron transfer activity [GO:0009055]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]; carbohydrate metabolic process [GO:0005975]; cellular aldehyde metabolic process [GO:0006081]; daunorubicin metabolic process [GO:0044597]; doxorubicin metabolic process [GO:0044598]; lipid metabolic process [GO:0006629]","aldo-keto reductase (NADPH) activity [GO:0004033]; aldose reductase (NADPH) activity [GO:0004032]; electron transfer activity [GO:0009055]; phenanthrene-9,10-epoxide hydrolase activity [GO:0019119]",,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000255}. Golgi apparatus {ECO:0000250|UniProtKB:Q8CG45}. Cytoplasm {ECO:0000269|PubMed:9576847}.,
1,,H3BLU7,H3BLU7_HUMAN,Aldo-keto reductase family 7 member A2,AKR7A2,Homo sapiens (Human),314,,,,,,,,
2,,H7C4Q7,H7C4Q7_HUMAN,Aldo-keto reductase family 7 member A2,AKR7A2,Homo sapiens (Human),55,,,,,,,,
3,,H7C5H7,H7C5H7_HUMAN,Aldo-keto reductase family 7 member A2,AKR7A2,Homo sapiens (Human),205,,cytosol [GO:0005829]; Golgi apparatus [GO:0005794],cytosol [GO:0005829]; Golgi apparatus [GO:0005794],,,,,
4,,V9HWA2,V9HWA2_HUMAN,"Aldo-keto reductase family 7, member A2 (Aflatoxin aldehyde reductase) (Epididymis secretory sperm binding protein Li 166mP)",HEL-S-166mP AKR7A2 hCG_40469,Homo sapiens (Human),359,,cytosol [GO:0005829]; Golgi apparatus [GO:0005794],cytosol [GO:0005829]; Golgi apparatus [GO:0005794],,,,,
0,"(gene:""EPHX1"")",P07099,HYEP_HUMAN,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) (mEH),EPHX1 EPHX EPOX,Homo sapiens (Human),455,arachidonic acid metabolic process [GO:0019369]; catabolic process [GO:0009056]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142]; arachidonic acid metabolic process [GO:0019369]; catabolic process [GO:0009056]; epoxide metabolic process [GO:0097176]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],cis-stilbene-oxide hydrolase activity [GO:0033961]; epoxide hydrolase activity [GO:0004301]; oxysterol binding [GO:0008142],"TOPO_DOM 22..455; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:P07687""","TRANSMEM 1..21; /note=""Helical; Signal-anchor for type III membrane protein""; /evidence=""ECO:0000250|UniProtKB:P07687""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:24958911}; Single-pass type III membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P07687}; Single-pass type III membrane protein {ECO:0000250|UniProtKB:P07687}.,
1,,Q6FGZ3,Q6FGZ3_HUMAN,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase),EPHX1,Homo sapiens (Human),455,arachidonic acid metabolic process [GO:0019369]; catabolic process [GO:0009056]; epoxide metabolic process [GO:0097176]; response to toxic substance [GO:0009636],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; cis-stilbene-oxide hydrolase activity [GO:0033961]; arachidonic acid metabolic process [GO:0019369]; catabolic process [GO:0009056]; epoxide metabolic process [GO:0097176]; response to toxic substance [GO:0009636],cis-stilbene-oxide hydrolase activity [GO:0033961],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004643}; Single-pass type III membrane protein {ECO:0000256|ARBA:ARBA00004643}. Membrane {ECO:0000256|ARBA:ARBA00004183}; Single-pass type III membrane protein {ECO:0000256|ARBA:ARBA00004183}. Microsome membrane {ECO:0000256|ARBA:ARBA00004390}; Single-pass type III membrane protein {ECO:0000256|ARBA:ARBA00004390}.,
2,,R4SBI6,R4SBI6_HUMAN,Epoxide hydrolase (EC 3.3.2.9),EPHX1 hCG_2039431,Homo sapiens (Human),455,catabolic process [GO:0009056]; lipid metabolic process [GO:0006629]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; cis-stilbene-oxide hydrolase activity [GO:0033961]; oxysterol binding [GO:0008142]; catabolic process [GO:0009056]; lipid metabolic process [GO:0006629]; response to organic cyclic compound [GO:0014070]; response to toxic substance [GO:0009636],cis-stilbene-oxide hydrolase activity [GO:0033961]; oxysterol binding [GO:0008142],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004643}; Single-pass type III membrane protein {ECO:0000256|ARBA:ARBA00004643}. Membrane {ECO:0000256|ARBA:ARBA00004183}; Single-pass type III membrane protein {ECO:0000256|ARBA:ARBA00004183}. Microsome membrane {ECO:0000256|ARBA:ARBA00004390}; Single-pass type III membrane protein {ECO:0000256|ARBA:ARBA00004390}.,
3,,A0A0S2Z3T1,A0A0S2Z3T1_HUMAN,Epoxide hydrolase 1 microsomal isoform 2,EPHX1,Homo sapiens (Human),60,,,hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,,,
4,,B1AQP8,B1AQP8_HUMAN,Epoxide hydrolase 1,EPHX1,Homo sapiens (Human),136,catabolic process [GO:0009056],,hydrolase activity [GO:0016787]; catabolic process [GO:0009056],hydrolase activity [GO:0016787],,,,
0,"(gene:""AKR7A3"")",O95154,ARK73_HUMAN,Aflatoxin B1 aldehyde reductase member 3 (EC 1.-.-.-) (AFB1 aldehyde reductase 2) (AFB1-AR 2),AKR7A3 AFAR2,Homo sapiens (Human),331,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; aldo-keto reductase (NADPH) activity [GO:0004033]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; cellular aldehyde metabolic process [GO:0006081],aldo-keto reductase (NADPH) activity [GO:0004033]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm.,
0,"(gene:""EPHX2"")",P34913,HYES_HUMAN,Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)],EPHX2,Homo sapiens (Human),555,cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; 10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643]; cholesterol homeostasis [GO:0042632]; dephosphorylation [GO:0016311]; epoxide metabolic process [GO:0097176]; phospholipid dephosphorylation [GO:0046839]; positive regulation of gene expression [GO:0010628]; regulation of cholesterol metabolic process [GO:0090181]; response to toxic substance [GO:0009636]; stilbene catabolic process [GO:0046272],10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity [GO:0033885]; epoxide hydrolase activity [GO:0004301]; lipid phosphatase activity [GO:0042577]; lysophosphatidic acid phosphatase activity [GO:0052642]; magnesium ion binding [GO:0000287]; phosphatase activity [GO:0016791]; protein homodimerization activity [GO:0042803]; toxic substance binding [GO:0015643],,,SUBCELLULAR LOCATION: Cytoplasm. Peroxisome.,
1,,E5RFH6,E5RFH6_HUMAN,Epoxide hydrolase 2,EPHX2,Homo sapiens (Human),372,,cytosol [GO:0005829],cytosol [GO:0005829]; epoxide hydrolase activity [GO:0004301],epoxide hydrolase activity [GO:0004301],,,,
2,,E5RFU2,E5RFU2_HUMAN,Epoxide hydrolase 2,EPHX2,Homo sapiens (Human),523,,cytosol [GO:0005829],cytosol [GO:0005829]; epoxide hydrolase activity [GO:0004301],epoxide hydrolase activity [GO:0004301],,,,
3,,E5RI53,E5RI53_HUMAN,Epoxide hydrolase 2,EPHX2,Homo sapiens (Human),158,,,,,,,,
4,,H0YAW7,H0YAW7_HUMAN,Epoxide hydrolase 2,EPHX2,Homo sapiens (Human),312,,,,,,,,
0,"(gene:""ALDH16A1"")",Q8IZ83,A16A1_HUMAN,Aldehyde dehydrogenase family 16 member A1,ALDH16A1,Homo sapiens (Human),802,,membrane [GO:0016020],"membrane [GO:0016020]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
1,,F5H4B6,F5H4B6_HUMAN,Aldehyde dehydrogenase 16 family member A1,ALDH16A1,Homo sapiens (Human),639,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
2,,M0QY06,M0QY06_HUMAN,Aldehyde dehydrogenase 16 family member A1,ALDH16A1,Homo sapiens (Human),163,,,,,,,,
3,,M0QYY1,M0QYY1_HUMAN,Aldehyde dehydrogenase 16 family member A1,ALDH16A1,Homo sapiens (Human),103,,,,,,,,
0,"(gene:""EPHX3"")",Q9H6B9,EPHX3_HUMAN,Epoxide hydrolase 3 (EH3) (EC 3.3.2.10) (Abhydrolase domain-containing protein 9),EPHX3 ABHD9,Homo sapiens (Human),360,epoxide metabolic process [GO:0097176]; lipid metabolic process [GO:0006629],endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787]; epoxide metabolic process [GO:0097176]; lipid metabolic process [GO:0006629],epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787],,"TRANSMEM 22..42; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000305|PubMed:22798687}; Single-pass membrane protein {ECO:0000255}.,
1,,M0QX48,M0QX48_HUMAN,Epoxide hydrolase 3,EPHX3,Homo sapiens (Human),125,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 26..49; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""ALDH1A1"")",P00352,AL1A1_HUMAN,"Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.3) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1) (RALDH 1) (RalDH1)",ALDH1A1 ALDC ALDH1 PUMB1,Homo sapiens (Human),501,cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; synapse [GO:0045202]; 3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758]; cellular aldehyde metabolic process [GO:0006081]; cellular detoxification of aldehyde [GO:0110095]; fructosamine catabolic process [GO:0030392]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; maintenance of lens transparency [GO:0036438]; negative regulation of cold-induced thermogenesis [GO:0120163]; retinoid metabolic process [GO:0001523]; retinol metabolic process [GO:0042572],3-deoxyglucosone dehydrogenase activity [GO:0106373]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; androgen binding [GO:0005497]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; GTPase activator activity [GO:0005096]; NAD binding [GO:0051287]; retinal dehydrogenase activity [GO:0001758],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12941160}. Cell projection, axon {ECO:0000250|UniProtKB:P24549}.",
1,,Q5SYQ7,Q5SYQ7_HUMAN,"Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1)",ALDH1A1,Homo sapiens (Human),203,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
2,,Q5SYQ8,Q5SYQ8_HUMAN,"Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1)",ALDH1A1,Homo sapiens (Human),238,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
3,,Q5SYQ9,Q5SYQ9_HUMAN,"Aldehyde dehydrogenase 1A1 (EC 1.2.1.19) (EC 1.2.1.28) (EC 1.2.1.36) (3-deoxyglucosone dehydrogenase) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic) (Retinal dehydrogenase 1)",ALDH1A1,Homo sapiens (Human),230,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""EPHX4"")",Q8IUS5,EPHX4_HUMAN,Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein),EPHX4 ABHD7 EH4 EPHXRP,Homo sapiens (Human),362,,membrane [GO:0016020],membrane [GO:0016020]; epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787],epoxide hydrolase activity [GO:0004301]; hydrolase activity [GO:0016787],,"TRANSMEM 17..37; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.,
0,"(gene:""ALDH1A2"")",O94788,AL1A2_HUMAN,Retinal dehydrogenase 2 (RALDH 2) (RalDH2) (EC 1.2.1.36) (Aldehyde dehydrogenase family 1 member A2) (ALDH1A2) (Retinaldehyde-specific dehydrogenase type 2) (RALDH(II)),ALDH1A2 RALDH2,Homo sapiens (Human),518,9-cis-retinoic acid biosynthetic process [GO:0042904]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cardiac muscle tissue development [GO:0048738]; cell population proliferation [GO:0008283]; cellular response to retinoic acid [GO:0071300]; determination of bilateral symmetry [GO:0009855]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic forelimb morphogenesis [GO:0035115]; face development [GO:0060324]; heart morphogenesis [GO:0003007]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; neural crest cell development [GO:0014032]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; retinol metabolic process [GO:0042572]; ureter maturation [GO:0035799]; vitamin A metabolic process [GO:0006776],cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471],cytoplasm [GO:0005737]; cytosol [GO:0005829]; perinuclear region of cytoplasm [GO:0048471]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; retinal binding [GO:0016918]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cardiac muscle tissue development [GO:0048738]; cell population proliferation [GO:0008283]; cellular response to retinoic acid [GO:0071300]; determination of bilateral symmetry [GO:0009855]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract development [GO:0048566]; embryonic forelimb morphogenesis [GO:0035115]; face development [GO:0060324]; heart morphogenesis [GO:0003007]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; liver development [GO:0001889]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of cell population proliferation [GO:0008285]; neural crest cell development [GO:0014032]; neural tube development [GO:0021915]; neuron differentiation [GO:0030182]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; protein homotetramerization [GO:0051289]; proximal/distal pattern formation [GO:0009954]; regulation of vascular endothelial cell proliferation [GO:1905562]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; retinol metabolic process [GO:0042572]; ureter maturation [GO:0035799]; vitamin A metabolic process [GO:0006776],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; retinal binding [GO:0016918]; retinal dehydrogenase activity [GO:0001758],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,H0YMG7,H0YMG7_HUMAN,Retinal dehydrogenase 2 (EC 1.2.1.36) (Aldehyde dehydrogenase family 1 member A2) (Retinaldehyde-specific dehydrogenase type 2),ALDH1A2,Homo sapiens (Human),489,,cytoplasm [GO:0005737],"cytoplasm [GO:0005737]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,A0A0G2JL97,A0A0G2JL97_HUMAN,Aldehyde dehydrogenase 1 family member A2,ALDH1A2,Homo sapiens (Human),9,,,,,,,,
3,,E9PF31,E9PF31_HUMAN,Aldehyde dehydrogenase 1 family member A2,ALDH1A2,Homo sapiens (Human),40,,,,,,,,
4,,H0YKL3,H0YKL3_HUMAN,Aldehyde dehydrogenase 1 family member A2,ALDH1A2,Homo sapiens (Human),85,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
5,,H0YMT5,H0YMT5_HUMAN,Aldehyde dehydrogenase 1 family member A2,ALDH1A2,Homo sapiens (Human),24,,,,,,,,
6,,Q9UED3,Q9UED3_HUMAN,Aldehyde dehydrogenase 1 family member A2 (RALDH2-T),ALDH1A2 RALDH2,Homo sapiens (Human),25,,,,,,,,
0,"(gene:""ESD"")",P10768,ESTD_HUMAN,S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56),ESD,Homo sapiens (Human),282,formaldehyde catabolic process [GO:0046294],cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062],"cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294]","carboxylic ester hydrolase activity [GO:0052689]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; S-formylglutathione hydrolase activity [GO:0018738]",,,SUBCELLULAR LOCATION: Cytoplasm. Cytoplasmic vesicle.,
1,,A0A140VJJ2,A0A140VJJ2_HUMAN,S-formylglutathione hydrolase (EC 3.1.2.12),ESD hCG_29992,Homo sapiens (Human),282,formaldehyde catabolic process [GO:0046294],cytosol [GO:0005829],cytosol [GO:0005829]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738],,,SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000256|ARBA:ARBA00004541}.,
2,,H7BZT7,H7BZT7_HUMAN,S-formylglutathione hydrolase (EC 3.1.2.12),ESD,Homo sapiens (Human),230,formaldehyde catabolic process [GO:0046294],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738],,,SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000256|ARBA:ARBA00004541}.,
3,,U3KQT1,U3KQT1_HUMAN,S-formylglutathione hydrolase (EC 3.1.2.12),ESD hCG_29992,Homo sapiens (Human),262,formaldehyde catabolic process [GO:0046294],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738],,,SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000256|ARBA:ARBA00004541}.,
4,,X6RA14,X6RA14_HUMAN,S-formylglutathione hydrolase (EC 3.1.2.12),ESD,Homo sapiens (Human),253,formaldehyde catabolic process [GO:0046294],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738]; formaldehyde catabolic process [GO:0046294],carboxylic ester hydrolase activity [GO:0052689]; S-formylglutathione hydrolase activity [GO:0018738],,,SUBCELLULAR LOCATION: Cytoplasmic vesicle {ECO:0000256|ARBA:ARBA00004541}.,
0,"(gene:""ALDH1A3"")",P47895,AL1A3_HUMAN,Retinaldehyde dehydrogenase 3 (RALDH-3) (RalDH3) (EC 1.2.1.36) (Aldehyde dehydrogenase 6) (Aldehyde dehydrogenase family 1 member A3) (ALDH1A3),ALDH1A3 ALDH6,Homo sapiens (Human),512,apoptotic process [GO:0006915]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324]; apoptotic process [GO:0006915]; embryonic camera-type eye development [GO:0031076]; embryonic eye morphogenesis [GO:0048048]; face development [GO:0060324]; Harderian gland development [GO:0070384]; inner ear morphogenesis [GO:0042472]; locomotory behavior [GO:0007626]; neuromuscular process controlling balance [GO:0050885]; nucleus accumbens development [GO:0021768]; olfactory pit development [GO:0060166]; optic cup morphogenesis involved in camera-type eye development [GO:0002072]; positive regulation of apoptotic process [GO:0043065]; protein homotetramerization [GO:0051289]; retinal metabolic process [GO:0042574]; retinoic acid biosynthetic process [GO:0002138]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; righting reflex [GO:0060013],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; NAD+ binding [GO:0070403]; protein homodimerization activity [GO:0042803]; retinal dehydrogenase activity [GO:0001758]; thyroid hormone binding [GO:0070324],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9JHW9}.,
1,,H0Y2X5,H0Y2X5_HUMAN,"Aldehyde dehydrogenase 1 family member A3 (Aldehyde dehydrogenase 1 family, member A3, isoform CRA_b)",ALDH1A3 hCG_28035,Homo sapiens (Human),405,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
2,,H0YKF9,H0YKF9_HUMAN,Aldehyde dehydrogenase 1 family member A3,ALDH1A3,Homo sapiens (Human),144,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
3,,H0YLT1,H0YLT1_HUMAN,Aldehyde dehydrogenase 1 family member A3,ALDH1A3,Homo sapiens (Human),102,,,,,,,,
4,,H0YNQ3,H0YNQ3_HUMAN,Aldehyde dehydrogenase 1 family member A3,ALDH1A3,Homo sapiens (Human),141,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""FMO1"")",Q01740,FMO1_HUMAN,Flavin-containing monooxygenase 1 (EC 1.14.13.148) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 1) (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1) (FMO 1) (Trimethylamine monooxygenase),FMO1,Homo sapiens (Human),532,energy homeostasis [GO:0097009]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; sulfur amino acid catabolic process [GO:0000098]; taurine biosynthetic process [GO:0042412]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]; energy homeostasis [GO:0097009]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; response to lipopolysaccharide [GO:0032496]; sulfur amino acid catabolic process [GO:0000098]; taurine biosynthetic process [GO:0042412]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]","TOPO_DOM 2..510; /note=""Lumenal""; /evidence=""ECO:0000250|UniProtKB:P16549""; TOPO_DOM 532; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:P16549""","TRANSMEM 511..531; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P36365}; Single-pass membrane protein {ECO:0000255}.,
1,,A0A1W2PNR8,A0A1W2PNR8_HUMAN,Flavin-containing monooxygenase (EC 1.-.-.-),FMO1,Homo sapiens (Human),126,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,,
2,,L8E7C3,L8E7C3_HUMAN,Alternative protein FMO1,FMO1,Homo sapiens (Human),66,,,,,,,,
0,"(gene:""ALDH1B1"")",P30837,AL1B1_HUMAN,"Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)",ALDH1B1 ALDH5 ALDHX,Homo sapiens (Human),517,carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287],,,SUBCELLULAR LOCATION: Mitochondrion matrix.,
1,,A0A0U1RQK9,A0A0U1RQK9_HUMAN,"Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase family 1 member B1)",ALDH1B1,Homo sapiens (Human),130,,cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""FMO2"")",P31512,FMO4_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 4 (EC 1.14.13.8) (Dimethylaniline oxidase 4) (Hepatic flavin-containing monooxygenase 4) (FMO 4),FMO4 FMO2,Homo sapiens (Human),558,energy homeostasis [GO:0097009]; negative regulation of fatty acid oxidation [GO:0046322]; xenobiotic catabolic process [GO:0042178],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; negative regulation of fatty acid oxidation [GO:0046322]; xenobiotic catabolic process [GO:0042178]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,"TRANSMEM 517..537; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:Q8K4B7}; Single-pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q8K4B7}; Single-pass membrane protein {ECO:0000255}.,
1,,Q99518,FMO2_HUMAN,Flavin-containing monooxygenase 2 (EC 1.14.13.-) (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2) (FMO 2),FMO2,Homo sapiens (Human),535,energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; NADP metabolic process [GO:0006739]; NADPH oxidation [GO:0070995]; negative regulation of fatty acid oxidation [GO:0046322]; organic acid metabolic process [GO:0006082]; oxygen metabolic process [GO:0072592]; toxin metabolic process [GO:0009404]; xenobiotic metabolic process [GO:0006805]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,"TRANSMEM 510..530; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:P17635}; Single-pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P17635}; Single-pass membrane protein {ECO:0000255}.,
2,,A0A0D9SFZ0,A0A0D9SFZ0_HUMAN,Dimethylaniline oxidase 2 (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2),FMO2,Homo sapiens (Human),153,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}. Microsome membrane {ECO:0000256|ARBA:ARBA00004111}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004111}.,
3,,A0A0D9SG76,A0A0D9SG76_HUMAN,Dimethylaniline oxidase 2 (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2),FMO2,Homo sapiens (Human),131,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}. Microsome membrane {ECO:0000256|ARBA:ARBA00004111}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004111}.,
0,"(gene:""ALDH1L1"")",O75891,AL1L1_HUMAN,Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),ALDH1L1 FTHFD,Homo sapiens (Human),902,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000305|PubMed:19933275}.",
1,,A0A0S2Z527,A0A0S2Z527_HUMAN,Cytosolic 10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),ALDH1L1,Homo sapiens (Human),555,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],cytosol [GO:0005829]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000256|ARBA:ARBA00004514}.",
2,,A0A0S2Z586,A0A0S2Z586_HUMAN,formyltetrahydrofolate dehydrogenase (EC 1.5.1.6),ALDH1L1,Homo sapiens (Human),505,10-formyltetrahydrofolate catabolic process [GO:0009258]; one-carbon metabolic process [GO:0006730],cytosol [GO:0005829],cytosol [GO:0005829]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; methionyl-tRNA formyltransferase activity [GO:0004479]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; one-carbon metabolic process [GO:0006730],formyltetrahydrofolate dehydrogenase activity [GO:0016155]; methionyl-tRNA formyltransferase activity [GO:0004479],,,,
3,,C9IZ36,C9IZ36_HUMAN,Aldehyde dehydrogenase 1 family member L1,ALDH1L1,Homo sapiens (Human),177,biosynthetic process [GO:0009058]; small molecule metabolic process [GO:0044281],,biosynthetic process [GO:0009058]; small molecule metabolic process [GO:0044281],,,,,
4,,C9JY00,C9JY00_HUMAN,Aldehyde dehydrogenase 1 family member L1,ALDH1L1,Homo sapiens (Human),157,biosynthetic process [GO:0009058]; small molecule metabolic process [GO:0044281],,biosynthetic process [GO:0009058]; small molecule metabolic process [GO:0044281],,,,,
5,,C9JYZ6,C9JYZ6_HUMAN,Aldehyde dehydrogenase 1 family member L1,ALDH1L1,Homo sapiens (Human),168,biosynthetic process [GO:0009058]; small molecule metabolic process [GO:0044281],,biosynthetic process [GO:0009058]; small molecule metabolic process [GO:0044281],,,,,
6,,D6RFJ7,D6RFJ7_HUMAN,Aldehyde dehydrogenase 1 family member L1,ALDH1L1,Homo sapiens (Human),100,biosynthetic process [GO:0009058],,biosynthetic process [GO:0009058],,,,,
7,,F2Z324,F2Z324_HUMAN,Aldehyde dehydrogenase 1 family member L1,ALDH1L1,Homo sapiens (Human),47,,,,,,,,
8,,F8WC34,F8WC34_HUMAN,Aldehyde dehydrogenase 1 family member L1,ALDH1L1,Homo sapiens (Human),81,,,,,,,,
0,"(gene:""FMO3"")",P31513,FMO3_HUMAN,Flavin-containing monooxygenase 3 (EC 1.14.13.148) (EC 1.14.13.32) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 3) (Dimethylaniline oxidase 3) (FMO II) (FMO form 2) (Hepatic flavin-containing monooxygenase 3) (FMO 3) (Trimethylamine monooxygenase),FMO3,Homo sapiens (Human),532,taurine biosynthetic process [GO:0042412],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; albendazole monooxygenase activity [GO:0047638]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]; taurine biosynthetic process [GO:0042412]","albendazole monooxygenase activity [GO:0047638]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; trimethylamine monooxygenase activity [GO:0034899]",,"TRANSMEM 510..530; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:P32417}; Single-pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P32417}; Single-pass membrane protein {ECO:0000255}.,
1,,A0A024R8Z4,A0A024R8Z4_HUMAN,Flavin-containing monooxygenase 3 (EC 1.14.13.148) (EC 1.14.13.32) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 3) (Trimethylamine monooxygenase),FMO3,Homo sapiens (Human),532,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}. Microsome membrane {ECO:0000256|ARBA:ARBA00004111}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004111}.,
2,,V9GZ60,V9GZ60_HUMAN,Flavin-containing monooxygenase 3 (EC 1.14.13.148) (EC 1.14.13.32) (EC 1.14.13.8) (Dimethylaniline monooxygenase [N-oxide-forming] 3) (Trimethylamine monooxygenase),FMO3,Homo sapiens (Human),218,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}. Microsome membrane {ECO:0000256|ARBA:ARBA00004111}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004111}.,
3,,A0A0S2Z3R0,A0A0S2Z3R0_HUMAN,Flavin-containing monooxygenase (EC 1.-.-.-),FMO3,Homo sapiens (Human),56,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,,
4,,V9GYP3,V9GYP3_HUMAN,Flavin-containing monooxygenase (EC 1.-.-.-),FMO3,Homo sapiens (Human),48,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,,
0,"(gene:""ALDH1L2"")",Q3SY69,AL1L2_HUMAN,Mitochondrial 10-formyltetrahydrofolate dehydrogenase (Mitochondrial 10-FTHFDH) (mtFDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L2),ALDH1L2,Homo sapiens (Human),923,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; fatty acid beta-oxidation [GO:0006635]; folic acid metabolic process [GO:0046655]; NADPH regeneration [GO:0006740]; one-carbon metabolic process [GO:0006730],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; formyltetrahydrofolate dehydrogenase activity [GO:0016155],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:20498374}.,
1,,A0A494C1M4,A0A494C1M4_HUMAN,10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6),ALDH1L2,Homo sapiens (Human),932,10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730],mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; formyltetrahydrofolate dehydrogenase activity [GO:0016155]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; 10-formyltetrahydrofolate catabolic process [GO:0009258]; biosynthetic process [GO:0009058]; one-carbon metabolic process [GO:0006730]","formyltetrahydrofolate dehydrogenase activity [GO:0016155]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
2,,H0YHN9,H0YHN9_HUMAN,Aldehyde dehydrogenase 1 family member L2,ALDH1L2,Homo sapiens (Human),92,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
0,"(gene:""FMO4"")",P31512,FMO4_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 4 (EC 1.14.13.8) (Dimethylaniline oxidase 4) (Hepatic flavin-containing monooxygenase 4) (FMO 4),FMO4 FMO2,Homo sapiens (Human),558,energy homeostasis [GO:0097009]; negative regulation of fatty acid oxidation [GO:0046322]; xenobiotic catabolic process [GO:0042178],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; energy homeostasis [GO:0097009]; negative regulation of fatty acid oxidation [GO:0046322]; xenobiotic catabolic process [GO:0042178]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,"TRANSMEM 517..537; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000250|UniProtKB:Q8K4B7}; Single-pass membrane protein {ECO:0000255}. Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q8K4B7}; Single-pass membrane protein {ECO:0000255}.,
0,"(gene:""ALDH2"")",P05091,ALDH2_HUMAN,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)",ALDH2 ALDM,Homo sapiens (Human),517,alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylesterase activity [GO:0106435]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; carbohydrate metabolic process [GO:0005975]; ethanol catabolic process [GO:0006068]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; carboxylesterase activity [GO:0106435]; electron transfer activity [GO:0009055]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; NAD binding [GO:0051287]; nitroglycerin reductase activity [GO:0018547]; phenylacetaldehyde dehydrogenase activity [GO:0008957],,,SUBCELLULAR LOCATION: Mitochondrion matrix.,
1,,A0A384NPN7,A0A384NPN7_HUMAN,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)",ALDH2 hCG_2039620,Homo sapiens (Human),517,regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],mitochondrial matrix [GO:0005759],mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; regulation of dopamine biosynthetic process [GO:1903179]; regulation of serotonin biosynthetic process [GO:1905627],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000256|ARBA:ARBA00004305}.,
2,,B4YAH7,B4YAH7_HUMAN,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)",ALDH2,Homo sapiens (Human),247,,mitochondrial matrix [GO:0005759],mitochondrial matrix [GO:0005759]; aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000256|ARBA:ARBA00004305}.,
3,,S4R3S4,S4R3S4_HUMAN,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2)",ALDH2,Homo sapiens (Human),117,,mitochondrial matrix [GO:0005759],"mitochondrial matrix [GO:0005759]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000256|ARBA:ARBA00004305}.,
4,,B0LUF9,B0LUF9_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH2,Homo sapiens (Human),35,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
5,,B0LUG0,B0LUG0_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH2,Homo sapiens (Human),35,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
6,,B0LUG2,B0LUG2_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH2,Homo sapiens (Human),35,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
7,,F8VSB0,F8VSB0_HUMAN,Aldehyde dehydrogenase 2 family member,ALDH2,Homo sapiens (Human),79,,,,,,,,
8,,Q9UN17,Q9UN17_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH2,Homo sapiens (Human),38,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
0,"(gene:""FMO5"")",P49326,FMO5_HUMAN,Flavin-containing monooxygenase 5 (FMO 5) (Baeyer-Villiger monooxygenase 1) (hBVMO1) (EC 1.14.13.-) (Dimethylaniline monooxygenase [N-oxide-forming] 5) (EC 1.14.13.8) (Dimethylaniline oxidase 5) (NADPH oxidase) (EC 1.6.3.1),FMO5,Homo sapiens (Human),533,lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; lipid metabolic process [GO:0006629]; NADPH oxidation [GO:0070995]; regulation of cholesterol metabolic process [GO:0090181]; xenobiotic metabolic process [GO:0006805]","aldehyde oxidase activity [GO:0004031]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; monooxygenase activity [GO:0004497]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]",,"TRANSMEM 513..533; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000305|PubMed:20947616}. Endoplasmic reticulum membrane.,
1,,E9PJF3,E9PJF3_HUMAN,Flavin-containing monooxygenase (EC 1.-.-.-),FMO5,Homo sapiens (Human),278,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]; lipid metabolic process [GO:0006629]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; NADPH oxidase H202-forming activity [GO:0106294]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
2,,Q9HA79,Q9HA79_HUMAN,Flavin-containing monooxygenase (EC 1.-.-.-),FMO5 hCG_1981889,Homo sapiens (Human),286,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661]; lipid metabolic process [GO:0006629]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NAD(P)H oxidase H2O2-forming activity [GO:0016174]; NADP binding [GO:0050661]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
3,,E9PP51,E9PP51_HUMAN,Flavin containing dimethylaniline monoxygenase 5,FMO5,Homo sapiens (Human),192,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,,
4,,E9PQ84,E9PQ84_HUMAN,Flavin containing dimethylaniline monoxygenase 5,FMO5,Homo sapiens (Human),145,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]","flavin adenine dinucleotide binding [GO:0050660]; hypotaurine dehydrogenase activity [GO:0047822]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]",,,,
0,"(gene:""ALDH3A1"")",P30838,AL3A1_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (ALDHIII) (Aldehyde dehydrogenase 3) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1 ALDH3,Homo sapiens (Human),453,cellular aldehyde metabolic process [GO:0006081]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; cellular aldehyde metabolic process [GO:0006081]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; alcohol dehydrogenase (NADP+) activity [GO:0008106]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P47739}.,
1,,A8MYB8,A8MYB8_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),389,cellular aldehyde metabolic process [GO:0006081],cytosol [GO:0005829]; plasma membrane [GO:0005886],"cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,C9JKT2,C9JKT2_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),259,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],"cytoplasm [GO:0005737]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
3,,C9JMC5,C9JMC5_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),372,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],"cytoplasm [GO:0005737]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
4,,E9PNN6,E9PNN6_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),396,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],"cytoplasm [GO:0005737]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
5,,I3L3I9,I3L3I9_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),380,cellular aldehyde metabolic process [GO:0006081],cytosol [GO:0005829]; plasma membrane [GO:0005886],"cytosol [GO:0005829]; plasma membrane [GO:0005886]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
6,,Q6PKA6,Q6PKA6_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),512,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],"cytoplasm [GO:0005737]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
7,,I3L1H6,I3L1H6_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),131,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
8,,I3L3W9,I3L3W9_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),74,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
9,,I3L4E5,I3L4E5_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (Aldehyde dehydrogenase family 3 member A1)",ALDH3A1,Homo sapiens (Human),119,cellular aldehyde metabolic process [GO:0006081],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
0,"(gene:""GGT1"")",P19440,GGT1_HUMAN,Glutathione hydrolase 1 proenzyme (EC 3.4.19.13) (Gamma-glutamyltransferase 1) (Gamma-glutamyltranspeptidase 1) (GGT 1) (EC 2.3.2.2) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Glutathione hydrolase 1 heavy chain; Glutathione hydrolase 1 light chain],GGT1 GGT,Homo sapiens (Human),569,amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; amino acid metabolic process [GO:0006520]; cysteine biosynthetic process [GO:0019344]; fatty acid metabolic process [GO:0006631]; glutamate metabolic process [GO:0006536]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; leukotriene metabolic process [GO:0006691]; peptide modification [GO:0031179]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; spermatogenesis [GO:0007283]; zymogen activation [GO:0031638],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],"TOPO_DOM 1..4; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:P07314""; TOPO_DOM 27..569; /note=""Extracellular""; /evidence=""ECO:0000250|UniProtKB:P07314""","TRANSMEM 5..26; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000250|UniProtKB:P07314""","SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23682772, ECO:0000269|PubMed:8095045}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:P07314}.",
1,,A2VCM7,A2VCM7_HUMAN,GGT1 protein,GGT1,Homo sapiens (Human),234,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
2,,B5MC34,B5MC34_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),252,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
3,,B5MC36,B5MC36_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),218,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
4,,C9JGF3,C9JGF3_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),30,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 7..27; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,C9JIY6,C9JIY6_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),37,,,,,,,,
6,,E7EM62,E7EM62_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),126,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
7,,E7ENJ5,E7ENJ5_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),120,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
8,,E7ERN9,E7ERN9_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),80,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
9,,E7ESL5,E7ESL5_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),108,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
10,,E7ET76,E7ET76_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),463,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
11,,E7ETJ6,E7ETJ6_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),127,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
12,,E7ETN1,E7ETN1_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),97,glutathione catabolic process [GO:0006751],membrane [GO:0016020],membrane [GO:0016020]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,"TRANSMEM 68..94; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
13,,E7ETR7,E7ETR7_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),174,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
14,,E7ETU4,E7ETU4_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),111,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
15,,E7EVF8,E7EVF8_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),116,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
16,,E9PHP2,E9PHP2_HUMAN,Gamma-glutamyltransferase 1,GGT1,Homo sapiens (Human),67,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
17,,O75693,O75693_HUMAN,Gamma-glutamyltransferase (EC 2.3.2.2),GGT1,Homo sapiens (Human),53,,,leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],,,,
18,,Q6ISU8,Q6ISU8_HUMAN,GGT1 protein,GGT1,Homo sapiens (Human),225,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
19,,Q6NZY2,Q6NZY2_HUMAN,GGT1 protein,GGT1,Homo sapiens (Human),239,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
0,"(gene:""ALDH3A2"")",P51648,AL3A2_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Aldehyde dehydrogenase 10) (Fatty aldehyde dehydrogenase) (Microsomal aldehyde dehydrogenase),ALDH3A2 ALDH10 FALDH,Homo sapiens (Human),485,cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803]; cellular aldehyde metabolic process [GO:0006081]; central nervous system development [GO:0007417]; epidermis development [GO:0008544]; fatty acid metabolic process [GO:0006631]; hexadecanal metabolic process [GO:0046458]; peripheral nervous system development [GO:0007422]; phytol metabolic process [GO:0033306]; sesquiterpenoid metabolic process [GO:0006714],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; long-chain-alcohol oxidase activity [GO:0046577]; long-chain-aldehyde dehydrogenase activity [GO:0050061]; medium-chain-aldehyde dehydrogenase activity [GO:0052814]; protein homodimerization activity [GO:0042803],"TOPO_DOM 1..463; /note=""Cytoplasmic""","TRANSMEM 464..484; /note=""Helical""; /evidence=""ECO:0000255""","SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:9133646}; Single-pass membrane protein {ECO:0000305|PubMed:25047030, ECO:0000305|PubMed:9133646}. Endoplasmic reticulum membrane {ECO:0000305|PubMed:9133646}; Single-pass membrane protein {ECO:0000305|PubMed:25047030, ECO:0000305|PubMed:9133646}; Cytoplasmic side {ECO:0000250|UniProtKB:P30839}.",
1,,A0A0D9SGC3,A0A0D9SGC3_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),97,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
2,,A0A5F9ZGX4,A0A5F9ZGX4_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),460,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,"TRANSMEM 416..432; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
3,,A0A5F9ZHI5,A0A5F9ZHI5_HUMAN,Aldehyde dehydrogenase,ALDH3A2,Homo sapiens (Human),403,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
4,,A0A5F9ZHN9,A0A5F9ZHN9_HUMAN,Aldehyde dehydrogenase,ALDH3A2,Homo sapiens (Human),521,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
5,,A0A5F9ZHP6,A0A5F9ZHP6_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),195,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,"TRANSMEM 151..167; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
6,,A0A5F9ZHZ9,A0A5F9ZHZ9_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),233,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
7,,A0A5F9ZI12,A0A5F9ZI12_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),393,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
8,,A0A5K1VW72,A0A5K1VW72_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),376,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,"TRANSMEM 355..373; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
9,,I3L0X1,I3L0X1_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),182,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
10,,I3L1M4,I3L1M4_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),162,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
11,,I3L2W1,I3L2W1_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),76,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
12,,J3KTG1,J3KTG1_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),146,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
13,,J3QRD1,J3QRD1_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),393,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
14,,J3QS00,J3QS00_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),134,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
15,,K7EN73,K7EN73_HUMAN,Aldehyde dehydrogenase family 3 member A2 (EC 1.2.1.3) (EC 1.2.1.94) (Fatty aldehyde dehydrogenase),ALDH3A2,Homo sapiens (Human),126,cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081]; fatty acid metabolic process [GO:0006631],oxidoreductase activity [GO:0016491],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004131}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004131}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004131}.,
16,,J3KTD9,J3KTD9_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH3A2,Homo sapiens (Human),85,cellular aldehyde metabolic process [GO:0006081],membrane [GO:0016020],membrane [GO:0016020]; oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,"TRANSMEM 64..82; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
17,,I3L4G6,I3L4G6_HUMAN,Aldehyde dehydrogenase 3 family member A2,ALDH3A2,Homo sapiens (Human),85,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 46..64; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
18,,J3QKK9,J3QKK9_HUMAN,Aldehyde dehydrogenase 3 family member A2,ALDH3A2,Homo sapiens (Human),54,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
19,,J3QQV9,J3QQV9_HUMAN,Aldehyde dehydrogenase 3 family member A2,ALDH3A2,Homo sapiens (Human),58,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 36..56; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""GGT5"")",P36269,GGT5_HUMAN,Glutathione hydrolase 5 proenzyme (EC 3.4.19.13) (Gamma-glutamyl transpeptidase-related enzyme) (GGT-rel) (Gamma-glutamyltransferase 5) (GGT 5) (EC 2.3.2.2) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) [Cleaved into: Glutathione hydrolase 5 heavy chain; Glutathione hydrolase 5 light chain],GGT5 GGTLA1,Homo sapiens (Human),586,amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048]; amino acid metabolic process [GO:0006520]; fatty acid metabolic process [GO:0006631]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; inflammatory response [GO:0006954]; leukotriene D4 biosynthetic process [GO:1901750]; proteolysis [GO:0006508],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; leukotriene-C(4) hydrolase [GO:0002951]; peptidyltransferase activity [GO:0000048],"TOPO_DOM 1..8; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:Q9Z2A9""; TOPO_DOM 30..586; /note=""Extracellular""; /evidence=""ECO:0000250|UniProtKB:Q9Z2A9""","TRANSMEM 9..29; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000250|UniProtKB:Q9Z2A9""",SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q9Z2A9}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q9Z2A9}.,
1,,C9JU68,C9JU68_HUMAN,Gamma-glutamyltransferase 5,GGT5,Homo sapiens (Human),73,,,,,,,,
2,,H7C1X2,H7C1X2_HUMAN,Gamma-glutamyltransferase 5,GGT5,Homo sapiens (Human),220,,,,,,,,
0,"(gene:""ALDH3B1"")",P43353,AL3B1_HUMAN,Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.28) (EC 1.2.1.5) (EC 1.2.1.7) (Aldehyde dehydrogenase 7),ALDH3B1 ALDH7,Homo sapiens (Human),468,alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid catabolic process [GO:0030149],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; vesicle [GO:0031982]; 3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477]; alcohol metabolic process [GO:0006066]; aldehyde catabolic process [GO:0046185]; cellular aldehyde metabolic process [GO:0006081]; cellular response to oxidative stress [GO:0034599]; ethanol catabolic process [GO:0006068]; lipid metabolic process [GO:0006629]; response to oxidative stress [GO:0006979]; sphingolipid catabolic process [GO:0030149],3-chloroallyl aldehyde dehydrogenase activity [GO:0004028]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aldehyde dehydrogenase [NAD(P)+] activity [GO:0004030]; benzaldehyde dehydrogenase (NAD+) activity [GO:0018479]; benzaldehyde dehydrogenase (NADP+) activity [GO:0018477],,,SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:23721920}; Lipid-anchor {ECO:0000269|PubMed:23721920}. Note=Primarily in the plasma membrane as well as in some punctate structures in the cytoplasm.,
1,,A0A087WTE0,A0A087WTE0_HUMAN,Aldehyde dehydrogenase 3 family member B1,ALDH3B1,Homo sapiens (Human),66,cellular aldehyde metabolic process [GO:0006081],,oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,,,
2,,A0A087WU54,A0A087WU54_HUMAN,Aldehyde dehydrogenase 3 family member B1,ALDH3B1,Homo sapiens (Human),71,cellular aldehyde metabolic process [GO:0006081],,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
3,,A0A087WUF8,A0A087WUF8_HUMAN,Aldehyde dehydrogenase 3 family member B1,ALDH3B1,Homo sapiens (Human),169,cellular aldehyde metabolic process [GO:0006081],,oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,,,
4,,A0A087X192,A0A087X192_HUMAN,Aldehyde dehydrogenase 3 family member B1,ALDH3B1,Homo sapiens (Human),211,cellular aldehyde metabolic process [GO:0006081],,oxidoreductase activity [GO:0016491]; cellular aldehyde metabolic process [GO:0006081],oxidoreductase activity [GO:0016491],,,,
5,,A0A087X2D4,A0A087X2D4_HUMAN,Aldehyde dehydrogenase 3 family member B1,ALDH3B1,Homo sapiens (Human),351,cellular aldehyde metabolic process [GO:0006081],,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]; cellular aldehyde metabolic process [GO:0006081]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
0,"(gene:""GGT7"")",Q9UJ14,GGT7_HUMAN,Glutathione hydrolase 7 (EC 3.4.19.13) (Gamma-glutamyltransferase 7) (GGT 7) (EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) [Cleaved into: Glutathione hydrolase 7 heavy chain; Glutathione hydrolase 7 light chain],GGT7 GGTL3 GGTL5,Homo sapiens (Human),662,glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883],glutathione hydrolase activity [GO:0036374]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068],"TOPO_DOM 1..106; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:P07314""; TOPO_DOM 128..662; /note=""Extracellular""; /evidence=""ECO:0000250|UniProtKB:P07314""","TRANSMEM 107..127; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P19440}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:P07314}.,
1,,A0PJJ9,A0PJJ9_HUMAN,Glutathione hydrolase (EC 2.3.2.2) (EC 3.4.19.13) (Gamma-glutamyltransferase) (Gamma-glutamyltranspeptidase),GGT7,Homo sapiens (Human),592,glutathione catabolic process [GO:0006751],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU368068}; Single-pass type II membrane protein {ECO:0000256|RuleBase:RU368068}.,
2,,A4FU32,A4FU32_HUMAN,Glutathione hydrolase (EC 2.3.2.2) (EC 3.4.19.13) (Gamma-glutamyltransferase) (Gamma-glutamyltranspeptidase),GGT7,Homo sapiens (Human),616,glutathione catabolic process [GO:0006751],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU368068}; Single-pass type II membrane protein {ECO:0000256|RuleBase:RU368068}.,
3,,A5D8W8,A5D8W8_HUMAN,Glutathione hydrolase (EC 2.3.2.2) (EC 3.4.19.13) (Gamma-glutamyltransferase) (Gamma-glutamyltranspeptidase),GGT7,Homo sapiens (Human),662,glutathione catabolic process [GO:0006751],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU368068}; Single-pass type II membrane protein {ECO:0000256|RuleBase:RU368068}.,
4,,A2A2G5,A2A2G5_HUMAN,Gamma-glutamyltransferase 7,GGT7,Homo sapiens (Human),202,glutathione catabolic process [GO:0006751],membrane [GO:0016020],membrane [GO:0016020]; acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374],,"TRANSMEM 124..148; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,A0A0D9SF08,A0A0D9SF08_HUMAN,Gamma-glutamyltransferase 7,GGT7,Homo sapiens (Human),88,glutathione catabolic process [GO:0006751],,acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374],,,,
6,,A0A0D9SFH0,A0A0D9SFH0_HUMAN,Gamma-glutamyltransferase 7,GGT7,Homo sapiens (Human),151,glutathione catabolic process [GO:0006751],,acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],acyltransferase activity [GO:0016746]; glutathione hydrolase activity [GO:0036374],,,,
7,,A4IF34,A4IF34_HUMAN,GGT7 protein,GGT7,Homo sapiens (Human),62,,,,,,,,
0,"(gene:""ALDH4A1"")",P30038,AL4A1_HUMAN,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)",ALDH4A1 ALDH4 P5CDH,Homo sapiens (Human),563,4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802]; 4-hydroxyproline catabolic process [GO:0019470]; proline catabolic process [GO:0006562]; proline catabolic process to glutamate [GO:0010133]; proline metabolic process [GO:0006560],1-pyrroline-5-carboxylate dehydrogenase activity [GO:0003842]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; electron transfer activity [GO:0009055]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Mitochondrion matrix.,
1,,Q5TF55,Q5TF55_HUMAN,Aldehyde dehydrogenase 4 family member A1,ALDH4A1,Homo sapiens (Human),214,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""GGTLC2"")",Q14390,GGTL2_HUMAN,Glutathione hydrolase light chain 2 (Gamma-glutamyltransferase light chain 2) (Gamma-glutamyltransferase-like protein 4),GGTLC2 GGTL4,Homo sapiens (Human),218,glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750],extracellular exosome [GO:0070062],extracellular exosome [GO:0070062]; glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750],glutathione hydrolase activity [GO:0036374],,,,
1,,A0A494C0N1,A0A494C0N1_HUMAN,Gamma-glutamyltransferase light chain 2,GGTLC2,Homo sapiens (Human),136,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
2,,A0A494C112,A0A494C112_HUMAN,Gamma-glutamyltransferase light chain 2,GGTLC2,Homo sapiens (Human),100,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
3,,A0A494C1E1,A0A494C1E1_HUMAN,Gamma-glutamyltransferase light chain 2,GGTLC2,Homo sapiens (Human),131,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
4,,A0A494C1J8,A0A494C1J8_HUMAN,Gamma-glutamyltransferase light chain 2,GGTLC2,Homo sapiens (Human),252,glutathione catabolic process [GO:0006751],,glutathione hydrolase activity [GO:0036374]; glutathione catabolic process [GO:0006751],glutathione hydrolase activity [GO:0036374],,,,
5,,A0A494C1L7,A0A494C1L7_HUMAN,Gamma-glutamyltransferase light chain 2,GGTLC2,Homo sapiens (Human),40,,,,,,,,
0,"(gene:""ALDH5A1"")",P51649,SSDH_HUMAN,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",ALDH5A1 SSADH,Homo sapiens (Human),535,"central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202],"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; synapse [GO:0045202]; identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; central nervous system development [GO:0007417]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",identical protein binding [GO:0042802]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,SUBCELLULAR LOCATION: Mitochondrion.,
1,,C9J8Q5,C9J8Q5_HUMAN,Succinate-semialdehyde dehydrogenase (EC 1.2.1.24),ALDH5A1,Homo sapiens (Human),507,gamma-aminobutyric acid catabolic process [GO:0009450],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450],succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173, ECO:0000256|RuleBase:RU365091}.",
2,,X5D299,X5D299_HUMAN,Succinate-semialdehyde dehydrogenase (EC 1.2.1.24),ALDH5A1,Homo sapiens (Human),548,gamma-aminobutyric acid catabolic process [GO:0009450],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450],succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173, ECO:0000256|RuleBase:RU365091}.",
3,,X5DQN2,X5DQN2_HUMAN,Succinate-semialdehyde dehydrogenase (EC 1.2.1.24),ALDH5A1,Homo sapiens (Human),535,"gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",mitochondrion [GO:0005739]; synapse [GO:0045202],"mitochondrion [GO:0005739]; synapse [GO:0045202]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450]; glutamate metabolic process [GO:0006536]; post-embryonic development [GO:0009791]; succinate metabolic process [GO:0006105]; synaptic transmission, GABAergic [GO:0051932]",succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173, ECO:0000256|RuleBase:RU365091}.",
4,,A0A5F9ZI23,A0A5F9ZI23_HUMAN,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",ALDH5A1,Homo sapiens (Human),408,,mitochondrion [GO:0005739],"mitochondrion [GO:0005739]; oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
5,,X5D8T4,X5D8T4_HUMAN,Succinate-semialdehyde dehydrogenase (EC 1.2.1.24),ALDH5A1,Homo sapiens (Human),535,gamma-aminobutyric acid catabolic process [GO:0009450],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450],succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173, ECO:0000256|RuleBase:RU365091}.",
6,,X5DNC0,X5DNC0_HUMAN,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",ALDH5A1,Homo sapiens (Human),516,gamma-aminobutyric acid catabolic process [GO:0009450],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450],succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
7,,A0A5F9ZH05,A0A5F9ZH05_HUMAN,Aldehyde dehydrogenase 5 family member A1,ALDH5A1,Homo sapiens (Human),99,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
8,,A0A5F9ZH98,A0A5F9ZH98_HUMAN,Aldehyde dehydrogenase 5 family member A1,ALDH5A1,Homo sapiens (Human),229,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
9,,Q8N3W7,Q8N3W7_HUMAN,Succinate semialdehyde dehydrogenase (EC 1.2.1.24),ALDH5A1,Homo sapiens (Human),222,gamma-aminobutyric acid catabolic process [GO:0009450],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777]; gamma-aminobutyric acid catabolic process [GO:0009450],succinate-semialdehyde dehydrogenase (NAD+) activity [GO:0004777],,,,
0,"(gene:""GLYAT"")",Q6IB77,GLYAT_HUMAN,Glycine N-acyltransferase (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase) (AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase) (EC 2.3.1.71) (HRP-1(CLP)),GLYAT ACGNAT CAT GAT,Homo sapiens (Human),296,acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; acyltransferase activity [GO:0016746]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962]; acyl-CoA metabolic process [GO:0006637]; benzoyl-CoA metabolic process [GO:1901787]; glycine metabolic process [GO:0006544]; monocarboxylic acid metabolic process [GO:0032787]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],acyltransferase activity [GO:0016746]; glycine N-acyltransferase activity [GO:0047961]; glycine N-benzoyltransferase activity [GO:0047962],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:22475485}.,
1,,K7ES21,K7ES21_HUMAN,Glycine-N-acyltransferase,GLYAT,Homo sapiens (Human),71,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
0,"(gene:""ALDH6A1"")",Q02252,MMSA_HUMAN,"Methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) (Malonate-semialdehyde dehydrogenase [acylating])",ALDH6A1 MMSDH,Homo sapiens (Human),535,branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity [GO:0004491]; RNA binding [GO:0003723]; branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573]","malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity [GO:0004491]; RNA binding [GO:0003723]",,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305|PubMed:23835272}.,
1,,G3V4Z4,G3V4Z4_HUMAN,methylmalonate-semialdehyde dehydrogenase (CoA acylating) (EC 1.2.1.27),ALDH6A1,Homo sapiens (Human),252,,mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity [GO:0004491]","malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity [GO:0004491]",,,,
0,"(gene:""GLYATL1"")",Q969I3,GLYL1_HUMAN,Glycine N-acyltransferase-like protein 1 (EC 2.3.1.68) (Acyl-CoA:glycine N-acyltransferase-like protein 1) (Glutamine N-acyltransferase),GLYATL1 GNAT,Homo sapiens (Human),302,glutamine metabolic process [GO:0006541],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961]; glutamine metabolic process [GO:0006541],glutamine N-acyltransferase activity [GO:0047946]; glycine N-acyltransferase activity [GO:0047961],,,,
1,,A9ZM15,A9ZM15_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GATF-C GLYATL1 hCG_1729956,Homo sapiens (Human),302,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
2,,E9PP99,E9PP99_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GLYATL1,Homo sapiens (Human),173,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
3,,E9PR27,E9PR27_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GLYATL1,Homo sapiens (Human),79,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
4,,A0A8I5KR82,A0A8I5KR82_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GLYATL1,Homo sapiens (Human),261,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
5,,A0A8I5KVG3,A0A8I5KVG3_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GLYATL1,Homo sapiens (Human),325,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
6,,E9PJV1,E9PJV1_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GLYATL1,Homo sapiens (Human),68,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
7,,E9PK55,E9PK55_HUMAN,Glycine-N-acyltransferase like 1,GLYATL1,Homo sapiens (Human),50,,,,,,,,
8,,E9PNJ8,E9PNJ8_HUMAN,Glycine-N-acyltransferase like 1,GLYATL1,Homo sapiens (Human),58,,,,,,,,
9,,E9PP95,E9PP95_HUMAN,Glycine-N-acyltransferase like 1,GLYATL1,Homo sapiens (Human),73,,,,,,,,
0,"(gene:""ALDH7A1"")",P49419,AL7A1_HUMAN,Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase),ALDH7A1 ATQ1,Homo sapiens (Human),539,cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043]; cellular aldehyde metabolic process [GO:0006081]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285]; sensory perception of sound [GO:0007605],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; betaine-aldehyde dehydrogenase activity [GO:0008802]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; identical protein binding [GO:0042802]; L-aminoadipate-semialdehyde dehydrogenase activity [GO:0004043],,,"SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm, cytosol {ECO:0000269|PubMed:20207735}. Nucleus {ECO:0000269|PubMed:20207735}.; SUBCELLULAR LOCATION: [Isoform 1]: Mitochondrion {ECO:0000269|PubMed:20207735}.",
1,,A0A1B0GTJ4,A0A1B0GTJ4_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,Homo sapiens (Human),499,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
2,,A0A1B0GUA1,A0A1B0GUA1_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,Homo sapiens (Human),521,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
3,,A0A1B0GUY0,A0A1B0GUY0_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,Homo sapiens (Human),348,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
4,,A0A1B0GV49,A0A1B0GV49_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,Homo sapiens (Human),472,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
5,,A0A1B0GW77,A0A1B0GW77_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,Homo sapiens (Human),554,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
6,,A0A1B0GW82,A0A1B0GW82_HUMAN,aldehyde dehydrogenase (NAD(+)) (EC 1.2.1.3),ALDH7A1,Homo sapiens (Human),545,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],aldehyde dehydrogenase (NAD+) activity [GO:0004029]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878],,,,
7,,A0A0J9YWF7,A0A0J9YWF7_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),294,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
8,,A0A0J9YWK1,A0A0J9YWK1_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),27,,,,,,,,
9,,A0A0J9YWM6,A0A0J9YWM6_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),41,,,,,,,,
10,,A0A1B0GTG2,A0A1B0GTG2_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),536,,cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
11,,A0A1B0GTY9,A0A1B0GTY9_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),479,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
12,,A0A1B0GVU0,A0A1B0GVU0_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),164,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
13,,A0A1B0GW65,A0A1B0GW65_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),77,,,,,,,,
14,,F8VVF2,F8VVF2_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),193,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
15,,F8WD33,F8WD33_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),97,,,,,,,,
16,,F8WDY6,F8WDY6_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),136,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
17,,H0YHM6,H0YHM6_HUMAN,Aldehyde dehydrogenase 7 family member A1,ALDH7A1,Homo sapiens (Human),239,,,aldehyde dehydrogenase (NAD+) activity [GO:0004029],aldehyde dehydrogenase (NAD+) activity [GO:0004029],,,,
0,"(gene:""GLYATL2"")",Q8WU03,GLYL2_HUMAN,Glycine N-acyltransferase-like protein 2 (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase-like protein 2),GLYATL2,Homo sapiens (Human),294,long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739],endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; long-chain fatty acid catabolic process [GO:0042758]; medium-chain fatty acid catabolic process [GO:0051793]; monounsaturated fatty acid catabolic process [GO:1903965],glycine N-acyltransferase activity [GO:0047961],,,SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:20305126}.,
0,"(gene:""ALDH8A1"")",Q9H2A2,AL8A1_HUMAN,2-aminomuconic semialdehyde dehydrogenase (EC 1.2.1.32) (Aldehyde dehydrogenase 12) (Aldehyde dehydrogenase family 8 member A1),ALDH8A1 ALDH12,Homo sapiens (Human),487,9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; L-kynurenine catabolic process [GO:0097053]; retinal metabolic process [GO:0042574]; retinoic acid metabolic process [GO:0042573],aminomuconate-semialdehyde dehydrogenase activity [GO:0047102]; retinal dehydrogenase activity [GO:0001758],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,
1,,E9PKV1,E9PKV1_HUMAN,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,Homo sapiens (Human),15,,,,,,,,
2,,H0YF40,H0YF40_HUMAN,Aldehyde dehydrogenase 8 family member A1,ALDH8A1,Homo sapiens (Human),134,,,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]","oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor [GO:0016620]",,,,
0,"(gene:""GLYATL3"")",Q5SZD4,GLYL3_HUMAN,Glycine N-acyltransferase-like protein 3 (EC 2.3.1.13) (Acyl-CoA:glycine-N-acyltransferase-like protein 3),GLYATL3 C6orf140,Homo sapiens (Human),288,lipid metabolic process [GO:0006629],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961]; lipid metabolic process [GO:0006629],glycine N-acyltransferase activity [GO:0047961],,,,
1,,F5GXQ5,F5GXQ5_HUMAN,Glycine N-acyltransferase-like protein (EC 2.3.1.-),GLYATL3,Homo sapiens (Human),156,,mitochondrion [GO:0005739],mitochondrion [GO:0005739]; glycine N-acyltransferase activity [GO:0047961],glycine N-acyltransferase activity [GO:0047961],,,,
0,"(gene:""ALDH9A1"")",P49189,AL9A1_HUMAN,"4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH) (TMABALDH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Formaldehyde dehydrogenase) (EC 1.2.1.46) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed]",ALDH9A1 ALDH4 ALDH7 ALDH9,Homo sapiens (Human),494,carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; formaldehyde dehydrogenase activity [GO:0018467]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; small molecule binding [GO:0036094]; carnitine biosynthetic process [GO:0045329]; cellular aldehyde metabolic process [GO:0006081]; protein homotetramerization [GO:0051289],4-trimethylammoniobutyraldehyde dehydrogenase activity [GO:0047105]; aldehyde dehydrogenase (NAD+) activity [GO:0004029]; aminobutyraldehyde dehydrogenase activity [GO:0019145]; formaldehyde dehydrogenase activity [GO:0018467]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity [GO:0043878]; small molecule binding [GO:0036094],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q9JLJ3}. Cytoplasm {ECO:0000269|PubMed:1799975}.",
0,"(gene:""GPX1"")",P07203,GPX1_HUMAN,Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) (Phospholipid-hydroperoxide glutathione peroxidase GPX1) (EC 1.11.1.12),GPX1,Homo sapiens (Human),203,angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; epigenetic regulation of gene expression [GO:0040029]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cell redox homeostasis [GO:0045454]; cellular response to glucose stimulus [GO:0071333]; cellular response to oxidative stress [GO:0034599]; endothelial cell development [GO:0001885]; epigenetic regulation of gene expression [GO:0040029]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; lipoxygenase pathway [GO:0019372]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of supramolecular fiber organization [GO:1902905]; regulation of mammary gland epithelial cell proliferation [GO:0033599]; regulation of proteasomal protein catabolic process [GO:0061136]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; UV protection [GO:0009650]; vasodilation [GO:0042311],glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; SH3 domain binding [GO:0017124],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11352}. Mitochondrion {ECO:0000250|UniProtKB:P11352}.,
1,,Q7L4Q3,Q7L4Q3_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),203,angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; vasodilation [GO:0042311],cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; angiogenesis involved in wound healing [GO:0060055]; arachidonic acid metabolic process [GO:0019369]; biological process involved in interaction with symbiont [GO:0051702]; blood vessel endothelial cell migration [GO:0043534]; cellular response to glucose stimulus [GO:0071333]; endothelial cell development [GO:0001885]; fat cell differentiation [GO:0045444]; fibroblast proliferation [GO:0048144]; glutathione metabolic process [GO:0006749]; heart contraction [GO:0060047]; hydrogen peroxide catabolic process [GO:0042744]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neuron apoptotic process [GO:0051402]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; response to estradiol [GO:0032355]; response to folic acid [GO:0051593]; response to gamma radiation [GO:0010332]; response to hormone [GO:0009725]; response to hydrogen peroxide [GO:0042542]; response to hydroperoxide [GO:0033194]; response to nicotine [GO:0035094]; response to selenium ion [GO:0010269]; response to symbiotic bacterium [GO:0009609]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; skeletal muscle fiber development [GO:0048741]; skeletal muscle tissue regeneration [GO:0043403]; temperature homeostasis [GO:0001659]; triglyceride metabolic process [GO:0006641]; vasodilation [GO:0042311],glutathione peroxidase activity [GO:0004602],,,,
2,,A0A2R8Y6B6,A0A2R8Y6B6_HUMAN,Glutathione peroxidase 1 (EC 1.11.1.9) (Cellular glutathione peroxidase),GPX1,Homo sapiens (Human),157,response to oxidative stress [GO:0006979],cytosol [GO:0005829],cytosol [GO:0005829]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
3,,A0A7I2UQ36,A0A7I2UQ36_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),170,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
4,,A0A7I2YMD7,A0A7I2YMD7_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),104,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
5,,A0A994J430,A0A994J430_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),202,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
6,,A0A994J4K6,A0A994J4K6_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),122,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
7,,A0A994J4L4,A0A994J4L4_HUMAN,Glutathione peroxidase 1 (EC 1.11.1.9) (Cellular glutathione peroxidase),GPX1,Homo sapiens (Human),148,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
8,,A0A994J702,A0A994J702_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),190,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
9,,A0A994J707,A0A994J707_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),124,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
10,,Q6NSD4,Q6NSD4_HUMAN,Glutathione peroxidase,GPX1,Homo sapiens (Human),145,glutathione metabolic process [GO:0006749]; hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]; response to selenium ion [GO:0010269],cytosol [GO:0005829]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrion [GO:0005739]; glutathione peroxidase activity [GO:0004602]; glutathione metabolic process [GO:0006749]; hydrogen peroxide catabolic process [GO:0042744]; response to hydrogen peroxide [GO:0042542]; response to selenium ion [GO:0010269],glutathione peroxidase activity [GO:0004602],,,,
11,,A0A994J4E2,A0A994J4E2_HUMAN,Glutathione peroxidase 1,GPX1,Homo sapiens (Human),46,,,,,,,,
12,,A0A994J7E8,A0A994J7E8_HUMAN,Glutathione peroxidase 1,GPX1,Homo sapiens (Human),51,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
13,,X5D926,X5D926_HUMAN,Glutathione peroxidase 1 isoform A,GPX1,Homo sapiens (Human),48,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
14,,X5DQZ7,X5DQZ7_HUMAN,Glutathione peroxidase 1 isoform A,GPX1,Homo sapiens (Human),46,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
0,"(gene:""ALOX12"")",P18054,LOX12_HUMAN,Polyunsaturated fatty acid lipoxygenase ALOX12 (EC 1.13.11.-) (Arachidonate (12S)-lipoxygenase) (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Arachidonate (15S)-lipoxygenase) (EC 1.13.11.33) (Linoleate (13S)-lipoxygenase) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12),ALOX12 12LO LOG12,Homo sapiens (Human),663,arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; sarcolemma [GO:0042383],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; sarcolemma [GO:0042383]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; arachidonic acid metabolic process [GO:0019369]; establishment of skin barrier [GO:0061436]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; leukotriene A4 metabolic process [GO:1901751]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxin B4 biosynthetic process [GO:2001306]; lipoxygenase pathway [GO:0019372]; negative regulation of muscle cell apoptotic process [GO:0010656]; negative regulation of platelet aggregation [GO:0090331]; superoxide anion generation [GO:0042554]; unsaturated fatty acid metabolic process [GO:0033559],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; hepoxilin-epoxide hydrolase activity [GO:0047977]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol. Membrane. Note=Membrane association is stimulated by EGF.",
1,,K7ENN9,K7ENN9_HUMAN,"Arachidonate 12-lipoxygenase, 12S type",ALOX12,Homo sapiens (Human),147,lipid oxidation [GO:0034440],,"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; lipid oxidation [GO:0034440]","iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",,,,
0,"(gene:""GPX2"")",P18283,GPX2_HUMAN,Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Gastrointestinal glutathione peroxidase) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI) (Glutathione peroxidase-related protein 2) (GPRP-2) (Phospholipid hydroperoxide glutathione peroxidase GPX2) (EC 1.11.1.12),GPX2,Homo sapiens (Human),190,response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; mitotic spindle [GO:0072686]; electron transfer activity [GO:0009055]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; response to oxidative stress [GO:0006979],electron transfer activity [GO:0009055]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:8428933}.",
1,,G3V323,G3V323_HUMAN,Glutathione peroxidase,GPX2,Homo sapiens (Human),78,response to oxidative stress [GO:0006979],cytosol [GO:0005829],cytosol [GO:0005829]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000256|ARBA:ARBA00004514}.",
2,,G3V4J6,G3V4J6_HUMAN,Glutathione peroxidase,GPX2,Homo sapiens (Human),78,response to oxidative stress [GO:0006979],cytosol [GO:0005829],cytosol [GO:0005829]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000256|ARBA:ARBA00004514}.",
3,,H0YJK8,H0YJK8_HUMAN,glutathione peroxidase (EC 1.11.1.9),GPX2,Homo sapiens (Human),134,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
0,"(gene:""ALOX15"")",P16050,LOX15_HUMAN,"Polyunsaturated fatty acid lipoxygenase ALOX15 (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate 15-lipoxygenase) (15-LOX) (15-LOX-1) (EC 1.13.11.33) (Arachidonate omega-6 lipoxygenase) (Hepoxilin A3 synthase Alox15) (EC 1.13.11.-) (Linoleate 13S-lipoxygenase) (EC 1.13.11.12)",ALOX15 LOG15,Homo sapiens (Human),662,apoptotic cell clearance [GO:0043277]; arachidonic acid metabolic process [GO:0019369]; bone mineralization [GO:0030282]; cellular response to calcium ion [GO:0071277]; cellular response to interleukin-13 [GO:0035963]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; inflammatory response [GO:0006954]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of adaptive immune response [GO:0002820]; ossification [GO:0001503]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of engulfment of apoptotic cell [GO:1901074]; regulation of inflammatory response [GO:0050727]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; response to endoplasmic reticulum stress [GO:0034976]; wound healing [GO:0042060],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886],"cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; apoptotic cell clearance [GO:0043277]; arachidonic acid metabolic process [GO:0019369]; bone mineralization [GO:0030282]; cellular response to calcium ion [GO:0071277]; cellular response to interleukin-13 [GO:0035963]; fatty acid oxidation [GO:0019395]; hepoxilin biosynthetic process [GO:0051122]; inflammatory response [GO:0006954]; linoleic acid metabolic process [GO:0043651]; lipid metabolic process [GO:0006629]; lipid oxidation [GO:0034440]; lipoxin A4 biosynthetic process [GO:2001303]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of adaptive immune response [GO:0002820]; ossification [GO:0001503]; phosphatidylethanolamine biosynthetic process [GO:0006646]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; regulation of engulfment of apoptotic cell [GO:1901074]; regulation of inflammatory response [GO:0050727]; regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035358]; response to endoplasmic reticulum stress [GO:0034976]; wound healing [GO:0042060]","arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 15-lipoxygenase activity [GO:0050473]; iron ion binding [GO:0005506]; linoleate 13S-lipoxygenase activity [GO:0016165]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:17052953, ECO:0000269|PubMed:21831839}. Cell membrane {ECO:0000269|PubMed:21831839}; Peripheral membrane protein {ECO:0000269|PubMed:17052953}. Lipid droplet {ECO:0000269|PubMed:19528634}. Note=Predominantly cytosolic; becomes enriched at membranes upon calcium binding (By similarity). Translocates from the cytosol to the plasma membrane when stimulated by IL13/interleukin-13 and in macrophages binding apoptotic cells (By similarity). {ECO:0000250|UniProtKB:P39654}.",
0,"(gene:""GPX3"")",P22352,GPX3_HUMAN,Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P),GPX3 GPXP,Homo sapiens (Human),226,hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; selenium binding [GO:0008430]; hydrogen peroxide catabolic process [GO:0042744]; response to lipid hydroperoxide [GO:0006982],glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; selenium binding [GO:0008430],,,SUBCELLULAR LOCATION: Secreted.,
1,,E5RG32,E5RG32_HUMAN,Glutathione peroxidase,GPX3,Homo sapiens (Human),138,response to oxidative stress [GO:0006979],extracellular region [GO:0005576],extracellular region [GO:0005576]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Secreted {ECO:0000256|ARBA:ARBA00004613}.,
2,,H0YBE4,H0YBE4_HUMAN,glutathione peroxidase (EC 1.11.1.9),GPX3,Homo sapiens (Human),79,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
3,,H0YC19,H0YC19_HUMAN,Glutathione peroxidase,GPX3,Homo sapiens (Human),174,response to oxidative stress [GO:0006979],extracellular region [GO:0005576],extracellular region [GO:0005576]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Secreted {ECO:0000256|ARBA:ARBA00004613}.,
4,,A0A182DWH9,A0A182DWH9_HUMAN,Glutathione peroxidase 3,GPX3,Homo sapiens (Human),100,,,,,,,,
5,,A0A182DWI0,A0A182DWI0_HUMAN,Glutathione peroxidase 3,GPX3,Homo sapiens (Human),63,,,,,,,,
6,,Q6NXQ3,Q6NXQ3_HUMAN,GPX3 protein,GPX3,Homo sapiens (Human),72,response to oxidative stress [GO:0006979],,peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,,
0,"(gene:""ALOX5"")",P09917,LOX5_HUMAN,Polyunsaturated fatty acid 5-lipoxygenase (EC 1.13.11.-) (Arachidonate 5-lipoxygenase) (5-LO) (5-lipoxygenase) (EC 1.13.11.34),ALOX5 LOG5,Homo sapiens (Human),674,arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774],cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nuclear envelope [GO:0005635]; nuclear envelope lumen [GO:0005641]; nuclear matrix [GO:0016363]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; secretory granule lumen [GO:0034774]; arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; dendritic cell migration [GO:0036336]; glucose homeostasis [GO:0042593]; humoral immune response [GO:0006959]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; leukocyte migration involved in inflammatory response [GO:0002523]; leukotriene A4 biosynthetic process [GO:1901753]; leukotriene biosynthetic process [GO:0019370]; leukotriene metabolic process [GO:0006691]; leukotriene production involved in inflammatory response [GO:0002540]; lipid oxidation [GO:0034440]; lipoxin biosynthetic process [GO:2001301]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of wound healing [GO:0061045]; positive regulation of bone mineralization [GO:0030501]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of fat cell differentiation [GO:0045598]; regulation of inflammatory response [GO:0050727]; regulation of inflammatory response to wounding [GO:0106014]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species biosynthetic process [GO:1903426],arachidonate 12(S)-lipoxygenase activity [GO:0004052]; arachidonate 5-lipoxygenase activity [GO:0004051]; arachidonate 8(S)-lipoxygenase activity [GO:0036403]; hydrolase activity [GO:0016787]; iron ion binding [GO:0005506],,,"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P48999, ECO:0000269|PubMed:18978352}. Nucleus matrix {ECO:0000269|PubMed:19233132}. Nucleus membrane {ECO:0000269|PubMed:16275640}; Peripheral membrane protein {ECO:0000269|PubMed:16275640}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:19022417}. Cytoplasm, cytosol {ECO:0000269|PubMed:19233132}. Nucleus envelope {ECO:0000269|PubMed:16275640, ECO:0000269|PubMed:19233132, ECO:0000269|PubMed:8245774}. Nucleus intermembrane space {ECO:0000269|PubMed:8245774}. Note=Shuttles between cytoplasm and nucleus (PubMed:19233132). Found exclusively in the nucleus, when phosphorylated on Ser-272 (PubMed:18978352). Calcium binding promotes translocation from the cytosol and the nuclear matrix to the nuclear envelope and membrane association (PubMed:16275640, PubMed:19233132, PubMed:3118366, PubMed:8245774). {ECO:0000269|PubMed:16275640, ECO:0000269|PubMed:18978352, ECO:0000269|PubMed:19233132, ECO:0000269|PubMed:3118366, ECO:0000269|PubMed:8245774}.",
1,,A0A087X109,A0A087X109_HUMAN,Arachidonate 5-lipoxygenase,ALOX5,Homo sapiens (Human),139,,,"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]","iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",,,,
2,,I0CLG0,I0CLG0_HUMAN,LOX-5 splice variant,ALOX5,Homo sapiens (Human),139,,,"iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]","iron ion binding [GO:0005506]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]",,,,
0,"(gene:""GPX4"")",P36969,GPX4_HUMAN,Phospholipid hydroperoxide glutathione peroxidase GPX4 (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (EC 1.11.1.9),GPX4,Homo sapiens (Human),197,arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of ferroptosis [GO:0110076]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430]; arachidonic acid metabolic process [GO:0019369]; chromatin organization [GO:0006325]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; negative regulation of ferroptosis [GO:0110076]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; response to estradiol [GO:0032355]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430],,,SUBCELLULAR LOCATION: [Isoform Mitochondrial]: Mitochondrion {ECO:0000250|UniProtKB:O70325}.; SUBCELLULAR LOCATION: [Isoform Cytoplasmic]: Cytoplasm {ECO:0000269|PubMed:11115402}.,
1,,A0A087X247,A0A087X247_HUMAN,phospholipid-hydroperoxide glutathione peroxidase (EC 1.11.1.12) (Glutathione peroxidase 4),GPX4,Homo sapiens (Human),134,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
2,,A0A0A0MTT1,A0A0A0MTT1_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),166,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
3,,A0A9L9PXS3,A0A9L9PXS3_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),195,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
4,,K7EJ20,K7EJ20_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),242,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
5,,K7EKX7,K7EKX7_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),255,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
6,,K7ENB4,K7ENB4_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),180,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
7,,K7ERP4,K7ERP4_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),155,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
8,,Q6PI42,Q6PI42_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),197,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739]; nucleus [GO:0005634],mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; response to oxidative stress [GO:0006979],glutathione peroxidase activity [GO:0004602]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
9,,Q6PJX4,Q6PJX4_HUMAN,phospholipid-hydroperoxide glutathione peroxidase (EC 1.11.1.12) (Glutathione peroxidase 4),GPX4,Homo sapiens (Human),69,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
10,,R4GNE4,R4GNE4_HUMAN,Glutathione peroxidase,GPX4,Homo sapiens (Human),234,response to oxidative stress [GO:0006979],mitochondrion [GO:0005739],mitochondrion [GO:0005739]; peroxidase activity [GO:0004601]; response to oxidative stress [GO:0006979],peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000256|ARBA:ARBA00004173}.,
0,"(gene:""AOC2"")",O75106,AOC2_HUMAN,Amine oxidase [copper-containing] 2 (EC 1.4.3.21) (Amine oxidase copper-containing 2) (Retina-specific copper amine oxidase) (RAO) (Semicarbazide-sensitive amine oxidase) (SSAO),AOC2,Homo sapiens (Human),756,amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; plasma membrane [GO:0005886],cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; aliphatic amine oxidase activity [GO:0052595]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; visual perception [GO:0007601]; xenobiotic metabolic process [GO:0006805],aliphatic amine oxidase activity [GO:0052595]; copper ion binding [GO:0005507]; electron transfer activity [GO:0009055]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038],"TOPO_DOM 1..4; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:Q16853""; TOPO_DOM 26..756; /note=""Extracellular""; /evidence=""ECO:0000250|UniProtKB:Q16853""","TRANSMEM 5..25; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000269|PubMed:19588076}; Single-pass type II membrane protein {ECO:0000250|UniProtKB:Q16853}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:19588076}. Note=Either not translocated to the plasma membrane or below detection level. {ECO:0000269|PubMed:19588076}.,
0,"(gene:""GPX7"")",Q96SL4,GPX7_HUMAN,Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683),GPX7 GPX6 UNQ469/PRO828,Homo sapiens (Human),187,cellular response to oxidative stress [GO:0034599],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599],catalase activity [GO:0004096]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601],,,SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,
0,"(gene:""AOC3"")",Q16853,AOC3_HUMAN,Amine oxidase [copper-containing] 3 (EC 1.4.3.21) (Amine oxidase copper-containing 3) (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1),AOC3 VAP1,Homo sapiens (Human),763,amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; response to antibiotic [GO:0046677],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886],cell surface [GO:0009986]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; aliphatic amine oxidase activity [GO:0052595]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308]; cell adhesion [GO:0007155]; inflammatory response [GO:0006954]; response to antibiotic [GO:0046677],aliphatic amine oxidase activity [GO:0052595]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; primary amine oxidase activity [GO:0008131]; protein heterodimerization activity [GO:0046982]; quinone binding [GO:0048038],"TOPO_DOM 1..5; /note=""Cytoplasmic""; /evidence=""ECO:0000305|PubMed:9653080""; TOPO_DOM 27..763; /note=""Extracellular""; /evidence=""ECO:0000305|PubMed:9653080""","TRANSMEM 6..26; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:9653080}; Single-pass type II membrane protein {ECO:0000269|PubMed:9653080}.,
1,,K7EIK5,K7EIK5_HUMAN,Amine oxidase (EC 1.4.3.-),AOC3,Homo sapiens (Human),144,amine metabolic process [GO:0009308],,copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038],,,,
2,,K7EL47,K7EL47_HUMAN,Amine oxidase (EC 1.4.3.-),AOC3,Homo sapiens (Human),152,amine metabolic process [GO:0009308],,copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038],,,,
3,,K7EQZ5,K7EQZ5_HUMAN,Amine oxidase (EC 1.4.3.-),AOC3,Homo sapiens (Human),112,amine metabolic process [GO:0009308],,copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038]; amine metabolic process [GO:0009308],copper ion binding [GO:0005507]; primary amine oxidase activity [GO:0008131]; quinone binding [GO:0048038],,,,
0,"(gene:""GPX8"")",Q8TED1,GPX8_HUMAN,Probable glutathione peroxidase 8 (GPx-8) (GSHPx-8) (EC 1.11.1.9),GPX8 UNQ847/PRO1785,Homo sapiens (Human),209,cellular response to oxidative stress [GO:0034599],endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020],endoplasmic reticulum lumen [GO:0005788]; membrane [GO:0016020]; glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601]; cellular response to oxidative stress [GO:0034599],glutathione peroxidase activity [GO:0004602]; peroxidase activity [GO:0004601],,"TRANSMEM 18..40; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,
1,,E7ETY7,E7ETY7_HUMAN,Glutathione peroxidase,GPX8,Homo sapiens (Human),158,response to oxidative stress [GO:0006979],membrane [GO:0016020],membrane [GO:0016020]; glutathione peroxidase activity [GO:0004602]; response to oxidative stress [GO:0006979],glutathione peroxidase activity [GO:0004602],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}.,
2,,J3KNB5,J3KNB5_HUMAN,Glutathione peroxidase 8 (putative),GPX8,Homo sapiens (Human),90,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 18..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""AOX1"")",Q06278,AOXA_HUMAN,Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-),AOX1 AO,Homo sapiens (Human),1338,lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062],"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805]","2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; protein homodimerization activity [GO:0042803]",,,"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:18671973, ECO:0000269|PubMed:20444863, ECO:0000269|PubMed:23857892}.",
1,,A0A286LWX1,A0A286LWX1_HUMAN,aldehyde oxidase (EC 1.2.3.1),AOX1,Homo sapiens (Human),1338,lipid metabolic process [GO:0006629],cytoplasm [GO:0005737],"cytoplasm [GO:0005737]; 2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]; lipid metabolic process [GO:0006629]","2 iron, 2 sulfur cluster binding [GO:0051537]; aldehyde oxidase activity [GO:0004031]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; NAD binding [GO:0051287]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,C9J244,C9J244_HUMAN,Aldehyde oxidase 1,AOX1,Homo sapiens (Human),151,,,"2 iron, 2 sulfur cluster binding [GO:0051537]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]","2 iron, 2 sulfur cluster binding [GO:0051537]; iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]",,,,
3,,H7BXF7,H7BXF7_HUMAN,Aldehyde oxidase 1,AOX1,Homo sapiens (Human),193,,,iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491],,,,
4,,H7C3Q1,H7C3Q1_HUMAN,Aldehyde oxidase 1,AOX1,Homo sapiens (Human),190,,,iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491],,,,
0,"(gene:""GSTA1"")",P08263,GSTA1_HUMAN,"Glutathione S-transferase A1 (EC 2.5.1.18) (13-hydroperoxyoctadecadienoate peroxidase) (EC 1.11.1.-) (Androst-5-ene-3,17-dione isomerase) (EC 5.3.3.-) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed]",GSTA1,Homo sapiens (Human),222,epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769]; epithelial cell differentiation [GO:0030855]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; linoleic acid metabolic process [GO:0043651]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; steroid delta-isomerase activity [GO:0004769],,,SUBCELLULAR LOCATION: Cytoplasm.,
0,"(gene:""XDH"")",P47989,XDH_HUMAN,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],XDH XDHA,Homo sapiens (Human),1333,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; amide catabolic process [GO:0043605]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115],cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529],"cytosol [GO:0005829]; extracellular space [GO:0005615]; peroxisome [GO:0005777]; sarcoplasmic reticulum [GO:0016529]; 2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adenosine catabolic process [GO:0006154]; allantoin metabolic process [GO:0000255]; amide catabolic process [GO:0043605]; AMP catabolic process [GO:0006196]; dAMP catabolic process [GO:0046059]; deoxyadenosine catabolic process [GO:0006157]; deoxyguanosine catabolic process [GO:0006161]; deoxyinosine catabolic process [GO:0006149]; dGMP catabolic process [GO:0046055]; GMP catabolic process [GO:0046038]; guanine catabolic process [GO:0006147]; hypoxanthine catabolic process [GO:0009114]; IMP catabolic process [GO:0006204]; inosine catabolic process [GO:0006148]; iron-sulfur cluster assembly [GO:0016226]; lactation [GO:0007595]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; negative regulation of vasculogenesis [GO:2001213]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xanthine catabolic process [GO:0009115]","2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; hypoxanthine dehydrogenase activity [GO:0070674]; hypoxanthine oxidase activity [GO:0070675]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; protein homodimerization activity [GO:0042803]; xanthine dehydrogenase activity [GO:0004854]; xanthine oxidase activity [GO:0004855]",,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Peroxisome {ECO:0000250}. Secreted.,
1,,A0AA96C912,A0AA96C912_HUMAN,Xanthine dehydrogenase/oxidase (EC 1.17.1.4) (EC 1.17.3.2),XDH,Homo sapiens (Human),1333,xanthine catabolic process [GO:0009115],extracellular space [GO:0005615]; peroxisome [GO:0005777],"extracellular space [GO:0005615]; peroxisome [GO:0005777]; 2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]; xanthine catabolic process [GO:0009115]","2 iron, 2 sulfur cluster binding [GO:0051537]; FAD binding [GO:0071949]; iron ion binding [GO:0005506]; molybdopterin cofactor binding [GO:0043546]; xanthine dehydrogenase activity [GO:0004854]",,,SUBCELLULAR LOCATION: Peroxisome {ECO:0000256|ARBA:ARBA00004275}.,
2,,Q585T6,Q585T6_HUMAN,Uncharacterized protein XDH,XDH,Homo sapiens (Human),31,,,flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity [GO:0016491],,,,
0,"(gene:""GSTA2"")",P09210,GSTA2_HUMAN,Glutathione S-transferase A2 (EC 2.5.1.18) (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2),GSTA2 GST2,Homo sapiens (Human),222,epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; epithelial cell differentiation [GO:0030855]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,A0A140VKE2,A0A140VKE2_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTA2 hCG_1779105,Homo sapiens (Human),222,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
0,"(gene:""BAAT"")",Q14032,BAAT_HUMAN,Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Bile acid-CoA thioesterase) (Choloyl-CoA hydrolase) (EC 3.1.2.27) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2),BAAT,Homo sapiens (Human),418,acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777],cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]; acyltransferase activity [GO:0016746]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817]; acyl-CoA metabolic process [GO:0006637]; animal organ regeneration [GO:0031100]; bile acid biosynthetic process [GO:0006699]; bile acid conjugation [GO:0002152]; bile acid metabolic process [GO:0008206]; fatty acid metabolic process [GO:0006631]; glycine metabolic process [GO:0006544]; liver development [GO:0001889]; taurine metabolic process [GO:0019530],acyltransferase activity [GO:0016746]; carboxylic ester hydrolase activity [GO:0052689]; choloyl-CoA hydrolase activity [GO:0033882]; fatty acyl-CoA hydrolase activity [GO:0047617]; glycine N-choloyltransferase activity [GO:0047963]; long-chain fatty acyl-CoA hydrolase activity [GO:0052816]; medium-chain fatty acyl-CoA hydrolase activity [GO:0052815]; N-acyltransferase activity [GO:0016410]; very long-chain fatty acyl-CoA hydrolase activity [GO:0052817],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12810727, ECO:0000269|PubMed:23415802, ECO:0000269|PubMed:8034703}. Peroxisome {ECO:0000250|UniProtKB:Q63276}.",
1,,A0A6Q8PF60,A0A6Q8PF60_HUMAN,Bile acid-CoA:amino acid N-acyltransferase,BAAT,Homo sapiens (Human),277,,,carboxylic ester hydrolase activity [GO:0052689],carboxylic ester hydrolase activity [GO:0052689],,,,
2,,A0A6Q8PHR9,A0A6Q8PHR9_HUMAN,Bile acid-CoA:amino acid N-acyltransferase,BAAT,Homo sapiens (Human),291,,,carboxylic ester hydrolase activity [GO:0052689],carboxylic ester hydrolase activity [GO:0052689],,,,
0,"(gene:""GSTA4"")",O15217,GSTA4_HUMAN,Glutathione S-transferase A4 (EC 2.5.1.18) (GST class-alpha member 4) (Glutathione S-transferase A4-4),GSTA4,Homo sapiens (Human),222,glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,Q5JW88,Q5JW88_HUMAN,Glutathione S-transferase alpha 4,GSTA4,Homo sapiens (Human),89,,cytosol [GO:0005829],cytosol [GO:0005829],,,,,
0,"(gene:""BCHE"")",P06276,CHLE_HUMAN,Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase),BCHE CHE1,Homo sapiens (Human),602,acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805],blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886],"blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nuclear envelope lumen [GO:0005641]; plasma membrane [GO:0005886]; acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]; acetylcholine catabolic process [GO:0006581]; choline metabolic process [GO:0019695]; cocaine metabolic process [GO:0050783]; learning [GO:0007612]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of synaptic transmission [GO:0050805]; neuroblast differentiation [GO:0014016]; peptide hormone processing [GO:0016486]; response to alkaloid [GO:0043279]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; xenobiotic metabolic process [GO:0006805]","acetylcholinesterase activity [GO:0003990]; amyloid-beta binding [GO:0001540]; catalytic activity [GO:0003824]; choline binding [GO:0033265]; cholinesterase activity [GO:0004104]; enzyme binding [GO:0019899]; hydrolase activity, acting on ester bonds [GO:0016788]; identical protein binding [GO:0042802]",,,"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19368529, ECO:0000269|PubMed:19542320}.",
1,,F8WEX7,F8WEX7_HUMAN,Carboxylic ester hydrolase (EC 3.1.1.-),BCHE,Homo sapiens (Human),525,,,cholinesterase activity [GO:0004104],cholinesterase activity [GO:0004104],,,,
2,,F8WF14,F8WF14_HUMAN,Carboxylic ester hydrolase (EC 3.1.1.-),BCHE,Homo sapiens (Human),562,,,cholinesterase activity [GO:0004104],cholinesterase activity [GO:0004104],,,,
3,,H0Y885,H0Y885_HUMAN,Butyrylcholinesterase,BCHE,Homo sapiens (Human),132,,,,,,,,
4,,H7C4Y0,H7C4Y0_HUMAN,Butyrylcholinesterase,BCHE,Homo sapiens (Human),120,,,,,,,,
5,,Q96HL2,Q96HL2_HUMAN,"BCHE protein (Butyrylcholinesterase, isoform CRA_a)",BCHE hCG_14822,Homo sapiens (Human),64,,,,,,,,
0,"(gene:""GSTA5"")",Q7RTV2,GSTA5_HUMAN,Glutathione S-transferase A5 (EC 2.5.1.18) (GST class-alpha member 5) (Glutathione S-transferase A5-5),GSTA5,Homo sapiens (Human),222,glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749]; xenobiotic metabolic process [GO:0006805],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,
1,,A0AAA9YHN5,A0AAA9YHN5_HUMAN,Glutathione S-transferase alpha 5,GSTA5,Homo sapiens (Human),54,,,,,,,,
0,"(gene:""BLVRA"")",P53004,BIEA_HUMAN,Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase),BLVRA BLVR BVR,Homo sapiens (Human),296,heme catabolic process [GO:0042167],cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)H) activity [GO:0004074]; biliverdin reductase (NADPH) activity [GO:0106277]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]; heme catabolic process [GO:0042167],biliberdin reductase NAD+ activity [GO:0106276]; biliverdin reductase (NAD(P)H) activity [GO:0004074]; biliverdin reductase (NADPH) activity [GO:0106277]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:7929092, ECO:0000269|PubMed:8424666}.",
1,,C9J1E1,C9J1E1_HUMAN,Biliverdin reductase A,BLVRA,Homo sapiens (Human),102,,cytosol [GO:0005829],cytosol [GO:0005829]; catalytic activity [GO:0003824]; nucleotide binding [GO:0000166],catalytic activity [GO:0003824]; nucleotide binding [GO:0000166],,,,
0,"(gene:""GSTM1"")",P09488,GSTM1_HUMAN,Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4),GSTM1 GST1,Homo sapiens (Human),218,cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; nitrobenzene metabolic process [GO:0018916]; prostaglandin metabolic process [GO:0006693]; xenobiotic catabolic process [GO:0042178],enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,B9ZVX7,B9ZVX7_HUMAN,glutathione transferase (EC 2.5.1.18),GSTM1,Homo sapiens (Human),149,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,E7EWW9,E7EWW9_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM1,Homo sapiens (Human),237,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
3,,H3BRM6,H3BRM6_HUMAN,glutathione transferase (EC 2.5.1.18),GSTM1,Homo sapiens (Human),102,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
4,,X5D932,X5D932_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM1,Homo sapiens (Human),181,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
5,,X5DNN9,X5DNN9_HUMAN,glutathione transferase (EC 2.5.1.18),GSTM1,Homo sapiens (Human),149,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
6,,X5DR03,X5DR03_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM1,Homo sapiens (Human),218,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
7,,H3BQT3,H3BQT3_HUMAN,Glutathione S-transferase mu 1,GSTM1,Homo sapiens (Human),85,glutathione metabolic process [GO:0006749],,glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
8,,Q16041,Q16041_HUMAN,GSTM1 protein,GSTM1,Homo sapiens (Human),62,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
9,,X5D7U4,X5D7U4_HUMAN,Glutathione S-transferase mu 1 isoform A,GSTM1,Homo sapiens (Human),83,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
0,"(gene:""CES1"")",P02795,MT2_HUMAN,Metallothionein-2 (MT-2) (Metallothionein-2A) (Metallothionein-II) (MT-II),MT2A CES1 MT2,Homo sapiens (Human),61,cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to erythropoietin [GO:0036018]; cellular response to interleukin-3 [GO:0036016]; cellular response to zinc ion [GO:0071294]; detoxification of copper ion [GO:0010273]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of growth [GO:0045926],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; metal ion binding [GO:0046872]; zinc ion binding [GO:0008270]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to erythropoietin [GO:0036018]; cellular response to interleukin-3 [GO:0036016]; cellular response to zinc ion [GO:0071294]; detoxification of copper ion [GO:0010273]; intracellular copper ion homeostasis [GO:0006878]; intracellular zinc ion homeostasis [GO:0006882]; negative regulation of growth [GO:0045926],metal ion binding [GO:0046872]; zinc ion binding [GO:0008270],,,,
1,,P23141,EST1_HUMAN,Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (CE-1) (hCE-1) (EC 3.1.1.1) (Cholesteryl ester hydrolase) (CEH) (EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH),CES1 CES2 SES1,Homo sapiens (Human),567,cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]; cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691],carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771],,,SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:10562416}. Cytoplasm {ECO:0000269|PubMed:16024911}. Lipid droplet {ECO:0000269|PubMed:16024911}. Note=Moves from cytoplasm to lipid droplets upon lipid loading. Associates with lipid droplets independently of triglycerides (TG) content of the droplets and hydrolyzes cholesteryl esters more efficiently from mixed droplets. {ECO:0000269|PubMed:16024911}.,
2,,A0A140TA63,A0A140TA63_HUMAN,Carboxylesterase 1,CES1,Homo sapiens (Human),134,,,,,,,,
3,,H3BQR4,H3BQR4_HUMAN,Carboxylesterase 1,CES1,Homo sapiens (Human),44,,,,,,,,
4,,H3BQV8,H3BQV8_HUMAN,Carboxylesterase 1,CES1,Homo sapiens (Human),131,,endoplasmic reticulum [GO:0005783],endoplasmic reticulum [GO:0005783],,,,,
5,,H3BSU0,H3BSU0_HUMAN,Carboxylesterase 1,CES1,Homo sapiens (Human),84,,,,,,,,
0,"(gene:""GSTM2"")",P28161,GSTM2_HUMAN,Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST class-mu 2) (GSTM2-2),GSTM2 GST4,Homo sapiens (Human),218,cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; relaxation of cardiac muscle [GO:0055119]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; sarcoplasmic reticulum [GO:0016529],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; sarcoplasmic reticulum [GO:0016529]; enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; cellular detoxification of nitrogen compound [GO:0070458]; cellular response to caffeine [GO:0071313]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; nitrobenzene metabolic process [GO:0018916]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [GO:0014809]; relaxation of cardiac muscle [GO:0055119]; xenobiotic catabolic process [GO:0042178],enzyme binding [GO:0019899]; fatty acid binding [GO:0005504]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,A8HT81,A8HT81_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM2,Homo sapiens (Human),189,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,E9PHN6,E9PHN6_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM2,Homo sapiens (Human),193,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
3,,E9PHN7,E9PHN7_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM2,Homo sapiens (Human),181,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
4,,E9PLF1,E9PLF1_HUMAN,glutathione transferase (EC 2.5.1.18),GSTM2,Homo sapiens (Human),147,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
5,,F6XZQ7,F6XZQ7_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM2,Homo sapiens (Human),220,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
6,,Q0D2I8,Q0D2I8_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM2,Homo sapiens (Human),218,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
7,,E9PGV1,E9PGV1_HUMAN,Glutathione S-transferase mu 2,GSTM2,Homo sapiens (Human),87,,cytosol [GO:0005829],cytosol [GO:0005829],,,,,
0,"(gene:""CES2"")",O00748,EST2_HUMAN,Cocaine esterase (EC 3.1.1.84) (Carboxylesterase 2) (CE-2) (hCE-2) (EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56),CES2 ICE,Homo sapiens (Human),559,catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; intracellular membrane-bounded organelle [GO:0043231]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; catabolic process [GO:0009056]; prostaglandin metabolic process [GO:0006693]; xenobiotic metabolic process [GO:0006805],carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374],,,SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:22446793}.,
1,,P23141,EST1_HUMAN,Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (CE-1) (hCE-1) (EC 3.1.1.1) (Cholesteryl ester hydrolase) (CEH) (EC 3.1.1.13) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH),CES1 CES2 SES1,Homo sapiens (Human),567,cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; lipid droplet [GO:0005811]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771]; cellular response to cholesterol [GO:0071397]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cholesterol biosynthetic process [GO:0006695]; cholesterol ester hydrolysis involved in cholesterol transport [GO:0090122]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; epithelial cell differentiation [GO:0030855]; lipid catabolic process [GO:0016042]; medium-chain fatty acid metabolic process [GO:0051791]; negative regulation of cholesterol storage [GO:0010887]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of bile acid secretion [GO:0120188]; response to toxic substance [GO:0009636]; reverse cholesterol transport [GO:0043691],carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; methylumbelliferyl-acetate deacetylase activity [GO:0047374]; sterol esterase activity [GO:0004771],,,SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:10562416}. Cytoplasm {ECO:0000269|PubMed:16024911}. Lipid droplet {ECO:0000269|PubMed:16024911}. Note=Moves from cytoplasm to lipid droplets upon lipid loading. Associates with lipid droplets independently of triglycerides (TG) content of the droplets and hydrolyzes cholesteryl esters more efficiently from mixed droplets. {ECO:0000269|PubMed:16024911}.,
2,,H3BUN5,H3BUN5_HUMAN,Carboxylesterase 2,CES2,Homo sapiens (Human),58,,,,,,,,
3,,J3QLP1,J3QLP1_HUMAN,Carboxylesterase 2,CES2,Homo sapiens (Human),125,,,,,,,,
4,,J3QSC0,J3QSC0_HUMAN,Carboxylesterase 2,CES2,Homo sapiens (Human),201,,,,,,,,
5,,Q4G0E9,Q4G0E9_HUMAN,Carboxylic ester hydrolase (EC 3.1.1.-),CES2,Homo sapiens (Human),587,,,hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,,,
6,,Q6IPK9,Q6IPK9_HUMAN,Carboxylic ester hydrolase (EC 3.1.1.-),CES2,Homo sapiens (Human),586,,extracellular exosome [GO:0070062],extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,,,
0,"(gene:""GSTM3"")",P21266,GSTM3_HUMAN,Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3),GSTM3 GST5,Homo sapiens (Human),225,cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178],enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,Q6FGJ9,Q6FGJ9_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM3 hCG_40244,Homo sapiens (Human),225,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,A4UJ43,A4UJ43_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM3,Homo sapiens (Human),210,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
0,"(gene:""CES3"")",Q6UWW8,EST3_HUMAN,Carboxylesterase 3 (EC 3.1.1.1) (Liver carboxylesterase 31 homolog),CES3 UNQ869/PRO1887,Homo sapiens (Human),571,low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062],cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689]; low-density lipoprotein particle clearance [GO:0034383]; xenobiotic metabolic process [GO:0006805],carboxylesterase activity [GO:0106435]; carboxylic ester hydrolase activity [GO:0052689],,,SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000250}.,
1,,A0A0C4DFY7,A0A0C4DFY7_HUMAN,Carboxylic ester hydrolase (EC 3.1.1.-),CES3 FLJ21736 hCG_1775398,Homo sapiens (Human),568,,,hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,,,
2,,H3BUA3,H3BUA3_HUMAN,Carboxylic ester hydrolase (EC 3.1.1.-),CES3,Homo sapiens (Human),379,,,hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,,,
3,,H3BRE5,H3BRE5_HUMAN,Carboxylesterase 3,CES3,Homo sapiens (Human),40,,,,,,,,
0,"(gene:""GSTM4"")",Q03013,GSTM4_HUMAN,Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4) (Leukotriene C4 synthase GSTM4) (EC 4.4.1.20),GSTM4,Homo sapiens (Human),218,glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intercellular bridge [GO:0045171]; enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803]; glutathione metabolic process [GO:0006749]; long-chain fatty acid biosynthetic process [GO:0042759]; nitrobenzene metabolic process [GO:0018916]; xenobiotic catabolic process [GO:0042178],enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; leukotriene-C4 synthase activity [GO:0004464]; protein homodimerization activity [GO:0042803],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:8373352}.,
1,,A6NNT0,A6NNT0_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM4,Homo sapiens (Human),202,glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749]; lipid metabolic process [GO:0006629],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
0,"(gene:""CHDH"")",Q8NE62,CHDH_HUMAN,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",CHDH,Homo sapiens (Human),594,choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660]; choline catabolic process [GO:0042426]; glycine betaine biosynthetic process from choline [GO:0019285],choline dehydrogenase activity [GO:0008812]; flavin adenine dinucleotide binding [GO:0050660],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250}.,
1,,C9J7D8,C9J7D8_HUMAN,Choline dehydrogenase,CHDH,Homo sapiens (Human),155,,,"flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]","flavin adenine dinucleotide binding [GO:0050660]; oxidoreductase activity, acting on CH-OH group of donors [GO:0016614]",,,,
2,,C9JYW4,C9JYW4_HUMAN,Choline dehydrogenase,CHDH,Homo sapiens (Human),126,,,flavin adenine dinucleotide binding [GO:0050660],flavin adenine dinucleotide binding [GO:0050660],,,,
0,"(gene:""GSTM5"")",P46439,GSTM5_HUMAN,Glutathione S-transferase Mu 5 (EC 2.5.1.18) (GST class-mu 5) (GSTM5-5),GSTM5,Homo sapiens (Human),218,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,A0A3B3IRM5,A0A3B3IRM5_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM5,Homo sapiens (Human),189,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
2,,Q5T8R1,Q5T8R1_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM5,Homo sapiens (Human),218,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
3,,Q5T8R2,Q5T8R2_HUMAN,Glutathione S-transferase (EC 2.5.1.18),GSTM5 hCG_40245,Homo sapiens (Human),218,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
4,,A0A3B3IU61,A0A3B3IU61_HUMAN,Glutathione S-transferase mu 5,GSTM5,Homo sapiens (Human),110,,cytosol [GO:0005829],cytosol [GO:0005829],,,,,
0,"(gene:""COMT"")",P21964,COMT_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),271,"artery development [GO:0060840]; behavioral fear response [GO:0001662]; catecholamine catabolic process [GO:0042424]; cellular response to cocaine [GO:0071314]; cellular response to phosphate starvation [GO:0016036]; cerebellar cortex morphogenesis [GO:0021696]; cholesterol efflux [GO:0033344]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; dopamine secretion [GO:0014046]; exploration behavior [GO:0035640]; gene expression [GO:0010467]; glomerulus development [GO:0032835]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; mastication [GO:0071626]; memory [GO:0007613]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; norepinephrine metabolic process [GO:0042415]; norepinephrine secretion [GO:0048243]; prostaglandin metabolic process [GO:0006693]; renal albumin absorption [GO:0097018]; renal filtration [GO:0097205]; renal sodium excretion [GO:0035812]; renin secretion into blood stream [GO:0002001]; response to amphetamine [GO:0001975]; response to angiotensin [GO:1990776]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to dopamine [GO:1903350]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; visual learning [GO:0008542]",axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202],"axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; methyltransferase activity [GO:0008168]; O-methyltransferase activity [GO:0008171]; artery development [GO:0060840]; behavioral fear response [GO:0001662]; catecholamine catabolic process [GO:0042424]; cellular response to cocaine [GO:0071314]; cellular response to phosphate starvation [GO:0016036]; cerebellar cortex morphogenesis [GO:0021696]; cholesterol efflux [GO:0033344]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; developmental process [GO:0032502]; dopamine catabolic process [GO:0042420]; dopamine metabolic process [GO:0042417]; dopamine secretion [GO:0014046]; exploration behavior [GO:0035640]; gene expression [GO:0010467]; glomerulus development [GO:0032835]; glycogen metabolic process [GO:0005977]; habituation [GO:0046959]; mastication [GO:0071626]; memory [GO:0007613]; methylation [GO:0032259]; multicellular organism growth [GO:0035264]; norepinephrine metabolic process [GO:0042415]; norepinephrine secretion [GO:0048243]; prostaglandin metabolic process [GO:0006693]; renal albumin absorption [GO:0097018]; renal filtration [GO:0097205]; renal sodium excretion [GO:0035812]; renin secretion into blood stream [GO:0002001]; response to amphetamine [GO:0001975]; response to angiotensin [GO:1990776]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to dopamine [GO:1903350]; response to food [GO:0032094]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to salt [GO:1902074]; response to toxic substance [GO:0009636]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; startle response [GO:0001964]; synaptic transmission, dopaminergic [GO:0001963]; visual learning [GO:0008542]",catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; methyltransferase activity [GO:0008168]; O-methyltransferase activity [GO:0008171],"TOPO_DOM 1..6; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 27..271; /note=""Extracellular""; /evidence=""ECO:0000255""","TRANSMEM 7..26; /note=""Helical; Signal-anchor for type II membrane protein""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: [Isoform Soluble]: Cytoplasm {ECO:0000269|PubMed:11559542}.; SUBCELLULAR LOCATION: [Isoform Membrane-bound]: Cell membrane {ECO:0000269|PubMed:21846718}; Single-pass type II membrane protein {ECO:0000269|PubMed:21846718}; Extracellular side {ECO:0000269|PubMed:21846718}.,
1,,B8XPJ7,B8XPJ7_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),221,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886],axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287],,,SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004228}; Single-pass type II membrane protein {ECO:0000256|ARBA:ARBA00004228}; Extracellular side {ECO:0000256|ARBA:ARBA00004228}.,
2,,B8XPJ8,B8XPJ8_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),271,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886],axon [GO:0030424]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287],,,SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004228}; Single-pass type II membrane protein {ECO:0000256|ARBA:ARBA00004228}; Extracellular side {ECO:0000256|ARBA:ARBA00004228}.,
3,,A0A7I2V370,A0A7I2V370_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),302,catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287],,,SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004228}; Single-pass type II membrane protein {ECO:0000256|ARBA:ARBA00004228}; Extracellular side {ECO:0000256|ARBA:ARBA00004228}.,
4,,E7EMS6,E7EMS6_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),223,catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287],,,SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004228}; Single-pass type II membrane protein {ECO:0000256|ARBA:ARBA00004228}; Extracellular side {ECO:0000256|ARBA:ARBA00004228}.,
5,,E7EUU8,E7EUU8_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),235,catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],plasma membrane [GO:0005886],plasma membrane [GO:0005886]; catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287]; catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206]; magnesium ion binding [GO:0000287],,,SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|ARBA:ARBA00004228}; Single-pass type II membrane protein {ECO:0000256|ARBA:ARBA00004228}; Extracellular side {ECO:0000256|ARBA:ARBA00004228}.,
6,,A0A1S6YJG6,A0A1S6YJG6_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),44,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
7,,A0A286SD53,A0A286SD53_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
8,,A0A4D6GI07,A0A4D6GI07_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
9,,A0A4D6GI32,A0A4D6GI32_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
10,,A0A4D6GI39,A0A4D6GI39_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
11,,A0A4D6GI41,A0A4D6GI41_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
12,,A0A4D6GI48,A0A4D6GI48_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
13,,A0A4D6GI63,A0A4D6GI63_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
14,,A0A4D6GI65,A0A4D6GI65_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
15,,A0A4D6GI75,A0A4D6GI75_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
16,,A0A4D6GI82,A0A4D6GI82_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
17,,A0A4D6GIA3,A0A4D6GIA3_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
18,,A0A4D6GIK3,A0A4D6GIK3_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
19,,A0A4D6GIL3,A0A4D6GIL3_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
20,,A0A4D6GIW7,A0A4D6GIW7_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
21,,A0A4D6GKQ6,A0A4D6GKQ6_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
22,,A0A4D6GKX6,A0A4D6GKX6_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
23,,A0A4D6GL01,A0A4D6GL01_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
24,,A0A4D6GL07,A0A4D6GL07_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
25,,A0A4D6GL81,A0A4D6GL81_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),64,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
26,,A0A7I2V3G7,A0A7I2V3G7_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),242,catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],,O-methyltransferase activity [GO:0008171]; catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],O-methyltransferase activity [GO:0008171],,,,
27,,F8WBW9,F8WBW9_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),199,catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],,O-methyltransferase activity [GO:0008171]; catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],O-methyltransferase activity [GO:0008171],,,,
28,,H7BZ45,H7BZ45_HUMAN,catechol O-methyltransferase (EC 2.1.1.6),COMT,Homo sapiens (Human),292,catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],,O-methyltransferase activity [GO:0008171]; catecholamine metabolic process [GO:0006584]; methylation [GO:0032259],O-methyltransferase activity [GO:0008171],,,,
29,,A3F6Y9,A3F6Y9_HUMAN,Catechol-O-methyltransferase isoform,COMT,Homo sapiens (Human),88,catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020],axon [GO:0030424]; dendrite [GO:0030425]; membrane [GO:0016020]; catechol O-methyltransferase activity [GO:0016206]; catecholamine catabolic process [GO:0042424]; developmental process [GO:0032502]; dopamine metabolic process [GO:0042417]; methylation [GO:0032259],catechol O-methyltransferase activity [GO:0016206],,,,
30,,A3F7Q5,A3F7Q5_HUMAN,Catechol-O-methyltransferase isoform,COMT,Homo sapiens (Human),13,methylation [GO:0032259],,methyltransferase activity [GO:0008168]; methylation [GO:0032259],methyltransferase activity [GO:0008168],,,,
31,,A3F7Q6,A3F7Q6_HUMAN,Catechol-O-methyltransferase isoform,COMT,Homo sapiens (Human),22,methylation [GO:0032259],,methyltransferase activity [GO:0008168]; methylation [GO:0032259],methyltransferase activity [GO:0008168],,,,
32,,F2WW53,F2WW53_HUMAN,Catechol-O-methyltransferase,COMT,Homo sapiens (Human),27,methylation [GO:0032259],,methyltransferase activity [GO:0008168]; methylation [GO:0032259],methyltransferase activity [GO:0008168],,,,
33,,F2WW55,F2WW55_HUMAN,Catechol-O-methyltransferase,COMT,Homo sapiens (Human),27,methylation [GO:0032259],,methyltransferase activity [GO:0008168]; methylation [GO:0032259],methyltransferase activity [GO:0008168],,,,
0,"(gene:""GSTP1"")",P09211,GSTP1_HUMAN,Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1),GSTP1 FAEES3 GST3,Homo sapiens (Human),210,cellular response to lipopolysaccharide [GO:0071222]; central nervous system development [GO:0007417]; common myeloid progenitor cell proliferation [GO:0035726]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biosynthetic process [GO:0009890]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nitric oxide storage [GO:0035732]; positive regulation of superoxide anion generation [GO:0032930]; prostaglandin metabolic process [GO:0006693]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of stress-activated MAPK cascade [GO:0032872]; response to reactive oxygen species [GO:0000302]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; TRAF2-GSTP1 complex [GO:0097057]; vesicle [GO:0031982],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; TRAF2-GSTP1 complex [GO:0097057]; vesicle [GO:0031982]; dinitrosyl-iron complex binding [GO:0035731]; fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; JUN kinase binding [GO:0008432]; kinase regulator activity [GO:0019207]; nitric oxide binding [GO:0070026]; S-nitrosoglutathione binding [GO:0035730]; cellular response to lipopolysaccharide [GO:0071222]; central nervous system development [GO:0007417]; common myeloid progenitor cell proliferation [GO:0035726]; glutathione derivative biosynthetic process [GO:1901687]; glutathione metabolic process [GO:0006749]; hepoxilin biosynthetic process [GO:0051122]; linoleic acid metabolic process [GO:0043651]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biosynthetic process [GO:0009890]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of leukocyte proliferation [GO:0070664]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; nitric oxide storage [GO:0035732]; positive regulation of superoxide anion generation [GO:0032930]; prostaglandin metabolic process [GO:0006693]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of stress-activated MAPK cascade [GO:0032872]; response to reactive oxygen species [GO:0000302]; xenobiotic metabolic process [GO:0006805],dinitrosyl-iron complex binding [GO:0035731]; fatty acid binding [GO:0005504]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; JUN kinase binding [GO:0008432]; kinase regulator activity [GO:0019207]; nitric oxide binding [GO:0070026]; S-nitrosoglutathione binding [GO:0035730],,,"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19269317}. Mitochondrion {ECO:0000269|PubMed:19269317}. Nucleus {ECO:0000269|PubMed:19269317}. Note=The 83 N-terminal amino acids function as un uncleaved transit peptide, and arginine residues within it are crucial for mitochondrial localization.",
1,,V9HWE9,V9HWE9_HUMAN,Glutathione S-transferase (EC 2.5.1.18) (GST class-pi),HEL-S-22 GSTP1 hCG_21055,Homo sapiens (Human),210,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU368105}. Mitochondrion {ECO:0000256|RuleBase:RU368105}. Nucleus {ECO:0000256|RuleBase:RU368105}.,
2,,A8MX94,A8MX94_HUMAN,glutathione transferase (EC 2.5.1.18) (GST class-pi),GSTP1,Homo sapiens (Human),174,,cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
3,,C7DJS1,C7DJS1_HUMAN,Glutathione S-transferase (EC 2.5.1.18) (GST class-pi),GSTP1,Homo sapiens (Human),151,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU368105}. Mitochondrion {ECO:0000256|RuleBase:RU368105}. Nucleus {ECO:0000256|RuleBase:RU368105}.,
4,,C7DJS2,C7DJS2_HUMAN,Glutathione S-transferase (EC 2.5.1.18) (GST class-pi),GSTP1,Homo sapiens (Human),151,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU368105}. Mitochondrion {ECO:0000256|RuleBase:RU368105}. Nucleus {ECO:0000256|RuleBase:RU368105}.,
5,,A0A087X243,A0A087X243_HUMAN,Glutathione S-transferase pi 1,GSTP1,Homo sapiens (Human),69,,,,,,,,
6,,A0A087X2E9,A0A087X2E9_HUMAN,glutathione transferase (EC 2.5.1.18),GSTP1,Homo sapiens (Human),79,,cytoplasm [GO:0005737],cytoplasm [GO:0005737],,,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
7,,A0A0M4UT83,A0A0M4UT83_HUMAN,Glutathione S-transferase P,GSTP1,Homo sapiens (Human),18,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
8,,A0A0M5MRY8,A0A0M5MRY8_HUMAN,Glutathione S-transferase P,GSTP1,Homo sapiens (Human),18,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
9,,A0A2P1FDF0,A0A2P1FDF0_HUMAN,Glutathione S-transferase pi 1,GSTP1,Homo sapiens (Human),24,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
10,,A0A2R8Y5E5,A0A2R8Y5E5_HUMAN,Glutathione S-transferase pi 1,GSTP1,Homo sapiens (Human),58,,,,,,,,
11,,A0A3B6XSH2,A0A3B6XSH2_HUMAN,Glutathione S-transferase pi 1,GSTP1,Homo sapiens (Human),34,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
12,,B2C310,B2C310_HUMAN,Glutathione S-transferase pi,GSTP1,Homo sapiens (Human),34,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
13,,Q5D6A5,Q5D6A5_HUMAN,Mutant GSTP1,GSTP1,Homo sapiens (Human),52,,,,,,,,
0,"(gene:""CYP11A1"")",P05108,CP11A_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (CYPXIA1) (Cholesterol desmolase) (Cytochrome P450 11A1) (Cytochrome P450(scc))",CYP11A1 CYP11A,Homo sapiens (Human),521,C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; sterol metabolic process [GO:0016125]; vitamin D metabolic process [GO:0042359],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; sterol metabolic process [GO:0016125]; vitamin D metabolic process [GO:0042359],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P14137}; Peripheral membrane protein {ECO:0000305}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000250|UniProtKB:P14137}.,
1,,A0A0S2Z3R3,A0A0S2Z3R3_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),521,C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
2,,A0A0S2Z3H9,A0A0S2Z3H9_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),79,C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; metal ion binding [GO:0046872]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; metal ion binding [GO:0046872],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
3,,A0A0S2Z3T5,A0A0S2Z3T5_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),98,C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; metal ion binding [GO:0046872]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; metal ion binding [GO:0046872],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
4,,C9JPU9,C9JPU9_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),96,C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
5,,C9JXV4,C9JXV4_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),168,C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
6,,E7EPP8,E7EPP8_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),414,C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
7,,H3BSZ1,H3BSZ1_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (Cholesterol desmolase)",CYP11A1,Homo sapiens (Human),227,C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; C21-steroid hormone metabolic process [GO:0008207]; cholesterol metabolic process [GO:0008203]; steroid biosynthetic process [GO:0006694],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000256|RuleBase:RU364077}; Peripheral membrane protein {ECO:0000256|RuleBase:RU364077}. Note=Localizes to the matrix side of the mitochondrion inner membrane. {ECO:0000256|RuleBase:RU364077}.,
8,,A0A0S2Z3M2,A0A0S2Z3M2_HUMAN,Cytochrome P450 family 11 subfamily A polypeptide 1 isoform 3,CYP11A1,Homo sapiens (Human),89,C21-steroid hormone metabolic process [GO:0008207],,cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386]; C21-steroid hormone metabolic process [GO:0008207],cholesterol monooxygenase (side-chain-cleaving) activity [GO:0008386],,,,
9,,H3BS93,H3BS93_HUMAN,Cytochrome P450 family 11 subfamily A member 1,CYP11A1,Homo sapiens (Human),26,,,,,,,,
10,,Q2HZF3,Q2HZF3_HUMAN,Cytochrome P450 family 11 subfamily A polypeptide 1,CYP11A1,Homo sapiens (Human),35,,,,,,,,
0,"(gene:""GSTT1"")",P30711,GSTT1_HUMAN,Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) (Glutathione transferase T1-1),GSTT1,Homo sapiens (Human),240,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,A0A0G2JMS2,A0A0G2JMS2_HUMAN,Glutathione S-transferase theta 1,GSTT1 hCG_39955,Homo sapiens (Human),44,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
2,,A0A0G2JQD2,A0A0G2JQD2_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),65,,,,,,,,
3,,A0A0G2JQD8,A0A0G2JQD8_HUMAN,Glutathione S-transferase theta 1,GSTT1 hCG_39955,Homo sapiens (Human),45,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
4,,A0A0G2JQM0,A0A0G2JQM0_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT1 hCG_39955,Homo sapiens (Human),97,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
5,,A0A0G2JRG0,A0A0G2JRG0_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),46,,,,,,,,
6,,A0A0G2JRJ5,A0A0G2JRJ5_HUMAN,Glutathione S-transferase theta 1,GSTT1 hCG_39955,Homo sapiens (Human),114,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
7,,A0A0G2JRN4,A0A0G2JRN4_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT1 hCG_39955,Homo sapiens (Human),105,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
8,,A0A0G2JRQ5,A0A0G2JRQ5_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),226,,cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364],glutathione transferase activity [GO:0004364],,,,
9,,A0A1B0GXB6,A0A1B0GXB6_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),65,,,,,,,,
10,,Q4GZS9,Q4GZS9_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),86,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
11,,Q4W251,Q4W251_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),66,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
12,,Q4W252,Q4W252_HUMAN,Glutathione S-transferase theta 1,GSTT1,Homo sapiens (Human),125,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
0,"(gene:""CYP11B1"")",P15538,C11B1_HUMAN,"Cytochrome P450 11B1, mitochondrial (CYP11B1) (CYPXIB1) (Cytochrome P-450c11) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase, CYP11B1) (EC 1.14.15.4)",CYP11B1 S11BH,Homo sapiens (Human),503,aldosterone biosynthetic process [GO:0032342]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to hormone stimulus [GO:0032870]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to potassium ion [GO:0035865]; cholesterol metabolic process [GO:0008203]; cortisol biosynthetic process [GO:0034651]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; regulation of blood pressure [GO:0008217]; sterol metabolic process [GO:0016125],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507]; aldosterone biosynthetic process [GO:0032342]; C21-steroid hormone biosynthetic process [GO:0006700]; cellular response to hormone stimulus [GO:0032870]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to potassium ion [GO:0035865]; cholesterol metabolic process [GO:0008203]; cortisol biosynthetic process [GO:0034651]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704]; glucose homeostasis [GO:0042593]; immune response [GO:0006955]; regulation of blood pressure [GO:0008217]; sterol metabolic process [GO:0016125],corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507],,,SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P14137}; Peripheral membrane protein {ECO:0000250|UniProtKB:P14137}.,
1,,A9UF29,A9UF29_HUMAN,Mitochondrial 11beta-hydroxylase,CYP11B1,Homo sapiens (Human),56,aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507]; aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507],,,,
2,,H0YBR4,H0YBR4_HUMAN,Cytochrome P450 family 11 subfamily B member 1,CYP11B1,Homo sapiens (Human),181,lipid metabolic process [GO:0006629]; organic hydroxy compound metabolic process [GO:1901615],,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]; organic hydroxy compound metabolic process [GO:1901615]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,Q4VAR0,Q4VAR0_HUMAN,CYP11B1 protein (Cytochrome P450 family 11 subfamily B member 1),CYP11B1,Homo sapiens (Human),574,lipid metabolic process [GO:0006629]; organic hydroxy compound metabolic process [GO:1901615],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]; organic hydroxy compound metabolic process [GO:1901615]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
4,,Q8TE39,Q8TE39_HUMAN,Steroid 11-beta-hydroxylase (EC 1.14.15.4),CYP11B1,Homo sapiens (Human),186,aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507]; aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],corticosterone 18-monooxygenase activity [GO:0047783]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 11-beta-monooxygenase activity [GO:0004507],,,,
5,,Q8TE40,Q8TE40_HUMAN,Steroid 11-beta-hydroxylase (EC 1.14.15.4),CYP11B1,Homo sapiens (Human),51,aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; corticosterone 18-monooxygenase activity [GO:0047783]; steroid 11-beta-monooxygenase activity [GO:0004507]; aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],corticosterone 18-monooxygenase activity [GO:0047783]; steroid 11-beta-monooxygenase activity [GO:0004507],,,,
6,,D2KC07,D2KC07_HUMAN,Truncated mitochondrial cytochrome P450 11B1,CYP11B1,Homo sapiens (Human),51,aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],mitochondrial inner membrane [GO:0005743],mitochondrial inner membrane [GO:0005743]; corticosterone 18-monooxygenase activity [GO:0047783]; steroid 11-beta-monooxygenase activity [GO:0004507]; aldosterone biosynthetic process [GO:0032342]; cellular response to peptide hormone stimulus [GO:0071375]; cholesterol metabolic process [GO:0008203]; cortisol metabolic process [GO:0034650]; glucocorticoid biosynthetic process [GO:0006704],corticosterone 18-monooxygenase activity [GO:0047783]; steroid 11-beta-monooxygenase activity [GO:0004507],,,,
7,,Q8TE38,Q8TE38_HUMAN,Steroid 11-beta-hydroxylase (EC 1.14.15.4),CYP11B1,Homo sapiens (Human),37,,,steroid 11-beta-monooxygenase activity [GO:0004507],steroid 11-beta-monooxygenase activity [GO:0004507],,,,
8,,Q8TE41,Q8TE41_HUMAN,Truncated steroid 11beta-hydroxylase,CYP11B1,Homo sapiens (Human),20,,,,,,,,
0,"(gene:""GSTT2"")",P0CG30,GSTT2_HUMAN,Glutathione S-transferase theta-2B (EC 2.5.1.18) (Glutathione S-transferase theta-2) (GST class-theta-2),GSTT2B GSTT2,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:1417752}.",
1,,P0CG29,GST2_HUMAN,Glutathione S-transferase theta-2 (EC 2.5.1.18) (GST class-theta-2),GSTT2,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:1417752}. Nucleus {ECO:0000250|UniProtKB:P30713}.",
2,,G9J6Q4,G9J6Q4_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
3,,G9J6Q5,G9J6Q5_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2 hCG_41095,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
4,,G9J6Q6,G9J6Q6_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
5,,Q6IB75,Q6IB75_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytosol [GO:0005829],cytosol [GO:0005829]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,,
6,,Q6ICJ4,Q6ICJ4_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2B Em:AP000351.3 GSTT2 hCG_41095,Homo sapiens (Human),230,,,glutathione transferase activity [GO:0004364],glutathione transferase activity [GO:0004364],,,,
7,,A0AAG2UWG5,A0AAG2UWG5_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2,Homo sapiens (Human),230,,,,,,,,
0,"(gene:""CYP17A1"")",P05093,CP17A_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)",CYP17A1 CYP17 S17AH,Homo sapiens (Human),508,androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202],axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025],axon [GO:0030424]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508]; androgen biosynthetic process [GO:0006702]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; sex differentiation [GO:0007548]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202],heme binding [GO:0020037]; iron ion binding [GO:0005506]; lyase activity [GO:0016829]; oxygen binding [GO:0019825]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:2808364}. Microsome membrane {ECO:0000305|PubMed:2808364}.,
1,,A0A1W2PQ28,A0A1W2PQ28_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Steroid 17-alpha-monooxygenase)",CYP17A1,Homo sapiens (Human),356,hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
2,,A0A1W2PQT5,A0A1W2PQT5_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Steroid 17-alpha-monooxygenase)",CYP17A1,Homo sapiens (Human),479,hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
3,,A0A1W2PRK7,A0A1W2PRK7_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Steroid 17-alpha-monooxygenase)",CYP17A1,Homo sapiens (Human),509,hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
4,,A0A1W2PRY0,A0A1W2PRY0_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Steroid 17-alpha-monooxygenase)",CYP17A1,Homo sapiens (Human),407,hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; hormone metabolic process [GO:0042445]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
5,,Q1HB44,Q1HB44_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Steroid 17-alpha-monooxygenase)",CYP17A1 hCG_22577,Homo sapiens (Human),508,glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],axon [GO:0030424]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025],axon [GO:0030424]; endoplasmic reticulum membrane [GO:0005789]; neuronal cell body [GO:0043025]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; glucocorticoid biosynthetic process [GO:0006704]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
6,,A0A1L7H7K7,A0A1L7H7K7_HUMAN,Steroid 17-alpha-monooxygenase,CYP17A1,Homo sapiens (Human),53,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
7,,A0A1L7H7L1,A0A1L7H7L1_HUMAN,Steroid 17-alpha-monooxygenase,CYP17A1,Homo sapiens (Human),49,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
8,,A0A1L7H7S6,A0A1L7H7S6_HUMAN,Steroid 17-alpha-monooxygenase,CYP17A1,Homo sapiens (Human),56,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004586}. Microsome membrane {ECO:0000256|ARBA:ARBA00004524}.,
9,,C7F7K7,C7F7K7_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.99.9)",CYP17A1,Homo sapiens (Human),23,,,lyase activity [GO:0016829]; oxidoreductase activity [GO:0016491],lyase activity [GO:0016829]; oxidoreductase activity [GO:0016491],,,,
0,"(gene:""GSTT2B"")",P0CG30,GSTT2_HUMAN,Glutathione S-transferase theta-2B (EC 2.5.1.18) (Glutathione S-transferase theta-2) (GST class-theta-2),GSTT2B GSTT2,Homo sapiens (Human),244,glutathione metabolic process [GO:0006749],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutathione transferase activity [GO:0004364]; glutathione metabolic process [GO:0006749],glutathione transferase activity [GO:0004364],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:1417752}.",
1,,Q6ICJ4,Q6ICJ4_HUMAN,glutathione transferase (EC 2.5.1.18),GSTT2B Em:AP000351.3 GSTT2 hCG_41095,Homo sapiens (Human),230,,,glutathione transferase activity [GO:0004364],glutathione transferase activity [GO:0004364],,,,
0,"(gene:""CYP19A1"")",P11511,CP19A_HUMAN,Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase),CYP19A1 ARO1 CYAR CYP19,Homo sapiens (Human),503,androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]; female genitalia development [GO:0030540]; female gonad development [GO:0008585]; mammary gland development [GO:0030879]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of estradiol secretion [GO:2000866]; prostate gland growth [GO:0060736]; response to estradiol [GO:0032355]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; syncytium formation [GO:0006949]; testosterone biosynthetic process [GO:0061370]; uterus development [GO:0060065],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; aromatase activity [GO:0070330]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; androgen catabolic process [GO:0006710]; estrogen biosynthetic process [GO:0006703]; female genitalia development [GO:0030540]; female gonad development [GO:0008585]; mammary gland development [GO:0030879]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of macrophage chemotaxis [GO:0010760]; positive regulation of estradiol secretion [GO:2000866]; prostate gland growth [GO:0060736]; response to estradiol [GO:0032355]; steroid biosynthetic process [GO:0006694]; sterol metabolic process [GO:0016125]; syncytium formation [GO:0006949]; testosterone biosynthetic process [GO:0061370]; uterus development [GO:0060065]","aromatase activity [GO:0070330]; electron transfer activity [GO:0009055]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]",,"TRANSMEM 19..39; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 303..323; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:2973313}; Multi-pass membrane protein {ECO:0000305}. Microsome membrane {ECO:0000269|PubMed:2973313}; Multi-pass membrane protein {ECO:0000305}.,
1,,E7EQ08,E7EQ08_HUMAN,Aromatase (CYPXIX) (Cytochrome P450 19A1),CYP19A1,Homo sapiens (Human),352,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,E9PGZ6,E9PGZ6_HUMAN,Cytochrome P450 family 19 subfamily A member 1,CYP19A1,Homo sapiens (Human),166,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,H0YK57,H0YK57_HUMAN,Aromatase (CYPXIX) (Cytochrome P450 19A1),CYP19A1,Homo sapiens (Human),138,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..35; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,H0YKN1,H0YKN1_HUMAN,Cytochrome P450 family 19 subfamily A member 1,CYP19A1,Homo sapiens (Human),172,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,H0YLS2,H0YLS2_HUMAN,Cytochrome P450 family 19 subfamily A member 1,CYP19A1,Homo sapiens (Human),164,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,Q05CU4,Q05CU4_HUMAN,Aromatase (CYPXIX) (Cytochrome P450 19A1),CYP19A1,Homo sapiens (Human),360,female gonad development [GO:0008585]; response to estradiol [GO:0032355],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; female gonad development [GO:0008585]; response to estradiol [GO:0032355],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 20..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
7,,Q45RG7,Q45RG7_HUMAN,Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase),CYP19A1,Homo sapiens (Human),503,female gonad development [GO:0008585]; response to estradiol [GO:0032355],endoplasmic reticulum [GO:0005783],endoplasmic reticulum [GO:0005783]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; female gonad development [GO:0008585]; response to estradiol [GO:0032355],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
8,,Q7Z471,Q7Z471_HUMAN,Aromatase (CYPXIX) (Cytochrome P450 19A1),CYP19A1,Homo sapiens (Human),359,female gonad development [GO:0008585]; response to estradiol [GO:0032355],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; female gonad development [GO:0008585]; response to estradiol [GO:0032355],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 20..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
9,,Q8IYG4,Q8IYG4_HUMAN,Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase),CYP19A1,Homo sapiens (Human),503,female gonad development [GO:0008585]; response to estradiol [GO:0032355],endoplasmic reticulum [GO:0005783],endoplasmic reticulum [GO:0005783]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; female gonad development [GO:0008585]; response to estradiol [GO:0032355],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
10,,E7EPL6,E7EPL6_HUMAN,Cytochrome P450 family 19 subfamily A member 1,CYP19A1,Homo sapiens (Human),242,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
11,,H0YLP1,H0YLP1_HUMAN,Cytochrome P450 family 19 subfamily A member 1,CYP19A1,Homo sapiens (Human),283,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
12,,H0YNJ7,H0YNJ7_HUMAN,Cytochrome P450 family 19 subfamily A member 1,CYP19A1,Homo sapiens (Human),244,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""IL4I1"")",Q96RQ9,OXLA_HUMAN,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (EC 1.4.3.25) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (hIL4I1) (Protein Fig-1) (hFIG1),IL4I1 FIG1 UNQ636/PRO1265,Homo sapiens (Human),567,adaptive immune response [GO:0002250]; amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572],acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225],acrosomal vesicle [GO:0001669]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; lysosome [GO:0005764]; sperm midpiece [GO:0097225]; L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; polyamine oxidase activity [GO:0046592]; adaptive immune response [GO:0002250]; amino acid catabolic process [GO:0009063]; L-phenylalanine catabolic process [GO:0006559]; negative regulation of T cell activation [GO:0050868]; negative regulation of T cell mediated immune response to tumor cell [GO:0002841]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of adaptive immune response [GO:0002819]; regulation of B cell differentiation [GO:0045577]; tryptophan catabolic process [GO:0006569]; tryptophan catabolic process to indole-3-acetate [GO:0019440]; tyrosine catabolic process [GO:0006572],L-amino-acid oxidase activity [GO:0001716]; L-phenylalaine oxidase activity [GO:0106329]; polyamine oxidase activity [GO:0046592],,,"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:17356132, ECO:0000269|PubMed:28891065, ECO:0000269|PubMed:32818467}. Lysosome {ECO:0000250|UniProtKB:O09046}. Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000269|PubMed:25767141}. Note=Secreted at the immunological synapse. {ECO:0000269|PubMed:28891065}.",
1,,A2RRH1,A2RRH1_HUMAN,Amine oxidase (EC 1.4.3.-),IL4I1,Homo sapiens (Human),589,,,primary amine oxidase activity [GO:0008131],primary amine oxidase activity [GO:0008131],,,,
2,,M0QXY7,M0QXY7_HUMAN,Interleukin 4 induced 1,IL4I1,Homo sapiens (Human),82,,,,,,,,
3,,M0QYH9,M0QYH9_HUMAN,Interleukin 4 induced 1,IL4I1,Homo sapiens (Human),71,,,,,,,,
4,,M0QYW8,M0QYW8_HUMAN,Interleukin 4 induced 1,IL4I1,Homo sapiens (Human),150,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
5,,M0R1L1,M0R1L1_HUMAN,Interleukin 4 induced 1,IL4I1,Homo sapiens (Human),106,,,,,,,,
6,,M0R2S9,M0R2S9_HUMAN,Interleukin 4 induced 1,IL4I1,Homo sapiens (Human),32,,,,,,,,
0,"(gene:""CYP1A1"")",A0N0X8,A0N0X8_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1 hCG_40803,Homo sapiens (Human),512,9-cis-retinoic acid biosynthetic process [GO:0042904]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cellular response to copper ion [GO:0071280]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; maternal process involved in parturition [GO:0060137]; nitric oxide metabolic process [GO:0046209]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; progesterone metabolic process [GO:0042448]; response to 3-methylcholanthrene [GO:1904681]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]; tissue remodeling [GO:0048771],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743],"endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; steroid 17-alpha-monooxygenase activity [GO:0004508]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cellular response to copper ion [GO:0071280]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; maternal process involved in parturition [GO:0060137]; nitric oxide metabolic process [GO:0046209]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; progesterone metabolic process [GO:0042448]; response to 3-methylcholanthrene [GO:1904681]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]; tissue remodeling [GO:0048771]","aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; steroid 17-alpha-monooxygenase activity [GO:0004508]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
1,,A4F3V8,A4F3V8_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1,Homo sapiens (Human),175,retinol metabolic process [GO:0042572],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; retinol metabolic process [GO:0042572],aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
2,,A4F4K3,A4F4K3_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1,Homo sapiens (Human),229,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
3,,A4F4K4,A4F4K4_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1,Homo sapiens (Human),251,retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
4,,E7EMT5,E7EMT5_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1,Homo sapiens (Human),483,retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
5,,P04798,CP1A1_HUMAN,Cytochrome P450 1A1 (CYPIA1) (EC 1.14.14.1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),CYP1A1,Homo sapiens (Human),512,9-cis-retinoic acid biosynthetic process [GO:0042904]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; nitric oxide metabolic process [GO:0046209]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to 3-methylcholanthrene [GO:1904681]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; tissue remodeling [GO:0048771]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743],"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]; 9-cis-retinoic acid biosynthetic process [GO:0042904]; amine metabolic process [GO:0009308]; camera-type eye development [GO:0043010]; cellular response to copper ion [GO:0071280]; cellular response to organic cyclic compound [GO:0071407]; coumarin metabolic process [GO:0009804]; dibenzo-p-dioxin catabolic process [GO:0019341]; digestive tract development [GO:0048565]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; ethylene metabolic process [GO:0009692]; fatty acid metabolic process [GO:0006631]; flavonoid metabolic process [GO:0009812]; hepatocyte differentiation [GO:0070365]; hydrogen peroxide biosynthetic process [GO:0050665]; insecticide metabolic process [GO:0017143]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in parturition [GO:0060137]; nitric oxide metabolic process [GO:0046209]; omega-hydroxylase P450 pathway [GO:0097267]; porphyrin-containing compound metabolic process [GO:0006778]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; response to 3-methylcholanthrene [GO:1904681]; response to arsenic-containing substance [GO:0046685]; response to food [GO:0032094]; response to herbicide [GO:0009635]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to immobilization stress [GO:0035902]; response to iron(III) ion [GO:0010041]; response to lipopolysaccharide [GO:0032496]; response to nematode [GO:0009624]; response to vitamin A [GO:0033189]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; tissue remodeling [GO:0048771]; vitamin D metabolic process [GO:0042359]; xenobiotic metabolic process [GO:0006805]","arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; demethylase activity [GO:0032451]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; flavonoid 3'-monooxygenase activity [GO:0016711]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on diphenols and related substances as donors [GO:0016679]; oxygen binding [GO:0019825]; vitamin D 24-hydroxylase activity [GO:0070576]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P00185}; Peripheral membrane protein {ECO:0000250|UniProtKB:P00185}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:P00185}; Peripheral membrane protein {ECO:0000250|UniProtKB:P00185}. Microsome membrane {ECO:0000250|UniProtKB:P00185}; Peripheral membrane protein {ECO:0000250|UniProtKB:P00185}. Cytoplasm {ECO:0000250|UniProtKB:P00185}.,
6,,Q0VHD5,Q0VHD5_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1,Homo sapiens (Human),483,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
7,,Q5J9B1,Q5J9B1_HUMAN,Cytochrome P450 1A (EC 1.14.14.1),CYP1A1,Homo sapiens (Human),484,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572],aromatase activity [GO:0070330]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Microsome membrane {ECO:0000256|RuleBase:RU368045}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368045}. Membrane {ECO:0000256|ARBA:ARBA00004170}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004170}.,
0,"(gene:""LOXL2"")",Q9Y4K0,LOXL2_HUMAN,Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14),LOXL2,Homo sapiens (Human),774,collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein modification process [GO:0036211]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040],basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],basement membrane [GO:0005604]; chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720]; collagen fibril organization [GO:0030199]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epithelial to mesenchymal transition [GO:0001837]; heterochromatin organization [GO:0070828]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of stem cell population maintenance [GO:1902455]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; protein modification process [GO:0036211]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040],calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; oligosaccharide binding [GO:0070492]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane {ECO:0000269|PubMed:23319596}. Nucleus {ECO:0000269|PubMed:22204712, ECO:0000269|PubMed:24414204}. Chromosome {ECO:0000269|PubMed:27735137}. Endoplasmic reticulum {ECO:0000269|PubMed:28332555}. Note=Associated with chromatin (PubMed:27735137). It is unclear how LOXL2 is nuclear as it contains a signal sequence and has been shown to be secreted (PubMed:23319596). However, a number of reports confirm its intracellular location and its key role in transcription regulation (PubMed:22204712, PubMed:22483618). {ECO:0000269|PubMed:22204712, ECO:0000269|PubMed:23319596, ECO:0000269|PubMed:24414204, ECO:0000269|PubMed:27735137}.",
1,,W6I206,W6I206_HUMAN,Lysyl oxidase homolog (EC 1.4.3.13),LOXL2,Homo sapiens (Human),729,chromatin organization [GO:0006325]; collagen fibril organization [GO:0030199],basement membrane [GO:0005604]; chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],basement membrane [GO:0005604]; chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; chromatin organization [GO:0006325]; collagen fibril organization [GO:0030199],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Chromosome {ECO:0000256|ARBA:ARBA00004286}. Endoplasmic reticulum {ECO:0000256|ARBA:ARBA00004240}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Nucleus {ECO:0000256|ARBA:ARBA00004123}. Secreted, extracellular space, extracellular matrix, basement membrane {ECO:0000256|ARBA:ARBA00004302}.",
2,,W8QRJ0,W8QRJ0_HUMAN,Lysyl oxidase homolog (EC 1.4.3.13),LOXL2,Homo sapiens (Human),752,chromatin organization [GO:0006325]; collagen fibril organization [GO:0030199],basement membrane [GO:0005604]; chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],basement membrane [GO:0005604]; chromosome [GO:0005694]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; chromatin organization [GO:0006325]; collagen fibril organization [GO:0030199],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Chromosome {ECO:0000256|ARBA:ARBA00004286}. Endoplasmic reticulum {ECO:0000256|ARBA:ARBA00004240}. Membrane {ECO:0000256|ARBA:ARBA00004370}. Nucleus {ECO:0000256|ARBA:ARBA00004123}. Secreted, extracellular space, extracellular matrix, basement membrane {ECO:0000256|ARBA:ARBA00004302}.",
3,,E5RI22,E5RI22_HUMAN,Lysyl oxidase homolog 2 (Lysyl oxidase-like protein 2),LOXL2,Homo sapiens (Human),139,,membrane [GO:0016020],membrane [GO:0016020],,,,,
4,,E5RJL2,E5RJL2_HUMAN,Lysyl oxidase homolog 2 (Lysyl oxidase-like protein 2),LOXL2,Homo sapiens (Human),151,,membrane [GO:0016020],membrane [GO:0016020],,,,,
5,,H0YAR1,H0YAR1_HUMAN,Lysyl oxidase homolog 2 (Lysyl oxidase-like protein 2),LOXL2,Homo sapiens (Human),207,,membrane [GO:0016020],membrane [GO:0016020],,,,,
6,,E5RFE2,E5RFE2_HUMAN,Lysyl oxidase like 2,LOXL2,Homo sapiens (Human),95,,membrane [GO:0016020],membrane [GO:0016020],,,,,
7,,E5RFY0,E5RFY0_HUMAN,Lysyl oxidase homolog 2 (Lysyl oxidase-like protein 2),LOXL2,Homo sapiens (Human),258,,membrane [GO:0016020],membrane [GO:0016020],,,,,
8,,E5RHH3,E5RHH3_HUMAN,Lysyl oxidase homolog 2 (Lysyl oxidase-like protein 2),LOXL2,Homo sapiens (Human),218,,membrane [GO:0016020],membrane [GO:0016020],,,,,
9,,H0YAP6,H0YAP6_HUMAN,Lysyl oxidase homolog 2 (Lysyl oxidase-like protein 2),LOXL2,Homo sapiens (Human),67,,membrane [GO:0016020],membrane [GO:0016020],,,,,
10,,R4GMS2,R4GMS2_HUMAN,Lysyl oxidase like 2,LOXL2,Homo sapiens (Human),101,,,,,,,,
0,"(gene:""CYP1A2"")",P05177,CP1A2_HUMAN,Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),CYP1A2,Homo sapiens (Human),516,aflatoxin metabolic process [GO:0046222]; alkaloid metabolic process [GO:0009820]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cholesterol metabolic process [GO:0008203]; dibenzo-p-dioxin metabolic process [GO:0018894]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; hydrogen peroxide biosynthetic process [GO:0050665]; long-chain fatty acid biosynthetic process [GO:0042759]; lung development [GO:0030324]; methylation [GO:0032259]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; aflatoxin metabolic process [GO:0046222]; alkaloid metabolic process [GO:0009820]; cellular respiration [GO:0045333]; cellular response to cadmium ion [GO:0071276]; cholesterol metabolic process [GO:0008203]; dibenzo-p-dioxin metabolic process [GO:0018894]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; hydrogen peroxide biosynthetic process [GO:0050665]; long-chain fatty acid biosynthetic process [GO:0042759]; lung development [GO:0030324]; methylation [GO:0032259]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidative demethylation [GO:0070989]; porphyrin-containing compound metabolic process [GO:0006778]; post-embryonic development [GO:0009791]; regulation of gene expression [GO:0010468]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; toxin biosynthetic process [GO:0009403]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; demethylase activity [GO:0032451]; electron transfer activity [GO:0009055]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.,
0,"(gene:""LOXL3"")",P58215,LOXL3_HUMAN,Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3),LOXL3 LOXL,Homo sapiens (Human),753,collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720]; collagen fibril organization [GO:0030199]; epithelial to mesenchymal transition [GO:0001837]; fibronectin fibril organization [GO:1905590]; inflammatory response [GO:0006954]; lung development [GO:0030324]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; peptidyl-lysine oxidation [GO:0018057]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; roof of mouth development [GO:0060021]; somite development [GO:0061053]; spinal cord development [GO:0021510],copper ion binding [GO:0005507]; fibronectin binding [GO:0001968]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000250|UniProtKB:Q9Z175}. Cytoplasm {ECO:0000269|PubMed:28065600}. Nucleus {ECO:0000269|PubMed:28065600}. Note=It is unclear how LOXL3 is both intracellular (cytoplasmic and nuclear) and extracellular: it contains a clear signal sequence and is predicted to localize in the extracellular medium. However, the intracellular location is clearly reported and at least another protein of the family (LOXL2) also has intracellular and extracellular localization despite the presence of a signal sequence (PubMed:28065600). {ECO:0000269|PubMed:28065600}.; SUBCELLULAR LOCATION: [Isoform 1]: Secreted, extracellular space {ECO:0000305}.; SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm {ECO:0000269|PubMed:17018530}. Secreted, extracellular space {ECO:0000269|PubMed:17018530}.",
1,,B8ZZT6,B8ZZT6_HUMAN,Lysyl oxidase homolog (EC 1.4.3.13),LOXL3,Homo sapiens (Human),471,,extracellular space [GO:0005615]; membrane [GO:0016020],extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000256|RuleBase:RU367046}.",
2,,B9A025,B9A025_HUMAN,Lysyl oxidase homolog (EC 1.4.3.13),LOXL3,Homo sapiens (Human),586,,extracellular space [GO:0005615]; membrane [GO:0016020],extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000256|RuleBase:RU367046}.",
3,,E7END4,E7END4_HUMAN,Lysyl oxidase homolog (EC 1.4.3.13),LOXL3,Homo sapiens (Human),697,,extracellular space [GO:0005615]; membrane [GO:0016020],extracellular space [GO:0005615]; membrane [GO:0016020]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000256|RuleBase:RU367046}.",
4,,C9J5M1,C9J5M1_HUMAN,Lysyl oxidase like 3,LOXL3,Homo sapiens (Human),303,,membrane [GO:0016020],membrane [GO:0016020],,,,,
5,,H7C248,H7C248_HUMAN,Lysyl oxidase like 3,LOXL3,Homo sapiens (Human),180,,membrane [GO:0016020],membrane [GO:0016020],,,,,
6,,L8E911,L8E911_HUMAN,Alternative protein LOXL3,LOXL3,Homo sapiens (Human),49,,,,,,,,
7,,Q53TY1,Q53TY1_HUMAN,Uncharacterized protein LOXL3,LOXL3,Homo sapiens (Human),526,,membrane [GO:0016020],membrane [GO:0016020],,,,,
0,"(gene:""CYP1B1"")",Q16678,CP1B1_HUMAN,Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),CYP1B1,Homo sapiens (Human),543,adrenal gland development [GO:0030325]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; benzene-containing compound metabolic process [GO:0042537]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to cAMP [GO:0071320]; cellular response to cortisol stimulus [GO:0071387]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to organic cyclic compound [GO:0071407]; cellular response to progesterone stimulus [GO:0071393]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; collagen fibril organization [GO:0030199]; DNA modification [GO:0006304]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; estrous cycle [GO:0044849]; ganglion development [GO:0061548]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; male gonad development [GO:0008584]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of translation [GO:0045727]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to 3-methylcholanthrene [GO:1904681]; response to arsenic-containing substance [GO:0046685]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to indole-3-methanol [GO:0071680]; response to nutrient [GO:0007584]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],"endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; adrenal gland development [GO:0030325]; angiogenesis [GO:0001525]; arachidonic acid metabolic process [GO:0019369]; benzene-containing compound metabolic process [GO:0042537]; blood vessel endothelial cell migration [GO:0043534]; blood vessel morphogenesis [GO:0048514]; cell adhesion [GO:0007155]; cellular response to cAMP [GO:0071320]; cellular response to cortisol stimulus [GO:0071387]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to organic cyclic compound [GO:0071407]; cellular response to progesterone stimulus [GO:0071393]; cellular response to toxic substance [GO:0097237]; cellular response to tumor necrosis factor [GO:0071356]; collagen fibril organization [GO:0030199]; DNA modification [GO:0006304]; endothelial cell migration [GO:0043542]; endothelial cell-cell adhesion [GO:0071603]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; estrous cycle [GO:0044849]; ganglion development [GO:0061548]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; male gonad development [GO:0008584]; membrane lipid catabolic process [GO:0046466]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; nitric oxide biosynthetic process [GO:0006809]; omega-hydroxylase P450 pathway [GO:0097267]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of translation [GO:0045727]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of reactive oxygen species metabolic process [GO:2000377]; response to 3-methylcholanthrene [GO:1904681]; response to arsenic-containing substance [GO:0046685]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to follicle-stimulating hormone [GO:0032354]; response to indole-3-methanol [GO:0071680]; response to nutrient [GO:0007584]; retinal blood vessel morphogenesis [GO:0061304]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; sterol metabolic process [GO:0016125]; toxin metabolic process [GO:0009404]; trabecular meshwork development [GO:0002930]; xenobiotic metabolic process [GO:0006805]","aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q64429}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q64429}. Microsome membrane {ECO:0000250|UniProtKB:Q64429}; Peripheral membrane protein {ECO:0000250|UniProtKB:Q64429}. Mitochondrion {ECO:0000250|UniProtKB:Q64429}. Note=Located primarily in endoplasmic reticulum. Upon treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), CYP1B1 is also targeted to mitochondria. {ECO:0000250|UniProtKB:Q64429}.",
1,,A0A087WUQ7,A0A087WUQ7_HUMAN,Cytochrome P450 family 1 subfamily B member 1,CYP1B1,Homo sapiens (Human),143,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..40; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
2,,A0A087WW26,A0A087WW26_HUMAN,Cytochrome P450 family 1 subfamily B member 1,CYP1B1,Homo sapiens (Human),172,hormone metabolic process [GO:0042445]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; hormone metabolic process [GO:0042445]; steroid metabolic process [GO:0008202]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,,
3,,A0A2R4CIF1,A0A2R4CIF1_HUMAN,Dioxin-inducible cytochrome p450,CYP1B1,Homo sapiens (Human),195,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,,
4,,D0EZN8,D0EZN8_HUMAN,Cytochrome p450 (EC 1.14.14.1),CYP1B1,Homo sapiens (Human),59,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,,
5,,Q4U3K8,Q4U3K8_HUMAN,Cytochrome P450 1B1,CYP1B1,Homo sapiens (Human),195,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,,
6,,Q53TK1,Q53TK1_HUMAN,"Cytochrome P450, family 1, subfamily B, polypeptide 1, isoform CRA_a (cDNA, FLJ93081, Homo sapiens cytochrome P450, family 1, subfamily B, polypeptide 1(CYP1B1), mRNA)",CYP1B1 hCG_14819,Homo sapiens (Human),543,hormone metabolic process [GO:0042445]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]; hormone metabolic process [GO:0042445]; steroid metabolic process [GO:0008202]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,,
7,,C1KDE6,C1KDE6_HUMAN,Cytochrome P450,CYP1B1,Homo sapiens (Human),142,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
8,,C1KDE7,C1KDE7_HUMAN,Cytochrome P450,CYP1B1,Homo sapiens (Human),202,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..40; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
9,,C1KDE8,C1KDE8_HUMAN,Cytochrome P450,CYP1B1,Homo sapiens (Human),154,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; steroid hydroxylase activity [GO:0008395]",,,,
10,,D0EZN5,D0EZN5_HUMAN,Truncated cytochrome P450 (EC 1.14.14.1),CYP1B1,Homo sapiens (Human),44,,membrane [GO:0016020],membrane [GO:0016020]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..28; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
11,,D0EZN6,D0EZN6_HUMAN,Cytochrome p450 (EC 1.14.14.1),CYP1B1,Homo sapiens (Human),40,,,aromatase activity [GO:0070330],aromatase activity [GO:0070330],,,,
12,,D0EZN7,D0EZN7_HUMAN,Cytochrome p450 (EC 1.14.14.1),CYP1B1,Homo sapiens (Human),31,,,aromatase activity [GO:0070330],aromatase activity [GO:0070330],,,,
13,,Q2EN00,Q2EN00_HUMAN,Mutant cytochrome p450,CYP1B1,Homo sapiens (Human),150,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..40; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
14,,Q2HZ43,Q2HZ43_HUMAN,Dioxin-inducible cytochrome P450,CYP1B1,Homo sapiens (Human),347,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,,
0,"(gene:""LOXL4"")",Q96JB6,LOXL4_HUMAN,Lysyl oxidase homolog 4 (EC 1.4.3.13) (Lysyl oxidase-like protein 4) (Lysyl oxidase-related protein C),LOXL4 LOXC,Homo sapiens (Human),756,collagen fibril organization [GO:0030199],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235],collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; receptor complex [GO:0043235]; copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720]; collagen fibril organization [GO:0030199],copper ion binding [GO:0005507]; protein-lysine 6-oxidase activity [GO:0004720],,,"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000305}.",
0,"(gene:""CYP20A1"")",Q6UW02,CP20A_HUMAN,Cytochrome P450 20A1 (EC 1.14.-.-),CYP20A1 UNQ667/PRO1301,Homo sapiens (Human),462,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 4..24; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,
1,,E9PHG5,E9PHG5_HUMAN,Cytochrome P450 family 20 subfamily A member 1,CYP20A1,Homo sapiens (Human),470,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,C9J8K7,C9J8K7_HUMAN,Cytochrome P450 family 20 subfamily A member 1,CYP20A1,Homo sapiens (Human),258,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,F2Z3K6,F2Z3K6_HUMAN,Cytochrome P450 family 20 subfamily A member 1,CYP20A1,Homo sapiens (Human),44,,,,,,,,
4,,F8WBE2,F8WBE2_HUMAN,Cytochrome P450 family 20 subfamily A member 1,CYP20A1,Homo sapiens (Human),208,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
5,,Q53RS5,Q53RS5_HUMAN,Uncharacterized protein CYP20A1,CYP20A1,Homo sapiens (Human),79,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
6,,Q567U3,Q567U3_HUMAN,CYP20A1 protein,CYP20A1,Homo sapiens (Human),416,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""LTA4H"")",P09960,LKHA4_HUMAN,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4),LTA4H LTA4,Homo sapiens (Human),611,leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509],aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:6490615}.,
1,,Q49AK0,Q49AK0_HUMAN,LTA4H protein,LTA4H,Homo sapiens (Human),149,leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171],cytosol [GO:0005829]; nucleus [GO:0005634],cytosol [GO:0005829]; nucleus [GO:0005634]; aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270]; leukotriene biosynthetic process [GO:0019370]; peptide catabolic process [GO:0043171],aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],,,,
2,,B4DEH5,B4DEH5_HUMAN,"Leukotriene A4 hydrolase (cDNA FLJ51712, moderately similar to Leukotriene A-4 hydrolase)",LTA4H,Homo sapiens (Human),132,,,hydrolase activity [GO:0016787],hydrolase activity [GO:0016787],,,,
0,"(gene:""CYP24A1"")",Q07973,CP24A_HUMAN,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)",CYP24A1 CYP24,Homo sapiens (Human),514,osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin D receptor signaling pathway [GO:0070561]; vitamin metabolic process [GO:0006766],mitochondrial inner membrane [GO:0005743],"mitochondrial inner membrane [GO:0005743]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [GO:0030342]; 25-hydroxycholecalciferol-23-hydroxylase activity [GO:0062180]; 25-hydroxycholecalciferol-24-hydroxylase activity [GO:0008403]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; vitamin D 25-hydroxylase activity [GO:0070643]; osteoblast differentiation [GO:0001649]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin D receptor signaling pathway [GO:0070561]; vitamin metabolic process [GO:0006766]","1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; 1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity [GO:0030342]; 25-hydroxycholecalciferol-23-hydroxylase activity [GO:0062180]; 25-hydroxycholecalciferol-24-hydroxylase activity [GO:0008403]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; vitamin D 25-hydroxylase activity [GO:0070643]",,,SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250|UniProtKB:Q09128}.,
0,"(gene:""MAOA"")",P21397,AOFA_HUMAN,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),MAOA,Homo sapiens (Human),527,biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; positive regulation of signal transduction [GO:0009967],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; aliphatic amine oxidase activity [GO:0052595]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131]; biogenic amine metabolic process [GO:0006576]; dopamine catabolic process [GO:0042420]; positive regulation of signal transduction [GO:0009967],aliphatic amine oxidase activity [GO:0052595]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131],"TOPO_DOM 1..497; /note=""Cytoplasmic""; /evidence=""ECO:0000269|PubMed:18391214""; TOPO_DOM 519..527; /note=""Mitochondrial intermembrane""; /evidence=""ECO:0000269|PubMed:18391214""","TRANSMEM 498..518; /note=""Helical; Anchor for type IV membrane protein""",SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000250|UniProtKB:P21396}; Single-pass type IV membrane protein {ECO:0000250|UniProtKB:P21396}; Cytoplasmic side {ECO:0000250|UniProtKB:P21396}.,
1,,A0A1W5KJW8,A0A1W5KJW8_HUMAN,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A),MAOA,Homo sapiens (Human),53,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; flavin adenine dinucleotide binding [GO:0050660]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584],flavin adenine dinucleotide binding [GO:0050660]; primary amine oxidase activity [GO:0008131],,,SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
2,,A0A8I5KP93,A0A8I5KP93_HUMAN,Amine oxidase (EC 1.4.3.-),MAOA,Homo sapiens (Human),297,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584],primary amine oxidase activity [GO:0008131],,,SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
3,,A0A8I5KUC3,A0A8I5KUC3_HUMAN,Amine oxidase (EC 1.4.3.-),MAOA,Homo sapiens (Human),492,catecholamine metabolic process [GO:0006584],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584],primary amine oxidase activity [GO:0008131],,,SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
4,,Q53YE7,Q53YE7_HUMAN,Amine oxidase (EC 1.4.3.-),MAOA hCG_16826,Homo sapiens (Human),527,dopamine catabolic process [GO:0042420]; positive regulation of signal transduction [GO:0009967],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cytosol [GO:0005829]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; primary amine oxidase activity [GO:0008131]; dopamine catabolic process [GO:0042420]; positive regulation of signal transduction [GO:0009967],primary amine oxidase activity [GO:0008131],,,SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
5,,Q5ULA3,Q5ULA3_HUMAN,Amine oxidase [flavin-containing] A (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type A),MAOA,Homo sapiens (Human),103,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; flavin adenine dinucleotide binding [GO:0050660]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584],flavin adenine dinucleotide binding [GO:0050660]; primary amine oxidase activity [GO:0008131],,,SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
6,,Q49A63,Q49A63_HUMAN,Amine oxidase (EC 1.4.3.-),MAOA,Homo sapiens (Human),527,catecholamine metabolic process [GO:0006584],mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; aliphatic amine oxidase activity [GO:0052595]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131]; catecholamine metabolic process [GO:0006584],aliphatic amine oxidase activity [GO:0052595]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131],,,SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
7,,Q5UL91,Q5UL91_HUMAN,Monoamine oxidase A,MAOA,Homo sapiens (Human),31,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
8,,Q5UL94,Q5UL94_HUMAN,Monoamine oxidase A,MAOA,Homo sapiens (Human),24,,,,,,,,
9,,Q5ULA9,Q5ULA9_HUMAN,Monoamine oxidase A,MAOA,Homo sapiens (Human),65,,membrane [GO:0016020],membrane [GO:0016020]; oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
0,"(gene:""CYP26A1"")",O43174,CP26A_HUMAN,Cytochrome P450 26A1 (CYP26A1) (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome),CYP26A1 CYP26 P450RAI1,Homo sapiens (Human),497,kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; kidney development [GO:0001822]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]","all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; all-trans retinoic acid 4-hydrolase activity [GO:0062182]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:9716180}; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:9716180}; Peripheral membrane protein.,
1,,A0A096LNN2,A0A096LNN2_HUMAN,Cytochrome P450 family 26 subfamily A member 1,CYP26A1,Homo sapiens (Human),256,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,SUBCELLULAR LOCATION: Microsome membrane {ECO:0000256|ARBA:ARBA00004174}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004174}.,
0,"(gene:""MAOB"")",P27338,AOFB_HUMAN,Amine oxidase [flavin-containing] B (EC 1.4.3.21) (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),MAOB,Homo sapiens (Human),520,dopamine catabolic process [GO:0042420]; hydrogen peroxide biosynthetic process [GO:0050665]; negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to aluminum ion [GO:0010044]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; substantia nigra development [GO:0021762],dendrite [GO:0030425]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025],dendrite [GO:0030425]; mitochondrial envelope [GO:0005740]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; aliphatic amine oxidase activity [GO:0052595]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131]; dopamine catabolic process [GO:0042420]; hydrogen peroxide biosynthetic process [GO:0050665]; negative regulation of serotonin secretion [GO:0014063]; phenylethylamine catabolic process [GO:0019607]; positive regulation of dopamine metabolic process [GO:0045964]; response to aluminum ion [GO:0010044]; response to corticosterone [GO:0051412]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; substantia nigra development [GO:0021762],aliphatic amine oxidase activity [GO:0052595]; electron transfer activity [GO:0009055]; flavin adenine dinucleotide binding [GO:0050660]; identical protein binding [GO:0042802]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131],"TOPO_DOM 2..489; /note=""Cytoplasmic""; TOPO_DOM 517..520; /note=""Mitochondrial intermembrane""","TRANSMEM 490..516; /note=""Helical; Anchor for type IV membrane protein""",SUBCELLULAR LOCATION: Mitochondrion outer membrane; Single-pass type IV membrane protein; Cytoplasmic side.,
1,,Q8TBI1,Q8TBI1_HUMAN,Amine oxidase (EC 1.4.3.-),MAOB,Homo sapiens (Human),520,,mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131],flavin adenine dinucleotide binding [GO:0050660]; monoamine oxidase activity [GO:0097621]; primary amine oxidase activity [GO:0008131],,"TRANSMEM 491..511; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362067""",SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004362}; Single-pass type IV membrane protein {ECO:0000256|ARBA:ARBA00004362}; Cytoplasmic side {ECO:0000256|ARBA:ARBA00004362}.,
0,"(gene:""CYP26B1"")",Q9NR63,CP26B_HUMAN,Cytochrome P450 26B1 (EC 1.14.13.-) (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2) (Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome),CYP26B1 CYP26A2 P450RAI2,Homo sapiens (Human),512,bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; bone morphogenesis [GO:0060349]; cell fate determination [GO:0001709]; cellular response to retinoic acid [GO:0071300]; cornification [GO:0070268]; embryonic limb morphogenesis [GO:0030326]; establishment of skin barrier [GO:0061436]; establishment of T cell polarity [GO:0001768]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male meiotic nuclear division [GO:0007140]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; positive regulation of gene expression [GO:0010628]; positive regulation of tongue muscle cell differentiation [GO:2001037]; proximal/distal pattern formation [GO:0009954]; regulation of T cell differentiation [GO:0045580]; response to vitamin A [GO:0033189]; retinoic acid catabolic process [GO:0034653]; retinoic acid metabolic process [GO:0042573]; retinoic acid receptor signaling pathway [GO:0048384]; spermatogenesis [GO:0007283]; sterol metabolic process [GO:0016125]; tongue morphogenesis [GO:0043587]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]","all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:O43174}; Peripheral membrane protein {ECO:0000250|UniProtKB:O43174}. Microsome membrane {ECO:0000250|UniProtKB:O43174}; Peripheral membrane protein {ECO:0000250|UniProtKB:O43174}.,
1,,E7ER08,E7ER08_HUMAN,Cytochrome P450 26B1,CYP26B1,Homo sapiens (Human),321,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,E5RHM2,E5RHM2_HUMAN,Cytochrome P450 family 26 subfamily B member 1,CYP26B1,Homo sapiens (Human),182,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,E5RHN4,E5RHN4_HUMAN,Cytochrome P450 family 26 subfamily B member 1,CYP26B1,Homo sapiens (Human),172,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""MGST1"")",P10620,MGST1_HUMAN,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),MGST1 GST12 MGST,Homo sapiens (Human),155,cellular response to lipid hydroperoxide [GO:0071449]; glutathione transport [GO:0034635],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886],azurophil granule membrane [GO:0035577]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; cellular response to lipid hydroperoxide [GO:0071449]; glutathione transport [GO:0034635],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364],"TOPO_DOM 3..9; /note=""Lumenal""; /evidence=""ECO:0000250|UniProtKB:P08011""; TOPO_DOM 34..62; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:P08011""; TOPO_DOM 97..99; /note=""Lumenal""; /evidence=""ECO:0000250|UniProtKB:P08011""; TOPO_DOM 124..128; /note=""Cytoplasmic""; /evidence=""ECO:0000250|UniProtKB:P08011""; TOPO_DOM 149..155; /note=""Lumenal""; /evidence=""ECO:0000250|UniProtKB:P08011""","TRANSMEM 10..33; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 63..96; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 100..123; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 129..148; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P08011}; Multi-pass membrane protein {ECO:0000255}. Mitochondrion outer membrane {ECO:0000250|UniProtKB:P08011}.,
1,,F5H6X2,F5H6X2_HUMAN,Microsomal glutathione S-transferase 1 (EC 2.5.1.18),MGST1,Homo sapiens (Human),80,,mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; transferase activity [GO:0016740],transferase activity [GO:0016740],,"TRANSMEM 12..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004370}. Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004294}.,
2,,F5H760,F5H760_HUMAN,Microsomal glutathione S-transferase 1 (EC 2.5.1.18),MGST1,Homo sapiens (Human),106,,mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; glutathione transferase activity [GO:0004364],glutathione transferase activity [GO:0004364],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004370}. Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004294}.,
3,,F5H7F6,F5H7F6_HUMAN,Microsomal glutathione S-transferase 1 (EC 2.5.1.18),MGST1,Homo sapiens (Human),77,,mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; transferase activity [GO:0016740],transferase activity [GO:0016740],,"TRANSMEM 12..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004370}. Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004294}.,
4,,Q6LET6,Q6LET6_HUMAN,Microsomal glutathione S-transferase 1 (EC 2.5.1.18),MGST1,Homo sapiens (Human),155,,mitochondrial outer membrane [GO:0005741],mitochondrial outer membrane [GO:0005741]; glutathione transferase activity [GO:0004364],glutathione transferase activity [GO:0004364],,"TRANSMEM 12..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004370}. Mitochondrion outer membrane {ECO:0000256|ARBA:ARBA00004294}.,
5,,F5GX73,F5GX73_HUMAN,Microsomal glutathione S-transferase 1,MGST1,Homo sapiens (Human),42,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 12..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,F5H613,F5H613_HUMAN,Microsomal glutathione S-transferase 1,MGST1,Homo sapiens (Human),46,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 12..37; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""CYP26C1"")",Q6V0L0,CP26C_HUMAN,Cytochrome P450 26C1 (CYP26C1) (EC 1.14.14.1),CYP26C1,Homo sapiens (Human),522,anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; neural crest cell development [GO:0014032]; organelle fusion [GO:0048284]; retinoic acid catabolic process [GO:0034653]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; anterior/posterior pattern specification [GO:0009952]; central nervous system development [GO:0007417]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; neural crest cell development [GO:0014032]; organelle fusion [GO:0048284]; retinoic acid catabolic process [GO:0034653]; sterol metabolic process [GO:0016125]; vitamin metabolic process [GO:0006766],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972],,"TRANSMEM 9..29; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,
1,,A0A096LNL5,A0A096LNL5_HUMAN,"Cytochrome P450 family 26 subfamily C member 1 (Cytochrome P450, family 26, subfamily C, polypeptide 1, isoform CRA_a)",CYP26C1 hCG_39535,Homo sapiens (Human),302,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""MGST2"")",Q99735,MGST2_HUMAN,Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Glutathione peroxidase MGST2) (EC 1.11.1.-) (Leukotriene C4 synthase MGST2) (EC 4.4.1.20) (Microsomal glutathione S-transferase II) (Microsomal GST-II),MGST2 GST2,Homo sapiens (Human),147,glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; glutathione biosynthetic process [GO:0006750]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; membrane lipid catabolic process [GO:0046466]; positive regulation of inflammatory response [GO:0050729]; response to lipopolysaccharide [GO:0032496]; response to organonitrogen compound [GO:0010243],enzyme activator activity [GO:0008047]; glutathione binding [GO:0043295]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464],,"TRANSMEM 6..26; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 59..79; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 111..131; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:8703034}; Multi-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000269|PubMed:8703034}; Multi-pass membrane protein {ECO:0000255}.,
0,"(gene:""CYP27A1"")",Q02318,CP27A_HUMAN,"Sterol 26-hydroxylase, mitochondrial (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 26-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)",CYP27A1 CYP27,Homo sapiens (Human),531,bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125],mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],"mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; 3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; bile acid biosynthetic process [GO:0006699]; calcitriol biosynthetic process from calciol [GO:0036378]; cholesterol catabolic process [GO:0006707]; cholesterol metabolic process [GO:0008203]; sterol metabolic process [GO:0016125]","3-alpha,7-alpha,12-alpha-trihydroxycholestan-26-al 26-oxidoreductase activity [GO:0047103]; cholestanetetraol 26-dehydrogenase activity [GO:0047748]; cholestanetriol 26-monooxygenase activity [GO:0047749]; cholesterol 26-hydroxylase activity [GO:0031073]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]",,,"SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000250|UniProtKB:P17178}; Peripheral membrane protein {ECO:0000250|UniProtKB:P17178}. Note=Post-translationally targeted to mitochondria. All three of the receptor proteins in the TOM complex, TOMM70, TOMM20 and TOMM22 are required for the translocation across the mitochondrial outer membrane. After translocation into the matrix, associates with the inner membrane as a membrane extrinsic protein. {ECO:0000250|UniProtKB:P17178}.",
1,,C9J1K5,C9J1K5_HUMAN,Cytochrome P450 family 27 subfamily A member 1,CYP27A1,Homo sapiens (Human),221,lipid metabolic process [GO:0006629],,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,F8WD90,F8WD90_HUMAN,Cytochrome P450 family 27 subfamily A member 1,CYP27A1,Homo sapiens (Human),115,,,,,,,,
3,,Q96T86,Q96T86_HUMAN,Sterol 27-hydroxylase,CYP27A1,Homo sapiens (Human),41,,,,,,,,
0,"(gene:""MGST3"")",O14880,MGST3_HUMAN,"Glutathione S-transferase 3, mitochondrial (GST-3) (EC 2.5.1.-) (Glutathione peroxidase MGST3) (EC 1.11.1.-) (LTC4 synthase MGST3) (EC 4.4.1.20)",MGST3,Homo sapiens (Human),152,arachidonic acid metabolic process [GO:0019369]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; prostanoid metabolic process [GO:0006692],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; nuclear envelope [GO:0005635]; glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464]; arachidonic acid metabolic process [GO:0019369]; leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; prostanoid metabolic process [GO:0006692],glutathione peroxidase activity [GO:0004602]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; leukotriene-C4 synthase activity [GO:0004464],"TOPO_DOM 1..8; /note=""Mitochondrial intermembrane""; /evidence=""ECO:0000305|PubMed:27184847""; TOPO_DOM 30..70; /note=""Cytoplasmic""; /evidence=""ECO:0000305""; TOPO_DOM 92..119; /note=""Mitochondrial intermembrane""; /evidence=""ECO:0000305""; TOPO_DOM 141..152; /note=""Cytoplasmic""; /evidence=""ECO:0000305|PubMed:27184847""","TRANSMEM 9..29; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 71..91; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 120..140; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Mitochondrion outer membrane {ECO:0000269|PubMed:27184847}; Multi-pass membrane protein {ECO:0000255}.,
1,,Q5VV87,Q5VV87_HUMAN,Microsomal glutathione S-transferase 3,MGST3,Homo sapiens (Human),129,leukotriene metabolic process [GO:0006691],membrane [GO:0016020],membrane [GO:0016020]; leukotriene metabolic process [GO:0006691],,,"TRANSMEM 6..27; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004141}; Multi-pass membrane protein {ECO:0000256|ARBA:ARBA00004141}.,
2,,Q5VV89,Q5VV89_HUMAN,Microsomal glutathione S-transferase 3,MGST3,Homo sapiens (Human),166,leukotriene metabolic process [GO:0006691],membrane [GO:0016020],membrane [GO:0016020]; leukotriene metabolic process [GO:0006691],,,"TRANSMEM 21..41; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 131..151; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004141}; Multi-pass membrane protein {ECO:0000256|ARBA:ARBA00004141}.,
0,"(gene:""CYP27B1"")",O15528,CP27B_HUMAN,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1)",CYP27B1 CYP1ALPHA CYP27B,Homo sapiens (Human),508,bone mineralization [GO:0030282]; calcitriol biosynthetic process from calciol [GO:0036378]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; decidualization [GO:0046697]; G1 to G0 transition [GO:0070314]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of bone mineralization [GO:0030500]; response to estrogen [GO:0043627]; response to lipopolysaccharide [GO:0032496]; response to type II interferon [GO:0034341]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766],cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],cytoplasm [GO:0005737]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; calcidiol 1-monooxygenase activity [GO:0004498]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; secalciferol 1-monooxygenase activity [GO:0062185]; bone mineralization [GO:0030282]; calcitriol biosynthetic process from calciol [GO:0036378]; calcium ion homeostasis [GO:0055074]; calcium ion transport [GO:0006816]; decidualization [GO:0046697]; G1 to G0 transition [GO:0070314]; negative regulation of calcidiol 1-monooxygenase activity [GO:0010956]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of bone mineralization [GO:0030500]; response to estrogen [GO:0043627]; response to lipopolysaccharide [GO:0032496]; response to type II interferon [GO:0034341]; response to vitamin D [GO:0033280]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766],calcidiol 1-monooxygenase activity [GO:0004498]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; secalciferol 1-monooxygenase activity [GO:0062185],,,SUBCELLULAR LOCATION: Mitochondrion membrane.,
1,,A0AAA9YHN9,A0AAA9YHN9_HUMAN,Cytochrome P450 family 27 subfamily B member 1,CYP27B1,Homo sapiens (Human),535,calcitriol biosynthetic process from calciol [GO:0036378],,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; calcitriol biosynthetic process from calciol [GO:0036378]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,A0AAA9YHZ6,A0AAA9YHZ6_HUMAN,Cytochrome P450 family 27 subfamily B member 1,CYP27B1,Homo sapiens (Human),350,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,F8VWR7,F8VWR7_HUMAN,Cytochrome P450 family 27 subfamily B member 1,CYP27B1,Homo sapiens (Human),211,,,,,,,,
4,,Q9UP42,Q9UP42_HUMAN,"25-hydroxyvitamin D3-1alpha-hydroxylase (Cytochrome P450, family 27, subfamily B, polypeptide 1)",CYP27B1,Homo sapiens (Human),65,,,,,,,,
0,"(gene:""NAT2"")",P11245,ARY2_HUMAN,Arylamine N-acetyltransferase 2 (EC 2.3.1.5) (Arylamide acetylase 2) (N-acetyltransferase type 2) (NAT-2) (N-hydroxyarylamine O-acetyltransferase) (EC 2.3.1.118) (Polymorphic arylamine N-acetyltransferase) (PNAT),NAT2 AAC2,Homo sapiens (Human),290,xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829],cytosol [GO:0005829]; arylamine N-acetyltransferase activity [GO:0004060]; N-hydroxyarylamine O-acetyltransferase activity [GO:0046990]; xenobiotic metabolic process [GO:0006805],arylamine N-acetyltransferase activity [GO:0004060]; N-hydroxyarylamine O-acetyltransferase activity [GO:0046990],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,Q6N069,NAA16_HUMAN,"N-alpha-acetyltransferase 16, NatA auxiliary subunit (NMDA receptor-regulated 1-like protein) (NARG1-like protein)",NAA16 NARG1L NAT2,Homo sapiens (Human),864,N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription [GO:0045893]; protein stabilization [GO:0050821],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; NatA complex [GO:0031415]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667]; ribosome binding [GO:0043022]; N-terminal protein amino acid acetylation [GO:0006474]; negative regulation of apoptotic process [GO:0043066]; positive regulation of DNA-templated transcription [GO:0045893]; protein stabilization [GO:0050821],ribosome binding [GO:0043022],,,,
2,,Q9H2H9,S38A1_HUMAN,Sodium-coupled neutral amino acid symporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),SLC38A1 ATA1 NAT2 SAT1 SNAT1,Homo sapiens (Human),487,"amino acid import [GO:0043090]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; female pregnancy [GO:0007565]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamine metabolic process [GO:0006541]; glutamine transport [GO:0006868]; L-alpha-amino acid transmembrane transport [GO:1902475]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]; positive regulation of L-glutamine import across plasma membrane [GO:1901036]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; transport across blood-brain barrier [GO:0150104]",axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886],"axon [GO:0030424]; basolateral plasma membrane [GO:0016323]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; alanine:sodium symporter activity [GO:0015655]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium symporter activity [GO:0005295]; proline:sodium symporter activity [GO:0005298]; amino acid import [GO:0043090]; amino acid transmembrane transport [GO:0003333]; amino acid transport [GO:0006865]; female pregnancy [GO:0007565]; gamma-aminobutyric acid biosynthetic process [GO:0009449]; glutamine metabolic process [GO:0006541]; glutamine transport [GO:0006868]; L-alpha-amino acid transmembrane transport [GO:1902475]; neurotransmitter uptake [GO:0001504]; neutral amino acid transport [GO:0015804]; positive regulation of L-glutamine import across plasma membrane [GO:1901036]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, GABAergic [GO:0032228]; transport across blood-brain barrier [GO:0150104]",alanine:sodium symporter activity [GO:0015655]; amino acid transmembrane transporter activity [GO:0015171]; amino acid:sodium symporter activity [GO:0005283]; glycine:sodium symporter activity [GO:0015375]; L-amino acid transmembrane transporter activity [GO:0015179]; L-glutamine transmembrane transporter activity [GO:0015186]; neutral L-amino acid transmembrane transporter activity [GO:0015175]; neutral L-amino acid:sodium symporter activity [GO:0005295]; proline:sodium symporter activity [GO:0005298],"TOPO_DOM 1..74; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 98..112; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 134..147; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 169..188; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 212..216; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 238..275; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 297..312; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 334..350; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 372..393; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 415..416; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 438..452; /note=""Cytoplasmic""; /evidence=""ECO:0000255""; TOPO_DOM 474..487; /note=""Extracellular""; /evidence=""ECO:0000255""","TRANSMEM 75..97; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 113..133; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 148..168; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 189..211; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 217..237; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 276..296; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 313..333; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 351..371; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 394..414; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 417..437; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 453..473; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15054072}; Multi-pass membrane protein {ECO:0000250|UniProtKB:Q9JM15}. Note=Restricted to the somatodendritic compartment of neurons. Found in the cellular processes of neurons in the developing brain. {ECO:0000250|UniProtKB:Q9JM15}.,
3,,A0A0S2A4Q6,A0A0S2A4Q6_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,A0A0S2A5J2,A0A0S2A5J2_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,A0A0S2A5S1,A0A0S2A5S1_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,A0A0S2A5X5,A0A0S2A5X5_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
7,,A4Z6T7,A4Z6T7_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
8,,A4Z6T8,A4Z6T8_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
9,,A4Z6T9,A4Z6T9_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2 hCG_27151,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
10,,A4Z6U4,A4Z6U4_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
11,,A4Z6U6,A4Z6U6_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
12,,A4Z6U7,A4Z6U7_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
13,,A4Z6U9,A4Z6U9_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
14,,A4Z6V9,A4Z6V9_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
15,,A4Z6Y1,A4Z6Y1_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
16,,A4Z6Y3,A4Z6Y3_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
17,,A4Z6Y5,A4Z6Y5_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
18,,A4Z737,A4Z737_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
19,,A4Z787,A4Z787_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
20,,A4Z7F6,A4Z7F6_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
21,,A4Z7H3,A4Z7H3_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
22,,A4Z7J7,A4Z7J7_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
23,,A4Z7K4,A4Z7K4_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
24,,A4Z7P9,A4Z7P9_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
25,,A4Z7V0,A4Z7V0_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
26,,A4Z867,A4Z867_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
27,,A9X7Q9,A9X7Q9_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
28,,A9X7U6,A9X7U6_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
29,,A9X7X6,A9X7X6_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
30,,A9X816,A9X816_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
31,,A9X844,A9X844_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
32,,A9X854,A9X854_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
33,,A9X868,A9X868_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),290,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
34,,Q400I7,Q400I7_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),147,,membrane [GO:0016020],membrane [GO:0016020]; arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,"TRANSMEM 74..95; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
35,,E7EWF9,E7EWF9_HUMAN,arylamine N-acetyltransferase (EC 2.3.1.5),NAT2,Homo sapiens (Human),160,,,arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,,,
36,,Q400I5,Q400I5_HUMAN,Arylamine N-acetyltransferase 2 (EC 2.3.1.5),NAT2,Homo sapiens (Human),46,,,arylamine N-acetyltransferase activity [GO:0004060],arylamine N-acetyltransferase activity [GO:0004060],,,,
0,"(gene:""CYP2A13"")",Q16696,CP2AD_HUMAN,Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13),CYP2A13,Homo sapiens (Human),494,aflatoxin metabolic process [GO:0046222]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; aflatoxin metabolic process [GO:0046222]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; coumarin 7-hydroxylase activity [GO:0008389]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
0,"(gene:""NDOR1"")",Q9UHB4,NDOR1_HUMAN,NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1),NDOR1 NR1,Homo sapiens (Human),597,electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; intermediate filament cytoskeleton [GO:0045111]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO:0016731]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]; electron transport chain [GO:0022900]; iron-sulfur cluster assembly [GO:0016226]","electron transfer activity [GO:0009055]; FAD binding [GO:0071949]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; NADPH-hemoprotein reductase activity [GO:0003958]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO:0016731]; oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO:0016653]",,,"SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:10625700, ECO:0000269|PubMed:12871939}. Note=Concentrated in perinuclear structure. {ECO:0000255|HAMAP-Rule:MF_03178, ECO:0000269|PubMed:12871939}.",
0,"(gene:""CYP2A6"")",P11509,CP2A6_HUMAN,"Cytochrome P450 2A6 (EC 1.14.14.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIA6) (Coumarin 7-hydroxylase) (Cytochrome P450 IIA3) (Cytochrome P450(I))",CYP2A6 CYP2A3,Homo sapiens (Human),494,coumarin catabolic process [GO:0046226]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; cytoplasmic microtubule [GO:0005881]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; coumarin catabolic process [GO:0046226]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; coumarin 7-hydroxylase activity [GO:0008389]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,M0R2Z4,M0R2Z4_HUMAN,Cytochrome P450 family 2 subfamily A member 6,CYP2A6,Homo sapiens (Human),65,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 6..24; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""POR"")",P16435,NCPR_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR CYPOR,Homo sapiens (Human),677,cellular organofluorine metabolic process [GO:0090346]; electron transport chain [GO:0022900]; positive regulation of monooxygenase activity [GO:0032770]; response to hormone [GO:0009725]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; cellular organofluorine metabolic process [GO:0090346]; electron transport chain [GO:0022900]; positive regulation of monooxygenase activity [GO:0032770]; response to hormone [GO:0009725]; xenobiotic metabolic process [GO:0006805],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],"TOPO_DOM 2..21; /note=""Lumenal""; /evidence=""ECO:0000255|HAMAP-Rule:MF_03212""; TOPO_DOM 43..677; /note=""Cytoplasmic""; /evidence=""ECO:0000255|HAMAP-Rule:MF_03212""","TRANSMEM 22..42; /note=""Helical""; /evidence=""ECO:0000255|HAMAP-Rule:MF_03212""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000255|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000255|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000255|HAMAP-Rule:MF_03212}.,
1,,A0A9L9PXL8,A0A9L9PXL8_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR,Homo sapiens (Human),605,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000256|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000256|HAMAP-Rule:MF_03212}.,
2,,A0A9L9PXN4,A0A9L9PXN4_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR,Homo sapiens (Human),647,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],,"TRANSMEM 25..46; /note=""Helical""; /evidence=""ECO:0000256|HAMAP-Rule:MF_03212""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000256|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000256|HAMAP-Rule:MF_03212}.,
3,,A0A9L9PY49,A0A9L9PY49_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR hCG_41365,Homo sapiens (Human),680,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],,"TRANSMEM 25..46; /note=""Helical""; /evidence=""ECO:0000256|HAMAP-Rule:MF_03212""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000256|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000256|HAMAP-Rule:MF_03212}.,
4,,A8K3B4,A8K3B4_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR,Homo sapiens (Human),680,response to hormone [GO:0009725],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; response to hormone [GO:0009725],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],,"TRANSMEM 25..46; /note=""Helical""; /evidence=""ECO:0000256|HAMAP-Rule:MF_03212""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000256|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000256|HAMAP-Rule:MF_03212}.,
5,,B2R6E5,B2R6E5_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),POR,Homo sapiens (Human),680,response to hormone [GO:0009725],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; response to hormone [GO:0009725],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],,"TRANSMEM 25..46; /note=""Helical""; /evidence=""ECO:0000256|HAMAP-Rule:MF_03212""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000256|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000256|HAMAP-Rule:MF_03212}.,
6,,Q63HL4,Q63HL4_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),DKFZp686G04235 POR,Homo sapiens (Human),680,response to hormone [GO:0009725],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958]; response to hormone [GO:0009725],flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; NADP binding [GO:0050661]; NADPH-hemoprotein reductase activity [GO:0003958],,"TRANSMEM 25..46; /note=""Helical""; /evidence=""ECO:0000256|HAMAP-Rule:MF_03212""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|HAMAP-Rule:MF_03212}; Single-pass membrane protein {ECO:0000256|HAMAP-Rule:MF_03212}; Cytoplasmic side {ECO:0000256|HAMAP-Rule:MF_03212}.,
7,,A0A8V8NE24,A0A8V8NE24_HUMAN,NADPH--hemoprotein reductase (EC 1.6.2.4),POR,Homo sapiens (Human),630,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; FMN binding [GO:0010181]; NADPH-hemoprotein reductase activity [GO:0003958],FMN binding [GO:0010181]; NADPH-hemoprotein reductase activity [GO:0003958],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
8,,H0Y4R2,H0Y4R2_HUMAN,NADPH--hemoprotein reductase (EC 1.6.2.4),POR,Homo sapiens (Human),725,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; FMN binding [GO:0010181]; NADPH-hemoprotein reductase activity [GO:0003958],FMN binding [GO:0010181]; NADPH-hemoprotein reductase activity [GO:0003958],,,,
9,,A0A8V8NKH1,A0A8V8NKH1_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),163,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
10,,A0A8V8NLF0,A0A8V8NLF0_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),185,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
11,,A0A8V8NRY5,A0A8V8NRY5_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),137,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
12,,A0A8V8NVX2,A0A8V8NVX2_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),169,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
13,,A0A8V8NVY2,A0A8V8NVY2_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),59,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
14,,A0A8V8P1G2,A0A8V8P1G2_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),208,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
15,,A0A8V8P672,A0A8V8P672_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),143,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
16,,A0A8V8PBF2,A0A8V8PBF2_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),186,,membrane [GO:0016020],membrane [GO:0016020]; FMN binding [GO:0010181],FMN binding [GO:0010181],,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
17,,C9JDE2,C9JDE2_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),54,,,,,,,,
18,,C9JQ78,C9JQ78_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),36,,,,,,,,
19,,C9JU80,C9JU80_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),108,,,FMN binding [GO:0010181],FMN binding [GO:0010181],,,,
20,,E7EMD0,E7EMD0_HUMAN,NADPH--hemoprotein reductase (EC 1.6.2.4),POR,Homo sapiens (Human),418,,,oxidoreductase activity [GO:0016491],oxidoreductase activity [GO:0016491],,,,
21,,E7EWU0,E7EWU0_HUMAN,Cytochrome p450 oxidoreductase,POR,Homo sapiens (Human),98,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 20..43; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""CYP2A7"")",P20853,CP2A7_HUMAN,Cytochrome P450 2A7 (EC 1.14.14.1) (CYPIIA7) (Cytochrome P450 IIA4),CYP2A7,Homo sapiens (Human),494,coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; coumarin metabolic process [GO:0009804]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,B7ZKR0,B7ZKR0_HUMAN,Cytochrome P450 (EC 1.14.14.1),CYP2A7,Homo sapiens (Human),494,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368053}. Microsome membrane {ECO:0000256|RuleBase:RU368053}.,
2,,F8W816,F8W816_HUMAN,Cytochrome P450 family 2 subfamily A member 7,CYP2A7,Homo sapiens (Human),443,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,Q17RW7,Q17RW7_HUMAN,Cytochrome P450 (EC 1.14.14.1),CYP2A7,Homo sapiens (Human),494,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368053}. Microsome membrane {ECO:0000256|RuleBase:RU368053}.,
4,,M0R020,M0R020_HUMAN,Cytochrome P450 family 2 subfamily A member 7,CYP2A7,Homo sapiens (Human),80,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 6..24; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""SULT1A1"")",P50225,ST1A1_HUMAN,Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST),SULT1A1 STP STP1 OK/SW-cl.88,Homo sapiens (Human),295,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine metabolic process [GO:0009308]; catecholamine metabolic process [GO:0006584]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P17988}.,
1,,H3BQX5,H3BQX5_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A1,Homo sapiens (Human),169,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
2,,H3BRY5,H3BRY5_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A1,Homo sapiens (Human),281,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
0,"(gene:""CYP2B6"")",P20813,CP2B6_HUMAN,"Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)",CYP2B6,Homo sapiens (Human),491,cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]; cellular ketone metabolic process [GO:0042180]; epoxygenase P450 pathway [GO:0019373]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; arachidonic acid epoxygenase activity [GO:0008392]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 16-alpha-hydroxylase activity [GO:0008390]; testosterone 16-beta-hydroxylase activity [GO:0062184]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,M0QZJ2,M0QZJ2_HUMAN,Cytochrome P450 family 2 subfamily B member 6,CYP2B6,Homo sapiens (Human),255,lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; lipid metabolic process [GO:0006629]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,Q6NWU1,Q6NWU1_HUMAN,Cytochrome P450 (EC 1.14.14.1),CYP2B6,Homo sapiens (Human),491,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368046}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368046}. Microsome membrane {ECO:0000256|RuleBase:RU368046}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368046}.,
3,,Q6NWU2,Q6NWU2_HUMAN,Cytochrome P450 (EC 1.14.14.1),CYP2B6,Homo sapiens (Human),491,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368046}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368046}. Microsome membrane {ECO:0000256|RuleBase:RU368046}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368046}.,
4,,A0A2R8YFA4,A0A2R8YFA4_HUMAN,Cytochrome P450 family 2 subfamily B member 6,CYP2B6,Homo sapiens (Human),194,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
5,,F2X1A7,F2X1A7_HUMAN,Cytochrome P450 2B6 (EC 1.14.14.1),CYP2B6,Homo sapiens (Human),53,,,aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
6,,F2X1B0,F2X1B0_HUMAN,Cytochrome P450 2B6 (EC 1.14.14.1),CYP2B6,Homo sapiens (Human),53,,,aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
7,,Q9UNX8,Q9UNX8_HUMAN,Cytochrome P450,CYP2B6,Homo sapiens (Human),52,,,,,,,,
0,"(gene:""SULT1A2"")",P50226,ST1A2_HUMAN,Sulfotransferase 1A2 (ST1A2) (EC 2.8.2.1) (Aryl sulfotransferase 2) (Phenol sulfotransferase 2) (Phenol-sulfating phenol sulfotransferase 2) (P-PST 2),SULT1A2 STP2,Homo sapiens (Human),295,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine biosynthetic process [GO:0009309]; catecholamine metabolic process [GO:0006584]; ethanol catabolic process [GO:0006068]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; amine biosynthetic process [GO:0009309]; catecholamine metabolic process [GO:0006584]; ethanol catabolic process [GO:0006068]; phenol-containing compound metabolic process [GO:0018958]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],aryl sulfotransferase activity [GO:0004062]; flavonol 3-sulfotransferase activity [GO:0047894]; sulfotransferase activity [GO:0008146],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,E9PKW4,E9PKW4_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A2,Homo sapiens (Human),262,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
2,,E9PM76,E9PM76_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A2,Homo sapiens (Human),221,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
3,,E9PKR8,E9PKR8_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A2,Homo sapiens (Human),192,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
0,"(gene:""CYP2C18"")",P33260,CP2CI_HUMAN,Cytochrome P450 2C18 (EC 1.14.14.1) (CYPIIC18) (Cytochrome P450-6b/29c),CYP2C18,Homo sapiens (Human),490,epoxygenase P450 pathway [GO:0019373]; linoleic acid metabolic process [GO:0043651]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; epoxygenase P450 pathway [GO:0019373]; linoleic acid metabolic process [GO:0043651]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:11093772}; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:11093772}; Peripheral membrane protein.,
1,,Q2XN56,Q2XN56_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2C18,Homo sapiens (Human),214,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
0,"(gene:""SULT1A4"")",P0DMN0,ST1A4_HUMAN,Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4),SULT1A4,Homo sapiens (Human),295,catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; catecholamine metabolic process [GO:0006584]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,A0A0A6YYL2,A0A0A6YYL2_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A4,Homo sapiens (Human),301,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
2,,H3BNY7,H3BNY7_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A4,Homo sapiens (Human),87,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
3,,H3BRT0,H3BRT0_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A4 SULT1A3,Homo sapiens (Human),50,,,sulfotransferase activity [GO:0008146],sulfotransferase activity [GO:0008146],,,,
4,,Q2TAB3,Q2TAB3_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1A4,Homo sapiens (Human),295,sulfation [GO:0051923],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,,
0,"(gene:""CYP2C19"")",P33261,CP2CJ_HUMAN,Cytochrome P450 2C19 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Fenbendazole monooxygenase (4'-hydroxylating)) (EC 1.14.14.75) (Mephenytoin 4-hydroxylase),CYP2C19,Homo sapiens (Human),490,epoxygenase P450 pathway [GO:0019373]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; (R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]; epoxygenase P450 pathway [GO:0019373]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","(R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; steroid hydroxylase activity [GO:0008395]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,A0A087X125,A0A087X125_HUMAN,Cytochrome P450 family 2 subfamily C member 19,CYP2C19,Homo sapiens (Human),162,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,A0A2D1BII0,A0A2D1BII0_HUMAN,Cytochrome P450,CYP2C19,Homo sapiens (Human),59,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,A0A2D1BPP2,A0A2D1BPP2_HUMAN,Cytochrome P450,CYP2C19,Homo sapiens (Human),59,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
4,,B0ZDM8,B0ZDM8_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 19,CYP2C19,Homo sapiens (Human),10,,,,,,,,
5,,Q767A3,Q767A3_HUMAN,Cytochrome P450,CYP2C19,Homo sapiens (Human),48,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""SULT1B1"")",O43704,ST1B1_HUMAN,Sulfotransferase 1B1 (ST1B1) (EC 2.8.2.1) (Sulfotransferase 1B2) (Sulfotransferase family cytosolic 1B member 1) (Thyroid hormone sulfotransferase),SULT1B1 ST1B2 SULT1B2,Homo sapiens (Human),296,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; biogenic amine metabolic process [GO:0006576]; epithelial cell differentiation [GO:0030855]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; phenol-containing compound metabolic process [GO:0018958]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146],,,"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9443824, ECO:0000269|PubMed:9463486}.",
1,,D6RD70,D6RD70_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1B1,Homo sapiens (Human),155,sulfation [GO:0051923],,aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,,
2,,D6RIA8,D6RIA8_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1B1,Homo sapiens (Human),73,sulfation [GO:0051923],,aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,,
0,"(gene:""CYP2C8"")",P10632,CP2C8_HUMAN,Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase),CYP2C8,Homo sapiens (Human),490,epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,A0A0D9SG51,A0A0D9SG51_HUMAN,Cytochrome P450 family 2 subfamily C member 8,CYP2C8,Homo sapiens (Human),307,,intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,B7Z1F5,B7Z1F5_HUMAN,"Cytochrome P450 family 2 subfamily C member 8 (cDNA FLJ59467, highly similar to Cytochrome P450 2C8)",CYP2C8,Homo sapiens (Human),420,,intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
3,,E9PIW6,E9PIW6_HUMAN,Cytochrome P450 family 2 subfamily C member 8,CYP2C8,Homo sapiens (Human),99,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
4,,E9PLI9,E9PLI9_HUMAN,Cytochrome P450 family 2 subfamily C member 8,CYP2C8,Homo sapiens (Human),83,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
5,,G3V188,G3V188_HUMAN,"Cytochrome P450 family 2 subfamily C member 8 (Cytochrome P450, family 2, subfamily C, polypeptide 8, isoform CRA_b)",CYP2C8 hCG_39487,Homo sapiens (Human),393,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""SULT1C2"")",O00338,ST1C2_HUMAN,Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.1) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2),SULT1C2 SULT1C1,Homo sapiens (Human),296,amine metabolic process [GO:0009308]; sulfation [GO:0051923],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; amine metabolic process [GO:0009308]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O46503}. Lysosome {ECO:0000250|UniProtKB:Q9WUW8}.,
1,,O75897,ST1C4_HUMAN,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2),SULT1C4 SULT1C2,Homo sapiens (Human),302,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:28222028}.",
2,,B4DLP0,B4DLP0_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C2,Homo sapiens (Human),310,sulfation [GO:0051923],lysosome [GO:0005764],lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}. Lysosome {ECO:0000256|ARBA:ARBA00004371}.,
3,,B8ZZF7,B8ZZF7_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C2,Homo sapiens (Human),259,sulfation [GO:0051923],lysosome [GO:0005764],lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}. Lysosome {ECO:0000256|ARBA:ARBA00004371}.,
4,,C9JSR0,C9JSR0_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C2,Homo sapiens (Human),130,sulfation [GO:0051923],lysosome [GO:0005764],lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}. Lysosome {ECO:0000256|ARBA:ARBA00004371}.,
5,,H7BZ17,H7BZ17_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C2,Homo sapiens (Human),226,sulfation [GO:0051923],lysosome [GO:0005764],lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}. Lysosome {ECO:0000256|ARBA:ARBA00004371}.,
6,,H7C420,H7C420_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C2,Homo sapiens (Human),116,sulfation [GO:0051923],lysosome [GO:0005764],lysosome [GO:0005764]; aryl sulfotransferase activity [GO:0004062]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}. Lysosome {ECO:0000256|ARBA:ARBA00004371}.,
7,,Q6PD90,Q6PD90_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C4 SULT1C2 hCG_27301,Homo sapiens (Human),102,sulfation [GO:0051923],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923],sulfotransferase activity [GO:0008146],,,,
0,"(gene:""CYP2C9"")",P11712,CP2C9_HUMAN,Cytochrome P450 2C9 (EC 1.14.14.1) ((R)-limonene 6-monooxygenase) (EC 1.14.14.53) ((S)-limonene 6-monooxygenase) (EC 1.14.14.51) ((S)-limonene 7-monooxygenase) (EC 1.14.14.52) (CYPIIC9) (Cholesterol 25-hydroxylase) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase),CYP2C9 CYP2C10,Homo sapiens (Human),490,amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; (R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; amide metabolic process [GO:0043603]; cholesterol metabolic process [GO:0008203]; epoxygenase P450 pathway [GO:0019373]; estrogen metabolic process [GO:0008210]; icosanoid biosynthetic process [GO:0046456]; long-chain fatty acid biosynthetic process [GO:0042759]; monocarboxylic acid metabolic process [GO:0032787]; monoterpenoid metabolic process [GO:0016098]; omega-hydroxylase P450 pathway [GO:0097267]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]; urea metabolic process [GO:0019627]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","(R)-limonene 6-monooxygenase activity [GO:0052741]; (S)-limonene 6-monooxygenase activity [GO:0018675]; (S)-limonene 7-monooxygenase activity [GO:0018676]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.,
1,,A0A0A7MAK0,A0A0A7MAK0_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
2,,A0A1X9PW33,A0A1X9PW33_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
3,,A0A1X9PW55,A0A1X9PW55_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
4,,A0A1X9PW57,A0A1X9PW57_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
5,,A0A1X9PW73,A0A1X9PW73_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
6,,A0A1X9PW77,A0A1X9PW77_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
7,,A0A1X9PWC6,A0A1X9PWC6_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
8,,A0A1X9PWD6,A0A1X9PWD6_HUMAN,Cytochrome P450 (EC 1.14.13.48),CYP2C9,Homo sapiens (Human),59,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
9,,A0A2D1BLU4,A0A2D1BLU4_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
10,,A0A2H4QWJ3,A0A2H4QWJ3_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
11,,A0A2H4QWL2,A0A2H4QWL2_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
12,,A0A2H4QWQ3,A0A2H4QWQ3_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
13,,A0A2H4QWR6,A0A2H4QWR6_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
14,,A0A2H4QWR7,A0A2H4QWR7_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
15,,A0A2H4QWR8,A0A2H4QWR8_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
16,,A0A2H4QWS7,A0A2H4QWS7_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
17,,A0A2H4QWT3,A0A2H4QWT3_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
18,,A0A2H4QWT6,A0A2H4QWT6_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
19,,A0A2H4QWU1,A0A2H4QWU1_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
20,,A0A2H4QWU7,A0A2H4QWU7_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
21,,A0A2H4QWU8,A0A2H4QWU8_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
22,,A0A2H4QWU9,A0A2H4QWU9_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
23,,A0A2H4QWV3,A0A2H4QWV3_HUMAN,Cytochrome P450 (EC 1.14.14.51),CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; (S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],(S)-limonene 6-monooxygenase activity [GO:0018675]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
24,,Q9UEH3,Q9UEH3_HUMAN,Cytochrome P-450 2C,CYP2C9,Homo sapiens (Human),273,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
25,,S5R8G8,S5R8G8_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 9,CYP2C9,Homo sapiens (Human),490,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
26,,S5R8H1,S5R8H1_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 9,CYP2C9,Homo sapiens (Human),490,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
27,,S5RG22,S5RG22_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 9,CYP2C9,Homo sapiens (Human),490,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
28,,S5RV20,S5RV20_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 9,CYP2C9,Homo sapiens (Human),490,,intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
29,,S5RV29,S5RV29_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 9,CYP2C9,Homo sapiens (Human),490,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
30,,S5RXA4,S5RXA4_HUMAN,Cytochrome P450 family 2 subfamily C polypeptide 9,CYP2C9,Homo sapiens (Human),490,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
31,,A0A2D1BIX4,A0A2D1BIX4_HUMAN,Cytochrome P450,CYP2C9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
32,,A0A2D1BPV8,A0A2D1BPV8_HUMAN,Cytochrome P450,cyp2c9,Homo sapiens (Human),49,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
33,,A0A2R8YF67,A0A2R8YF67_HUMAN,Cytochrome P450 family 2 subfamily C member 9,CYP2C9,Homo sapiens (Human),282,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
34,,A0A345FZQ8,A0A345FZQ8_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),26,,,,,,,,
35,,A0A345FZQ9,A0A345FZQ9_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),26,,,,,,,,
36,,A0A7D5UNI7,A0A7D5UNI7_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),106,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
37,,A0A7D5UNN1,A0A7D5UNN1_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),106,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
38,,A0A7D5YV17,A0A7D5YV17_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),106,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
39,,A0A7D5YZ42,A0A7D5YZ42_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),106,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
40,,A0A7D5YZN0,A0A7D5YZN0_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),106,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
41,,A0A866U5P9,A0A866U5P9_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),25,,,,,,,,
42,,A0A866U6Z0,A0A866U6Z0_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),51,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
43,,A0A866U7A7,A0A866U7A7_HUMAN,Cytochrome P450 2C9,CYP2C9,Homo sapiens (Human),25,,,,,,,,
44,,Q5EDC5,Q5EDC5_HUMAN,Cytochrome p4502C9,CYP2C9,Homo sapiens (Human),62,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
45,,Q9UQ59,Q9UQ59_HUMAN,Cytochrome P-450 2C,CYP2C9,Homo sapiens (Human),169,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""SULT1C4"")",O75897,ST1C4_HUMAN,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.1) (Sulfotransferase 1C2) (SULT1C#2),SULT1C4 SULT1C2,Homo sapiens (Human),302,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; doxorubicin metabolic process [GO:0044598]; ethanol catabolic process [GO:0006068]; flavonoid metabolic process [GO:0009812]; sulfation [GO:0051923]; xenobiotic metabolic process [GO:0006805],aryl sulfotransferase activity [GO:0004062]; sulfotransferase activity [GO:0008146],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:28222028}.",
1,,Q6PD90,Q6PD90_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1C4 SULT1C2 hCG_27301,Homo sapiens (Human),102,sulfation [GO:0051923],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; sulfotransferase activity [GO:0008146]; sulfation [GO:0051923],sulfotransferase activity [GO:0008146],,,,
0,"(gene:""CYP2D6"")",P10635,CP2D6_HUMAN,Cytochrome P450 2D6 (EC 1.14.14.-) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase),CYP2D6 CYP2DL1,Homo sapiens (Human),497,alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; cholesterol metabolic process [GO:0008203]; coumarin metabolic process [GO:0009804]; estrogen metabolic process [GO:0008210]; isoquinoline alkaloid metabolic process [GO:0033076]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; negative regulation of binding [GO:0051100]; negative regulation of cellular organofluorine metabolic process [GO:0090350]; oxidative demethylation [GO:0070989]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739],"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; alkaloid catabolic process [GO:0009822]; alkaloid metabolic process [GO:0009820]; arachidonic acid metabolic process [GO:0019369]; cholesterol metabolic process [GO:0008203]; coumarin metabolic process [GO:0009804]; estrogen metabolic process [GO:0008210]; isoquinoline alkaloid metabolic process [GO:0033076]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; negative regulation of binding [GO:0051100]; negative regulation of cellular organofluorine metabolic process [GO:0090350]; oxidative demethylation [GO:0070989]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.,
1,,W5QSH4,W5QSH4_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6 cyp2d6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
2,,A0A0F7KYR9,A0A0F7KYR9_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
3,,A0A0F7KZW3,A0A0F7KZW3_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),343,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
4,,A0A0F7L0X4,A0A0F7L0X4_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
5,,A0A0G2JLK7,A0A0G2JLK7_HUMAN,Cytochrome P450 family 2 subfamily D member 6,CYP2D6,Homo sapiens (Human),446,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 247..272; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,A0A0G2JS23,A0A0G2JS23_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),180,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
7,,A0A1B0GV74,A0A1B0GV74_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),446,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
8,,C1ID52,C1ID52_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6 hCG_41551,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
9,,C1ID54,C1ID54_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
10,,D0U5L8,D0U5L8_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
11,,D5KMQ2,D5KMQ2_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
12,,D5KMR1,D5KMR1_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
13,,D5KMS0,D5KMS0_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
14,,D5KMU5,D5KMU5_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
15,,D5KMU6,D5KMU6_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
16,,D5KMZ1,D5KMZ1_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
17,,D5KN01,D5KN01_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
18,,D5KN10,D5KN10_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),496,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
19,,D5KN50,D5KN50_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
20,,D5KN61,D5KN61_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
21,,D5KN64,D5KN64_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
22,,D5KNB5,D5KNB5_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
23,,D5KND2,D5KND2_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
24,,G9CGD2,G9CGD2_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
25,,H7BY38,H7BY38_HUMAN,Cytochrome P450 family 2 subfamily D member 6,CYP2D6,Homo sapiens (Human),240,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
26,,Q007T9,Q007T9_HUMAN,Cytochrome P4502D6,CYP2D6,Homo sapiens (Human),58,hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508]; hormone biosynthetic process [GO:0042446]; progesterone metabolic process [GO:0042448],heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid 17-alpha-monooxygenase activity [GO:0004508],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|ARBA:ARBA00004167}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167}.,
27,,Q2XND0,Q2XND0_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),500,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
28,,Q2XND2,Q2XND2_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
29,,Q2XND3,Q2XND3_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
30,,Q2XND8,Q2XND8_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
31,,Q38LF9,Q38LF9_HUMAN,Cytochrome P450 2D6 (EC 1.14.14.1),CYP2D6,Homo sapiens (Human),117,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
32,,Q38LG0,Q38LG0_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6 LOC101929829,Homo sapiens (Human),497,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
33,,Q38LG2,Q38LG2_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
34,,Q3KPF3,Q3KPF3_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6,Homo sapiens (Human),497,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
35,,Q6ICD8,Q6ICD8_HUMAN,"CYP2D6 protein (Cytochrome P450, family 2, subfamily D, polypeptide 6)",CYP2D6,Homo sapiens (Human),446,arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; arachidonic acid metabolic process [GO:0019369]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
36,,Q6NWU0,Q6NWU0_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2D6 cyp2d6,Homo sapiens (Human),497,,endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
37,,A0A0U1RQH0,A0A0U1RQH0_HUMAN,Cytochrome P450 family 2 subfamily D member 6,CYP2D6,Homo sapiens (Human),240,,,,,,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
38,,A0A2L1K0E8,A0A2L1K0E8_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),21,,,,,,,,
39,,A0A2L1K0F2,A0A2L1K0F2_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),27,,,,,,,,
40,,A0A2L1K0F5,A0A2L1K0F5_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),22,,,,,,,,
41,,A0A2L1K0F9,A0A2L1K0F9_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),25,,,,,,,,
42,,A0A2L1K0G2,A0A2L1K0G2_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),23,,,,,,,,
43,,A0A2L1K0G7,A0A2L1K0G7_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),25,,,,,,,,
44,,A0A2L1K0H3,A0A2L1K0H3_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),24,,,,,,,,
45,,A0A2L1K0H6,A0A2L1K0H6_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),27,,,,,,,,
46,,A0A2L1K0H8,A0A2L1K0H8_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),27,,,,,,,,
47,,A0A2L1K0H9,A0A2L1K0H9_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),23,,,,,,,,
48,,A0A2L1K0I9,A0A2L1K0I9_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),26,,,,,,,,
49,,A0A2L1K0M4,A0A2L1K0M4_HUMAN,Cytochrome P450 2D6,CYP2D6,Homo sapiens (Human),23,,,,,,,,
50,,A9QKR9,A9QKR9_HUMAN,Nonfunctional cytochrome P450 family 2 subfamily D polypeptide 6 (EC 1.14.14.1),CYP2D6,Homo sapiens (Human),224,,membrane [GO:0016020],membrane [GO:0016020]; aromatase activity [GO:0070330],aromatase activity [GO:0070330],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
51,,C4MDQ5,C4MDQ5_HUMAN,Nonfunctional cytochrome P450 family 2 subfamily D polypeptide 6 (EC 1.14.14.1),CYP2D6,Homo sapiens (Human),252,,membrane [GO:0016020],membrane [GO:0016020]; aromatase activity [GO:0070330],aromatase activity [GO:0070330],,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
52,,D3IP03,D3IP03_HUMAN,Nonfunctional cytochrome P450 family 2 subfamily D polypeptide 6,CYP2D6,Homo sapiens (Human),252,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
53,,D3IP04,D3IP04_HUMAN,Nonfunctional cytochrome P450 family 2 subfamily D polypeptide 6,CYP2D6,Homo sapiens (Human),252,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
54,,D3IP05,D3IP05_HUMAN,Nonfunctional cytochrome P450 family 2 subfamily D polypeptide 6,CYP2D6,Homo sapiens (Human),252,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
55,,I1VC92,I1VC92_HUMAN,Cytochrome P450 IID6,CYP2D6,Homo sapiens (Human),81,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
56,,I1VC93,I1VC93_HUMAN,Cytochrome P450 IID6,CYP2D6,Homo sapiens (Human),81,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 6..23; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
57,,Q007T8,Q007T8_HUMAN,Cytochrome P4502D6,CYP2D6,Homo sapiens (Human),58,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""SULT1E1"")",P49888,ST1E1_HUMAN,"Sulfotransferase 1E1 (ST1E1) (EC 2.8.2.4) (EST-1) (Estrogen sulfotransferase) (Sulfotransferase, estrogen-preferring)",SULT1E1 STE,Homo sapiens (Human),294,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear membrane [GO:0031965]; aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; estrogen catabolic process [GO:0006711]; estrogen metabolic process [GO:0008210]; ethanol catabolic process [GO:0006068]; positive regulation of fat cell differentiation [GO:0045600]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062]; estrone sulfotransferase activity [GO:0004304]; flavonol 3-sulfotransferase activity [GO:0047894]; steroid binding [GO:0005496]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:11006110}.",
1,,Q53X91,Q53X91_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT1E1 hCG_38316,Homo sapiens (Human),294,sulfation [GO:0051923],cytosol [GO:0005829]; nuclear membrane [GO:0031965],cytosol [GO:0005829]; nuclear membrane [GO:0031965]; aryl sulfotransferase activity [GO:0004062]; steroid binding [GO:0005496]; sulfation [GO:0051923],aryl sulfotransferase activity [GO:0004062]; steroid binding [GO:0005496],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000256|ARBA:ARBA00004514}.",
0,"(gene:""CYP2E1"")",P05181,CP2E1_HUMAN,Cytochrome P450 2E1 (EC 1.14.14.1) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J),CYP2E1 CYP2E,Homo sapiens (Human),493,4-nitrophenol metabolic process [GO:0018960]; benzene metabolic process [GO:0018910]; carbon tetrachloride metabolic process [GO:0018885]; epoxygenase P450 pathway [GO:0019373]; halogenated hydrocarbon metabolic process [GO:0042197]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; 4-nitrophenol 2-monooxygenase activity [GO:0018601]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; 4-nitrophenol metabolic process [GO:0018960]; benzene metabolic process [GO:0018910]; carbon tetrachloride metabolic process [GO:0018885]; epoxygenase P450 pathway [GO:0019373]; halogenated hydrocarbon metabolic process [GO:0042197]; lipid hydroxylation [GO:0002933]; long-chain fatty acid biosynthetic process [GO:0042759]; long-chain fatty acid metabolic process [GO:0001676]; monoterpenoid metabolic process [GO:0016098]; response to bacterium [GO:0009617]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805]","4-nitrophenol 2-monooxygenase activity [GO:0018601]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; enzyme binding [GO:0019899]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; long-chain fatty acid omega-1 hydroxylase activity [GO:0120319]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]",,,"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P05182}; Peripheral membrane protein {ECO:0000250|UniProtKB:P05182}. Microsome membrane {ECO:0000250|UniProtKB:P05182}; Peripheral membrane protein {ECO:0000250|UniProtKB:P05182}. Mitochondrion inner membrane {ECO:0000250|UniProtKB:P05182}; Peripheral membrane protein {ECO:0000250|UniProtKB:P05182}. Note=Post-translationally targeted to mitochondria. TOMM70 is required for the translocation across the mitochondrial outer membrane. After translocation into the matrix, associates with the inner membrane as a membrane extrinsic protein. {ECO:0000250|UniProtKB:P05182}.",
1,,Q6NWT7,Q6NWT7_HUMAN,Cytochrome P450 2E1 (EC 1.14.13.n7) (EC 1.14.14.1),CYP2E1,Homo sapiens (Human),493,epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805],arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506],,,"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368050}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368050}. Microsome membrane {ECO:0000256|ARBA:ARBA00004174, ECO:0000256|RuleBase:RU368050}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004174, ECO:0000256|RuleBase:RU368050}. Mitochondrion inner membrane {ECO:0000256|RuleBase:RU368050}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368050}.",
2,,F5H694,F5H694_HUMAN,Cytochrome P450 2E1 (EC 1.14.13.n7) (EC 1.14.14.1),CYP2E1,Homo sapiens (Human),86,fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743],endoplasmic reticulum membrane [GO:0005789]; mitochondrial inner membrane [GO:0005743]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506]; fatty acid metabolic process [GO:0006631],aromatase activity [GO:0070330]; heme binding [GO:0020037]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron ion binding [GO:0005506],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368050}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368050}. Microsome membrane {ECO:0000256|RuleBase:RU368050}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368050}. Mitochondrion inner membrane {ECO:0000256|RuleBase:RU368050}; Peripheral membrane protein {ECO:0000256|RuleBase:RU368050}.,
3,,H0Y593,H0Y593_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2E1,Homo sapiens (Human),306,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,SUBCELLULAR LOCATION: Microsome membrane {ECO:0000256|ARBA:ARBA00004174}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004174}.,
4,,H0Y7H4,H0Y7H4_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2E1,Homo sapiens (Human),356,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,SUBCELLULAR LOCATION: Microsome membrane {ECO:0000256|ARBA:ARBA00004174}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004174}.,
5,,Q4LBD0,Q4LBD0_HUMAN,unspecific monooxygenase (EC 1.14.14.1),CYP2E1,Homo sapiens (Human),97,epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; epoxygenase P450 pathway [GO:0019373]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Microsome membrane {ECO:0000256|ARBA:ARBA00004174}; Peripheral membrane protein {ECO:0000256|ARBA:ARBA00004174}.,
6,,H0YGV5,H0YGV5_HUMAN,Cytochrome P450 family 2 subfamily E member 1,CYP2E1,Homo sapiens (Human),43,,,,,,,,
7,,Q16868,Q16868_HUMAN,CYP2E1 protein,CYP2E1,Homo sapiens (Human),68,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
8,,Q573G9,Q573G9_HUMAN,Cytochrome P450 2E1,CYP2E1,Homo sapiens (Human),42,,,,,,,,
9,,Q573H0,Q573H0_HUMAN,Cytochrome P450 2E1,CYP2E1,Homo sapiens (Human),42,,,,,,,,
10,,Q6LER5,Q6LER5_HUMAN,Cytochrome P450IIE1,CYP2E1,Homo sapiens (Human),21,,,,,,,,
0,"(gene:""SULT2A1"")",Q06520,ST2A1_HUMAN,Sulfotransferase 2A1 (ST2A1) (EC 2.8.2.2) (Bile salt sulfotransferase) (EC 2.8.2.14) (Dehydroepiandrosterone sulfotransferase) (DHEA-ST) (DHEA-ST8) (Hydroxysteroid Sulfotransferase) (HST) (ST2) (SULT2A3),SULT2A1 HST STD,Homo sapiens (Human),285,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; bile acid catabolic process [GO:0030573]; cholesterol metabolic process [GO:0008203]; ethanol catabolic process [GO:0006068]; lipid catabolic process [GO:0016042]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; cytosol [GO:0005829],cytoplasm [GO:0005737]; cytosol [GO:0005829]; 3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; bile-salt sulfotransferase activity [GO:0047704]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; bile acid catabolic process [GO:0030573]; cholesterol metabolic process [GO:0008203]; ethanol catabolic process [GO:0006068]; lipid catabolic process [GO:0016042]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923]; thyroid hormone metabolic process [GO:0042403]; xenobiotic metabolic process [GO:0006805],3'-phosphoadenosine 5'-phosphosulfate binding [GO:0050656]; alcohol sulfotransferase activity [GO:0004027]; bile-salt sulfotransferase activity [GO:0047704]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:2268288}.,
1,,A8K015,A8K015_HUMAN,Sulfotransferase (EC 2.8.2.-),SULT2A1 hCG_201431,Homo sapiens (Human),285,steroid metabolic process [GO:0008202],cytosol [GO:0005829],cytosol [GO:0005829]; sulfotransferase activity [GO:0008146]; steroid metabolic process [GO:0008202],sulfotransferase activity [GO:0008146],,,,
0,"(gene:""CYP2F1"")",P24903,CP2F1_HUMAN,Cytochrome P450 2F1 (EC 1.14.14.1) (CYPIIF1),CYP2F1,Homo sapiens (Human),491,epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]; epoxygenase P450 pathway [GO:0019373]; naphthalene catabolic process [GO:1901170]; response to toxic substance [GO:0009636]; xenobiotic metabolic process [GO:0006805]","arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; oxygen binding [GO:0019825]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:10383923}; Peripheral membrane protein {ECO:0000305|PubMed:10383923}. Microsome membrane {ECO:0000269|PubMed:10383923}; Peripheral membrane protein {ECO:0000269|PubMed:10383923}.,
1,,A0A075B795,A0A075B795_HUMAN,Cytochrome P450 family 2 subfamily F member 1,CYP2F1,Homo sapiens (Human),172,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,A7KAU4,A7KAU4_HUMAN,Truncated cytochrome P450 2F1 variant,CYP2F1,Homo sapiens (Human),26,,,,,,,,
3,,H0YGI9,H0YGI9_HUMAN,Cytochrome P450 family 2 subfamily F member 1,CYP2F1,Homo sapiens (Human),81,,endoplasmic reticulum [GO:0005783]; membrane [GO:0016020],"endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""SULT2B1"")",O00204,ST2B1_HUMAN,Sulfotransferase 2B1 (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1) (ST2B1),SULT2B1 HSST2,Homo sapiens (Human),365,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634]; cholesterol binding [GO:0015485]; cholesterol sulfotransferase activity [GO:0051922]; nucleic acid binding [GO:0003676]; small molecule binding [GO:0036094]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146]; 3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],cholesterol binding [GO:0015485]; cholesterol sulfotransferase activity [GO:0051922]; nucleic acid binding [GO:0003676]; small molecule binding [GO:0036094]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146],,,"SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:12923182, ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633, ECO:0000269|PubMed:28575648}. Microsome {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}. Nucleus {ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633}. Note=Phosphorylation of Ser-348 is required for translocation to the nucleus. {ECO:0000269|PubMed:21855633}.",
0,"(gene:""CYP2J2"")",P51589,CP2J2_HUMAN,Cytochrome P450 2J2 (EC 1.14.14.-) (Albendazole monooxygenase (hydroxylating)) (EC 1.14.14.74) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Arachidonic acid epoxygenase) (CYPIIJ2) (Hydroperoxy icosatetraenoate isomerase) (EC 5.4.4.7),CYP2J2,Homo sapiens (Human),502,epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid metabolic process [GO:0006690]; linoleic acid metabolic process [GO:0043651]; organic acid metabolic process [GO:0006082]; regulation of heart contraction [GO:0008016]; xenobiotic metabolic process [GO:0006805]","arachidonic acid 11,12-epoxygenase activity [GO:0008405]; arachidonic acid 14,15-epoxygenase activity [GO:0008404]; arachidonic acid 5,6-epoxygenase activity [GO:0106301]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydroperoxy icosatetraenoate isomerase activity [GO:0106255]; iron ion binding [GO:0005506]; isomerase activity [GO:0016853]; linoleic acid epoxygenase activity [GO:0071614]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000269|PubMed:8631948}; Peripheral membrane protein.,
1,,Q9UN91,Q9UN91_HUMAN,Cytochrome P450 epoxygenase,CYP2J2,Homo sapiens (Human),339,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
2,,A0A2D1BTF8,A0A2D1BTF8_HUMAN,Cytochrome P450,cyp2J2,Homo sapiens (Human),53,organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
3,,A0A3B3IT99,A0A3B3IT99_HUMAN,"Cytochrome P450 family 2 subfamily J member 2 (Cytochrome P450, family 2, subfamily J, polypeptide 2, isoform CRA_c)",CYP2J2 hCG_22170,Homo sapiens (Human),402,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
4,,A0A3B3ITF2,A0A3B3ITF2_HUMAN,Cytochrome P450 family 2 subfamily J member 2,CYP2J2,Homo sapiens (Human),84,,,,,,,,
5,,A0A3B3IU95,A0A3B3IU95_HUMAN,Cytochrome P450 family 2 subfamily J member 2,CYP2J2,Homo sapiens (Human),355,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,,
6,,Q96RX4,Q96RX4_HUMAN,Cytochrome P450,CYP2J2,Homo sapiens (Human),32,,,,,,,,
0,"(gene:""TPMT"")",P51580,TPMT_HUMAN,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),TPMT,Homo sapiens (Human),245,methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytosol [GO:0005829],cytosol [GO:0005829]; S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259]; nucleobase-containing compound metabolic process [GO:0006139]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],S-adenosyl-L-methionine binding [GO:1904047]; thiopurine S-methyltransferase activity [GO:0008119],,,SUBCELLULAR LOCATION: Cytoplasm.,
1,,Q9BS45,Q9BS45_HUMAN,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),TPMT,Homo sapiens (Human),245,methylation [GO:0032259],cytoplasm [GO:0005737],cytoplasm [GO:0005737]; thiopurine S-methyltransferase activity [GO:0008119]; methylation [GO:0032259],thiopurine S-methyltransferase activity [GO:0008119],,,SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|ARBA:ARBA00004496}.,
0,"(gene:""CYP2R1"")",Q6VVX0,CP2R1_HUMAN,Vitamin D 25-hydroxylase (EC 1.14.14.24) (Cytochrome P450 2R1),CYP2R1,Homo sapiens (Human),501,calcitriol biosynthetic process from calciol [GO:0036378]; organic acid metabolic process [GO:0006082]; response to cesium ion [GO:0010164]; response to ionizing radiation [GO:0010212]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; D3 vitamins binding [GO:1902271]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; protein homodimerization activity [GO:0042803]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]; calcitriol biosynthetic process from calciol [GO:0036378]; organic acid metabolic process [GO:0006082]; response to cesium ion [GO:0010164]; response to ionizing radiation [GO:0010212]; vitamin D metabolic process [GO:0042359]; vitamin metabolic process [GO:0006766]; xenobiotic metabolic process [GO:0006805]","D3 vitamins binding [GO:1902271]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; protein homodimerization activity [GO:0042803]; steroid hydroxylase activity [GO:0008395]; vitamin D3 25-hydroxylase activity [GO:0030343]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:15465040}; Peripheral membrane protein. Microsome membrane {ECO:0000305|PubMed:15465040}; Peripheral membrane protein.,
1,,E9PJT9,E9PJT9_HUMAN,Cytochrome P450 family 2 subfamily R member 1,CYP2R1,Homo sapiens (Human),268,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,E9PS56,E9PS56_HUMAN,Cytochrome P450 family 2 subfamily R member 1,CYP2R1,Homo sapiens (Human),37,,,,,,,,
3,,K7EMQ4,K7EMQ4_HUMAN,Cytochrome P450 family 2 subfamily R member 1,CYP2R1,Homo sapiens (Human),32,,,,,,,,
0,"(gene:""UGT1A1"")",P22309,UD11_HUMAN,UDP-glucuronosyltransferase 1A1 (UGT1A1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-1) (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (UDP-glucuronosyltransferase 1A isoform 1),UGT1A1 GNT1 UGT1,Homo sapiens (Human),533,acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],cytochrome complex [GO:0070069]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; bilirubin conjugation [GO:0006789]; biphenyl catabolic process [GO:0070980]; cellular glucuronidation [GO:0052695]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; estrogen metabolic process [GO:0008210]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496],,"TRANSMEM 491..507; /note=""Helical""; /evidence=""ECO:0000255""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:17179145, ECO:0000269|PubMed:17187418}; Single-pass membrane protein {ECO:0000255}. Cytoplasm, perinuclear region {ECO:0000269|PubMed:17187418}.",
1,,Q5DT03,Q5DT03_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A1 BILIQTL1 hCG_2039726,Homo sapiens (Human),533,acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; biphenyl catabolic process [GO:0070980]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; xenobiotic glucuronidation [GO:0052697],cytochrome complex [GO:0070069]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886],cytochrome complex [GO:0070069]; endoplasmic reticulum chaperone complex [GO:0034663]; endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; acute-phase response [GO:0006953]; animal organ regeneration [GO:0031100]; biphenyl catabolic process [GO:0070980]; cellular response to estradiol stimulus [GO:0071392]; cellular response to ethanol [GO:0071361]; cellular response to glucocorticoid stimulus [GO:0071385]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; xenobiotic glucuronidation [GO:0052697],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 491..514; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
2,,A0A0M4UT75,A0A0M4UT75_HUMAN,Bilirubin UDP-glucuronosyltranserase,UGT1A1,Homo sapiens (Human),149,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
3,,A0A1L2FNL9,A0A1L2FNL9_HUMAN,UDP glucuronosyltransferase 1 family polypeptide A1 (EC 2.4.1.17),UGT1A1,Homo sapiens (Human),17,,,glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,,,
4,,A0A346RP36,A0A346RP36_HUMAN,UDP glucuronosyltransferase family 1 member A1,UGT1A1,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
5,,A0A346RP37,A0A346RP37_HUMAN,UDP glucuronosyltransferase family 1 member A1,UGT1A1,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
6,,A0A346RP38,A0A346RP38_HUMAN,UDP glucuronosyltransferase family 1 member A1,UGT1A1,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
7,,B6EBF5,B6EBF5_HUMAN,Bilirubin UDP-glucuronosyltransferase 1 A1,UGT1A1,Homo sapiens (Human),29,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
8,,Q9BX76,Q9BX76_HUMAN,Bilirubin UDP-glucronosyltrasferase 1-1,UGT1A1,Homo sapiens (Human),66,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
9,,Q9H3F9,Q9H3F9_HUMAN,UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),294,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
10,,W6JGU4,W6JGU4_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),288,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
11,,W6JGU6,W6JGU6_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),98,cellular glucuronidation [GO:0052695],membrane [GO:0016020],membrane [GO:0016020]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 56..79; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
12,,W6JGV5,W6JGV5_HUMAN,Bilirubin UDP-glucuronoslytransferase,UGT1A1,Homo sapiens (Human),145,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
13,,W6JGV8,W6JGV8_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),98,cellular glucuronidation [GO:0052695],membrane [GO:0016020],membrane [GO:0016020]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 56..79; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
14,,W6JHY2,W6JHY2_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),287,cellular glucuronidation [GO:0052695],,enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,,,
15,,W6JIA6,W6JIA6_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),288,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
16,,W6JIB0,W6JIB0_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),72,cellular glucuronidation [GO:0052695],endoplasmic reticulum [GO:0005783],endoplasmic reticulum [GO:0005783]; enzyme binding [GO:0019899]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; hexosyltransferase activity [GO:0016758]; UDP-glycosyltransferase activity [GO:0008194],,,,
17,,W6JNV6,W6JNV6_HUMAN,Bilirubin UDP-glucuronosyltransferase,UGT1A1,Homo sapiens (Human),288,cellular glucuronidation [GO:0052695],,enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,,,
0,"(gene:""CYP2S1"")",Q96SQ9,CP2S1_HUMAN,Cytochrome P450 2S1 (EC 1.14.14.-) (CYPIIS1) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152) (Thromboxane-A synthase) (EC 5.3.99.5),CYP2S1 UNQ891/PRO1906,Homo sapiens (Human),504,cytochrome metabolic process [GO:1903604]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; thromboxane-A synthase activity [GO:0004796]; cytochrome metabolic process [GO:1903604]; epoxygenase P450 pathway [GO:0019373]; icosanoid metabolic process [GO:0006690]; prostaglandin metabolic process [GO:0006693]; retinoic acid metabolic process [GO:0042573]; xenobiotic metabolic process [GO:0006805]","12-hydroxyheptadecatrienoic acid synthase activity [GO:0036134]; arachidonic acid epoxygenase activity [GO:0008392]; heme binding [GO:0020037]; hydro-lyase activity [GO:0016836]; hydroperoxy icosatetraenoate dehydratase activity [GO:0106256]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; thromboxane-A synthase activity [GO:0004796]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:11181079}; Peripheral membrane protein {ECO:0000269|PubMed:11181079}. Microsome membrane {ECO:0000269|PubMed:11181079}; Peripheral membrane protein {ECO:0000269|PubMed:11181079}.,
1,,M0R057,M0R057_HUMAN,Cytochrome P450 family 2 subfamily S member 1,CYP2S1,Homo sapiens (Human),187,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,M0R152,M0R152_HUMAN,Cytochrome P450 family 2 subfamily S member 1,CYP2S1,Homo sapiens (Human),175,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 77..100; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,M0QY51,M0QY51_HUMAN,Cytochrome P450 family 2 subfamily S member 1,CYP2S1,Homo sapiens (Human),60,,,,,,,,
4,,M0QYI2,M0QYI2_HUMAN,Cytochrome P450 family 2 subfamily S member 1,CYP2S1,Homo sapiens (Human),73,,,,,,,,
5,,M0R2G8,M0R2G8_HUMAN,Cytochrome P450 family 2 subfamily S member 1,CYP2S1,Homo sapiens (Human),165,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""UGT1A10"")",Q9HAW8,UD110_HUMAN,UDP-glucuronosyltransferase 1A10 (UGT1A10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-10) (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J),UGT1A10 GNT1 UGT1,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; lipid metabolic process [GO:0006629]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; xenobiotic metabolic process [GO:0006805],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080],,"TRANSMEM 488..504; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:17179145}; Single-pass membrane protein {ECO:0000255}.,
1,,Q5DT02,Q5DT02_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A10 hCG_2039726,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 488..511; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
0,"(gene:""CYP2U1"")",Q7Z449,CP2U1_HUMAN,Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),CYP2U1,Homo sapiens (Human),544,cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial inner membrane [GO:0005743]; arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]; cytochrome metabolic process [GO:1903604]; omega-hydroxylase P450 pathway [GO:0097267]; organic acid metabolic process [GO:0006082]; xenobiotic metabolic process [GO:0006805]","arachidonic acid omega-hydroxylase activity [GO:0052869]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; steroid hydroxylase activity [GO:0008395]",,"TRANSMEM 30..50; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 113..133; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 261..281; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 342..362; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 495..515; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:14660610}; Multi-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000269|PubMed:14660610}; Multi-pass membrane protein {ECO:0000255}. Mitochondrion inner membrane {ECO:0000269|PubMed:23176821}; Multi-pass membrane protein {ECO:0000255}.,
1,,E9PGH5,E9PGH5_HUMAN,Cytochrome P450 (EC 1.14.14.-),CYP2U1,Homo sapiens (Human),335,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368047}. Microsome membrane {ECO:0000256|RuleBase:RU368047}.,
0,"(gene:""UGT1A3"")",P35503,UD13_HUMAN,UDP-glucuronosyltransferase 1A3 (UGT1A3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-3) (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A isoform 3),UGT1A3 GNT1 UGT1,Homo sapiens (Human),534,bile acid secretion [GO:0032782]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; vitamin D3 metabolic process [GO:0070640]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; bile acid secretion [GO:0032782]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; flavonoid glucuronidation [GO:0052696]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; vitamin D3 metabolic process [GO:0070640]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972],,"TRANSMEM 492..508; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:17179145}; Single-pass membrane protein {ECO:0000255}.,
1,,Q5DT01,Q5DT01_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A3 hCG_2039726,Homo sapiens (Human),534,cellular glucuronidation [GO:0052695],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 492..515; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
2,,A7E1U4,A7E1U4_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
3,,A7E1U5,A7E1U5_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
4,,A7E1U6,A7E1U6_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
5,,A7E1U7,A7E1U7_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
6,,A7E1U8,A7E1U8_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
7,,A7E1U9,A7E1U9_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
8,,A7ISW3,A7ISW3_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
9,,A9UKC8,A9UKC8_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),49,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
10,,A9UKC9,A9UKC9_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),49,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
11,,A9UKD1,A9UKD1_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),49,,,transferase activity [GO:0016740],transferase activity [GO:0016740],,,,
12,,B1MV79,B1MV79_HUMAN,UDP-glucuronosyltransferase 1A3,UGT1A3,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
13,,Q75XT3,Q75XT3_HUMAN,UDP-glucuronosyltransferase,UGT1A3,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
14,,Q75XT5,Q75XT5_HUMAN,UDP-glucuronosyltransferase,UGT1A3,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
15,,Q8WX89,Q8WX89_HUMAN,UDP-glucuronosyltransferase,UGT1A3,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
16,,Q8WX90,Q8WX90_HUMAN,UDP-glucuronosyltransferase,UGT1A3,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
17,,Q8WX91,Q8WX91_HUMAN,UDP-glucuronosyltransferase,UGT1A3,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP2W1"")",Q8TAV3,CP2W1_HUMAN,Cytochrome P450 2W1 (EC 1.14.14.-) (CYPIIW1),CYP2W1,Homo sapiens (Human),490,aflatoxin metabolic process [GO:0046222]; cytochrome metabolic process [GO:1903604]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805],cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886],"cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]; all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]; aflatoxin metabolic process [GO:0046222]; cytochrome metabolic process [GO:1903604]; organic acid metabolic process [GO:0006082]; phospholipid metabolic process [GO:0006644]; retinoic acid catabolic process [GO:0034653]; xenobiotic metabolic process [GO:0006805]","all-trans retinal binding [GO:0005503]; all-trans-retinol binding [GO:1904768]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; retinoic acid 4-hydroxylase activity [GO:0008401]; retinoic acid binding [GO:0001972]",,,SUBCELLULAR LOCATION: Endoplasmic reticulum lumen {ECO:0000269|PubMed:20805301}. Cell membrane {ECO:0000269|PubMed:20805301}. Microsome membrane {ECO:0000269|PubMed:20805301}. Note=About 8% are expressed on the cell surface. {ECO:0000269|PubMed:20805301}.,
1,,A6NJ10,A6NJ10_HUMAN,Cytochrome P450 family 2 subfamily W member 1,CYP2W1,Homo sapiens (Human),408,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,H7C015,H7C015_HUMAN,Cytochrome P450 family 2 subfamily W member 1,CYP2W1,Homo sapiens (Human),288,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""UGT1A4"")",P22310,UD14_HUMAN,UDP-glucuronosyltransferase 1A4 (UGT1A4) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 2) (hUG-BR2) (UDP-glucuronosyltransferase 1-4) (UDPGT 1-4) (UGT1*4) (UGT1-04) (UGT1.4) (UDP-glucuronosyltransferase 1-D) (UGT-1D) (UGT1D),UGT1A4 GNT1 UGT1,Homo sapiens (Human),534,bilirubin conjugation [GO:0006789]; cellular glucuronidation [GO:0052695]; heme catabolic process [GO:0042167]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; vitamin D3 metabolic process [GO:0070640],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; bilirubin conjugation [GO:0006789]; cellular glucuronidation [GO:0052695]; heme catabolic process [GO:0042167]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; vitamin D3 metabolic process [GO:0070640],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 492..508; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:17179145}; Single-pass membrane protein {ECO:0000255}.,
1,,A3KME6,A3KME6_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A4,Homo sapiens (Human),531,cellular glucuronidation [GO:0052695],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 489..512; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
2,,Q0VAJ1,Q0VAJ1_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A4,Homo sapiens (Human),445,cellular glucuronidation [GO:0052695],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,,"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
3,,A9UKD7,A9UKD7_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
4,,A9UKD8,A9UKD8_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
5,,A9UKD9,A9UKD9_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
6,,B8K2E8,B8K2E8_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
7,,B8K2E9,B8K2E9_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
8,,B8K2F1,B8K2F1_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
9,,B8K2F4,B8K2F4_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
10,,B8K2F8,B8K2F8_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1A4,Homo sapiens (Human),59,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
11,,Q53QD2,Q53QD2_HUMAN,UDP-glucuronosyltransferase 1A4,UGT1 UGT1A4,Homo sapiens (Human),289,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
12,,Q8WX86,Q8WX86_HUMAN,UDP-glucuronosyltransferase,UGT1A4,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
13,,Q8WX87,Q8WX87_HUMAN,UDP-glucuronosyltransferase,UGT1A4,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
14,,Q8WX88,Q8WX88_HUMAN,UDP-glucuronosyltransferase,UGT1A4,Homo sapiens (Human),287,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP39A1"")",Q9NYL5,CP39A_HUMAN,24-hydroxycholesterol 7-alpha-hydroxylase (EC 1.14.14.26) (Cytochrome P450 39A1) (hCYP39A1) (Oxysterol 7-alpha-hydroxylase),CYP39A1,Homo sapiens (Human),469,bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; sterol metabolic process [GO:0016125],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid 7-alpha-hydroxylase activity [GO:0008387]; bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; cholesterol homeostasis [GO:0042632]; digestion [GO:0007586]; sterol metabolic process [GO:0016125],24-hydroxycholesterol 7alpha-hydroxylase activity [GO:0033782]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxysterol 7-alpha-hydroxylase activity [GO:0008396]; steroid 7-alpha-hydroxylase activity [GO:0008387],,"TRANSMEM 267..287; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 352..372; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 412..432; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q64654}; Multi-pass membrane protein {ECO:0000255}. Microsome membrane {ECO:0000250|UniProtKB:Q64654}; Multi-pass membrane protein {ECO:0000255}.,
1,,A0A087WTD2,A0A087WTD2_HUMAN,Cytochrome P450 family 39 subfamily A member 1,CYP39A1,Homo sapiens (Human),297,organic hydroxy compound biosynthetic process [GO:1901617]; small molecule biosynthetic process [GO:0044283]; steroid biosynthetic process [GO:0006694],intracellular membrane-bounded organelle [GO:0043231],"intracellular membrane-bounded organelle [GO:0043231]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; organic hydroxy compound biosynthetic process [GO:1901617]; small molecule biosynthetic process [GO:0044283]; steroid biosynthetic process [GO:0006694]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""UGT1A8"")",Q9HAW9,UD18_HUMAN,UDP-glucuronosyltransferase 1A8 (UGT1A8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-8) (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H),UGT1A8 GNT1 UGT1,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695]; coumarin metabolic process [GO:0009804]; fatty acid metabolic process [GO:0006631]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; fatty acid binding [GO:0005504]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496]; cellular glucuronidation [GO:0052695]; coumarin metabolic process [GO:0009804]; fatty acid metabolic process [GO:0006631]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; negative regulation of steroid metabolic process [GO:0045939]; retinoic acid metabolic process [GO:0042573]; steroid metabolic process [GO:0008202]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; fatty acid binding [GO:0005504]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; steroid binding [GO:0005496],,"TRANSMEM 488..504; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:17179145}; Single-pass membrane protein {ECO:0000255}.,
1,,Q5DSZ6,Q5DSZ6_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A8 hCG_2039726,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 488..511; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
2,,A9JQZ1,A9JQZ1_HUMAN,UDP-glucuronosyltransferase 1A8,UGT1A8,Homo sapiens (Human),286,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
3,,A9JQZ2,A9JQZ2_HUMAN,UDP-glucuronosyltransferase 1A8,UGT1A8,Homo sapiens (Human),286,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
4,,A9JQZ4,A9JQZ4_HUMAN,UDP-glucuronosyltransferase 1A8,UGT1A8,Homo sapiens (Human),286,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP3A4"")",P08684,CP3A4_HUMAN,"Cytochrome P450 3A4 (EC 1.14.14.1) (1,4-cineole 2-exo-monooxygenase) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.14.56) (Albendazole monooxygenase (sulfoxide-forming)) (EC 1.14.14.73) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.14.55)",CYP3A4 CYP3A3,Homo sapiens (Human),503,aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]; aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; androgen metabolic process [GO:0008209]; cholesterol metabolic process [GO:0008203]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; lipid metabolic process [GO:0006629]; long-chain fatty acid biosynthetic process [GO:0042759]; monoterpenoid metabolic process [GO:0016098]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid catabolic process [GO:0006706]; steroid metabolic process [GO:0008202]; vitamin D catabolic process [GO:0042369]; vitamin D metabolic process [GO:0042359]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805]","1,8-cineole 2-exo-monooxygenase activity [GO:0102320]; 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity [GO:0062181]; anandamide 11,12 epoxidase activity [GO:0062188]; anandamide 14,15 epoxidase activity [GO:0062189]; anandamide 8,9 epoxidase activity [GO:0062187]; aromatase activity [GO:0070330]; caffeine oxidase activity [GO:0034875]; enzyme binding [GO:0019899]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; quinine 3-monooxygenase activity [GO:0050591]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid binding [GO:0005496]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; vitamin D 24-hydroxylase activity [GO:0070576]; vitamin D3 25-hydroxylase activity [GO:0030343]",,"TRANSMEM 2..22; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass membrane protein. Microsome membrane {ECO:0000269|PubMed:21576599}; Single-pass membrane protein.,
1,,Q86SK3,Q86SK3_HUMAN,Cytochrome P450 3A (EC 1.14.14.-),CYP3A43/CYP3A4,Homo sapiens (Human),503,xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],"endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]; testosterone 6-beta-hydroxylase activity [GO:0050649]",,"TRANSMEM 6..25; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 215..233; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368049}. Microsome membrane {ECO:0000256|RuleBase:RU368049}.,
2,,A0A494C0W7,A0A494C0W7_HUMAN,Cytochrome P450 family 3 subfamily A member 4,CYP3A4,Homo sapiens (Human),454,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 170..192; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,A0A499FJM4,A0A499FJM4_HUMAN,Cytochrome P450 3A (EC 1.14.14.-),CYP3A4,Homo sapiens (Human),534,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 219..241; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368049}. Microsome membrane {ECO:0000256|RuleBase:RU368049}.,
4,,E7EVM8,E7EVM8_HUMAN,Cytochrome P450 family 3 subfamily A member 4,CYP3A4,Homo sapiens (Human),353,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..31; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 69..91; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,Q6GRK0,Q6GRK0_HUMAN,Cytochrome P450 3A (EC 1.14.14.-),CYP3A4 hCG_17094 tcag7.603,Homo sapiens (Human),503,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 219..241; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368049}. Microsome membrane {ECO:0000256|RuleBase:RU368049}.,
6,,Q7Z448,Q7Z448_HUMAN,Cytochrome P450 3A (EC 1.14.14.-),CYP3A4,Homo sapiens (Human),430,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 146..168; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368049}. Microsome membrane {ECO:0000256|RuleBase:RU368049}.,
7,,Q86SK2,Q86SK2_HUMAN,Cytochrome P450,CYP3A43/CYP3A4,Homo sapiens (Human),353,xenobiotic metabolic process [GO:0006805],membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]; xenobiotic metabolic process [GO:0006805]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]",,"TRANSMEM 12..31; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 69..91; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
8,,C9JBD2,C9JBD2_HUMAN,Cytochrome P450 family 3 subfamily A member 4,CYP3A4,Homo sapiens (Human),153,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""UGT1A9"")",O60656,UD19_HUMAN,UDP-glucuronosyltransferase 1A9 (UGT1A9) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-9) (UDPGT 1-9) (UGT1*9) (UGT1-09) (UGT1.9) (UDP-glucuronosyltransferase 1-I) (UGT-1I) (UGT1I) (lugP4),UGT1A9 GNT1 UGT1,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972]; cellular glucuronidation [GO:0052695]; flavone metabolic process [GO:0051552]; flavonoid glucuronidation [GO:0052696]; liver development [GO:0001889]; negative regulation of cellular glucuronidation [GO:2001030]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of glucuronosyltransferase activity [GO:1904224]; retinoic acid metabolic process [GO:0042573]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; glucuronosyltransferase activity [GO:0015020]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; retinoic acid binding [GO:0001972],,"TRANSMEM 488..504; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:17179145}; Single-pass membrane protein {ECO:0000255}.,
1,,Q5DSZ5,Q5DSZ5_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A9 hCG_2039726,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; cellular glucuronidation [GO:0052695],enzyme binding [GO:0019899]; glucuronosyltransferase activity [GO:0015020]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],,"TRANSMEM 488..511; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|ARBA:ARBA00004389}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004389}. Membrane {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|ARBA:ARBA00004167, ECO:0000256|RuleBase:RU362059}.",
2,,A9UKF4,A9UKF4_HUMAN,UDP-glucuronosyltransferase 1A9,UGT1A9,Homo sapiens (Human),73,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
3,,A9UKF7,A9UKF7_HUMAN,UDP-glucuronosyltransferase 1A9,UGT1A9,Homo sapiens (Human),73,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
4,,Q330M4,Q330M4_HUMAN,UDP-glucuronosyltransferase 1A9,UGT1A9,Homo sapiens (Human),326,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
5,,Q4R0Z6,Q4R0Z6_HUMAN,UDP-glucuronosyltransferase variant (EC 2.4.1.17),UGT1A9,Homo sapiens (Human),285,,,glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,,,
6,,Q4R0Z7,Q4R0Z7_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT1A9,Homo sapiens (Human),285,,,glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,,,
7,,Q53E75,Q53E75_HUMAN,UDP-glucuronosyltransferase,UGT1A9,Homo sapiens (Human),285,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP3A5"")",P20815,CP3A5_HUMAN,Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450-PCN3),CYP3A5,Homo sapiens (Human),502,aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; testosterone 6-beta-hydroxylase activity [GO:0050649]; aflatoxin metabolic process [GO:0046222]; alkaloid catabolic process [GO:0009822]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202]; xenobiotic catabolic process [GO:0042178]; xenobiotic metabolic process [GO:0006805],aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity [GO:0016491]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; testosterone 6-beta-hydroxylase activity [GO:0050649],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,Q14V85,Q14V85_HUMAN,Cytochrome P450 3A (EC 1.14.14.-),CYP3A5,Homo sapiens (Human),347,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..25; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""; TRANSMEM 215..233; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368049}. Microsome membrane {ECO:0000256|RuleBase:RU368049}.,
2,,Q7Z446,Q7Z446_HUMAN,Cytochrome P450,CYP3A5,Homo sapiens (Human),84,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]",,,,
3,,Q7Z447,Q7Z447_HUMAN,Cytochrome P450,CYP3A5,Homo sapiens (Human),160,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]",,,,
4,,L8EC58,L8EC58_HUMAN,Alternative protein CYP3A5,CYP3A5,Homo sapiens (Human),82,,,,,,,,
5,,Q7Z3N0,Q7Z3N0_HUMAN,Cytochrome P450 family 3 subfamily A member 5 (Uncharacterized protein DKFZp686I18188),CYP3A5 DKFZp686I18188,Homo sapiens (Human),39,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 6..25; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,Q96RK6,Q96RK6_HUMAN,Cytochrome P-450,CYP3A5,Homo sapiens (Human),49,oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202],,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]; oxidative demethylation [GO:0070989]; steroid metabolic process [GO:0008202]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; testosterone 6-beta-hydroxylase activity [GO:0050649]",,,,
7,,Q96RK7,Q96RK7_HUMAN,Cytochrome P-450,CYP3A5,Homo sapiens (Human),32,,,,,,,,
8,,Q96RK8,Q96RK8_HUMAN,Cytochrome P-450,CYP3A5,Homo sapiens (Human),35,,,,,,,,
0,"(gene:""UGT2A3"")",Q6UWM9,UD2A3_HUMAN,UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) (EC 2.4.1.17),UGT2A3 UNQ2559/PRO6239,Homo sapiens (Human),527,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],"TOPO_DOM 24..491; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 513..527; /note=""Cytoplasmic""; /evidence=""ECO:0000255""","TRANSMEM 492..512; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,
1,,A0A0G2JRR8,A0A0G2JRR8_HUMAN,UDP glucuronosyltransferase family 2 member A3,UGT2A3,Homo sapiens (Human),173,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
2,,D6RBL8,D6RBL8_HUMAN,UDP glucuronosyltransferase family 2 member A3,UGT2A3,Homo sapiens (Human),172,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP3A7"")",P24462,CP3A7_HUMAN,Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA) (P450HLp2),CYP3A7,Homo sapiens (Human),503,estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649]; estrogen metabolic process [GO:0008210]; lipid hydroxylation [GO:0002933]; oxidative demethylation [GO:0070989]; retinoic acid metabolic process [GO:0042573]; retinol metabolic process [GO:0042572]; steroid biosynthetic process [GO:0006694]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],all-trans retinoic acid 18-hydroxylase activity [GO:0062183]; aromatase activity [GO:0070330]; estrogen 16-alpha-hydroxylase activity [GO:0101020]; estrogen 2-hydroxylase activity [GO:0101021]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; retinoic acid 4-hydroxylase activity [GO:0008401]; steroid hydroxylase activity [GO:0008395]; testosterone 6-beta-hydroxylase activity [GO:0050649],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane {ECO:0000305|PubMed:2492179}; Peripheral membrane protein.,
1,,A0A087WV96,A0A087WV96_HUMAN,Cytochrome P450 3A (EC 1.14.14.-),CYP3A7-CYP3A51P,Homo sapiens (Human),503,,endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen [GO:0016712]",,"TRANSMEM 6..25; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000256|RuleBase:RU368049}. Microsome membrane {ECO:0000256|RuleBase:RU368049}.,
2,,Q6KGV3,Q6KGV3_HUMAN,Cytochrome P450 variant 3A7,CYP3A7,Homo sapiens (Human),36,,,,,,,,
0,"(gene:""UGT2B10"")",P36537,UDB10_HUMAN,UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17),UGT2B10,Homo sapiens (Human),528,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; UDP-glycosyltransferase activity [GO:0008194]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629],UDP-glycosyltransferase activity [GO:0008194],,"TRANSMEM 492..512; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,
0,"(gene:""CYP46A1"")",Q9Y6A2,CP46A_HUMAN,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cholesterol 24-monooxygenase) (Cholesterol 24S-hydroxylase) (Cytochrome P450 46A1),CYP46A1 CYP46,Homo sapiens (Human),500,bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805],dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793],dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; postsynapse [GO:0098794]; presynapse [GO:0098793]; cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184]; bile acid biosynthetic process [GO:0006699]; cholesterol catabolic process [GO:0006707]; nervous system development [GO:0007399]; progesterone metabolic process [GO:0042448]; protein localization to membrane raft [GO:1903044]; regulation of long-term synaptic potentiation [GO:1900271]; sterol metabolic process [GO:0016125]; xenobiotic metabolic process [GO:0006805],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; steroid hydroxylase activity [GO:0008395]; testosterone 16-beta-hydroxylase activity [GO:0062184],,"TRANSMEM 3..23; /note=""Helical""; /evidence=""ECO:0000255""","SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q9WVK8}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q9WVK8}. Microsome membrane {ECO:0000250|UniProtKB:Q9WVK8}; Single-pass membrane protein {ECO:0000250|UniProtKB:Q9WVK8}. Postsynapse {ECO:0000250|UniProtKB:Q9WVK8}. Presynapse {ECO:0000250|UniProtKB:Q9WVK8}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q9WVK8}.",
1,,G3V366,G3V366_HUMAN,Cytochrome P450 family 46 subfamily A member 1,CYP46A1,Homo sapiens (Human),96,cholesterol catabolic process [GO:0006707],,cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; cholesterol catabolic process [GO:0006707],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
2,,H0YJI0,H0YJI0_HUMAN,Cytochrome P450 family 46 subfamily A member 1,CYP46A1,Homo sapiens (Human),164,cholesterol catabolic process [GO:0006707],,cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; cholesterol catabolic process [GO:0006707],cholesterol 24-hydroxylase activity [GO:0033781]; heme binding [GO:0020037]; iron ion binding [GO:0005506],,,,
3,,H0YJU5,H0YJU5_HUMAN,Cytochrome P450 family 46 subfamily A member 1,CYP46A1,Homo sapiens (Human),51,,,,,,,,
0,"(gene:""UGT2B11"")",P06133,UD2B4_HUMAN,UDP-glucuronosyltransferase 2B4 (UDPGT 2B4) (UGT2B4) (EC 2.4.1.17) (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1),UGT2B4 UGT2B11,Homo sapiens (Human),528,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 493..509; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:8333863}; Single-pass membrane protein {ECO:0000255}.,
1,,O75310,UDB11_HUMAN,UDP-glucuronosyltransferase 2B11 (UDPGT 2B11) (EC 2.4.1.17),UGT2B11,Homo sapiens (Human),529,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; xenobiotic glucuronidation [GO:0052697]; xenobiotic metabolic process [GO:0006805],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 493..513; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Microsome membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.,
2,,Q4W5B9,Q4W5B9_HUMAN,Uncharacterized protein UGT2B11,UGT2B11,Homo sapiens (Human),92,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 56..80; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""CYP4A11"")",Q02928,CP4AB_HUMAN,Cytochrome P450 4A11 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),CYP4A11 CYP4A2,Homo sapiens (Human),519,arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; leukotriene metabolic process [GO:0006691]; linoleic acid metabolic process [GO:0043651]; long-chain fatty acid metabolic process [GO:0001676]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078],alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid monooxygenase activity [GO:0008391]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:1739747}; Peripheral membrane protein {ECO:0000305}. Microsome membrane {ECO:0000305|PubMed:1739747}; Peripheral membrane protein {ECO:0000305}.,
1,,A0A0C4DFV7,A0A0C4DFV7_HUMAN,Cytochrome P450 family 4 subfamily A member 11,CYP4A11,Homo sapiens (Human),455,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 18..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
2,,V9GY41,V9GY41_HUMAN,Cytochrome P450 family 4 subfamily A member 11,CYP4A11,Homo sapiens (Human),215,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 18..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,V9GYC6,V9GYC6_HUMAN,Cytochrome P450 family 4 subfamily A member 11,CYP4A11,Homo sapiens (Human),377,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 18..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,V9GYK4,V9GYK4_HUMAN,Cytochrome P450 family 4 subfamily A member 11,CYP4A11,Homo sapiens (Human),264,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 18..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,V9GYQ2,V9GYQ2_HUMAN,Cytochrome P450 family 4 subfamily A member 11,CYP4A11,Homo sapiens (Human),249,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 18..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,V9GZ77,V9GZ77_HUMAN,Cytochrome P450 family 4 subfamily A member 11,CYP4A11,Homo sapiens (Human),421,,intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],"intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 18..39; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""UGT2B15"")",P54855,UDB15_HUMAN,UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (UGT2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3),UGT2B15 UGT2B8,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 495..515; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:23288867}; Single-pass membrane protein {ECO:0000255}.,
1,,A0A0G2JMZ5,A0A0G2JMZ5_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT2B15,Homo sapiens (Human),332,,membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 296..319; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|RuleBase:RU362059}.,
2,,Q9UHH3,Q9UHH3_HUMAN,UDP-glucuronosyltransferase UGT2B15,UGT2B15,Homo sapiens (Human),135,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP4A22"")",Q5TCH4,CP4AM_HUMAN,Cytochrome P450 4A22 (CYPIVA22) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80),CYP4A22,Homo sapiens (Human),519,arachidonic acid metabolic process [GO:0019369]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; linoleic acid metabolic process [GO:0043651]; lipid hydroxylation [GO:0002933],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231],endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; 16-hydroxypalmitate dehydrogenase activity [GO:0103002]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; medium-chain fatty acid omega-hydroxylase activity [GO:0140981]; arachidonic acid metabolic process [GO:0019369]; icosanoid biosynthetic process [GO:0046456]; kidney development [GO:0001822]; lauric acid metabolic process [GO:0048252]; linoleic acid metabolic process [GO:0043651]; lipid hydroxylation [GO:0002933],16-hydroxypalmitate dehydrogenase activity [GO:0103002]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid monooxygenase activity [GO:0008391]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; medium-chain fatty acid omega-hydroxylase activity [GO:0140981],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Microsome membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}.,
1,,A0A087WZX9,A0A087WZX9_HUMAN,Cytochrome P450 family 4 subfamily A member 22,CYP4A22,Homo sapiens (Human),357,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..32; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
2,,A0A0C4DFN9,A0A0C4DFN9_HUMAN,Cytochrome P450 family 4 subfamily A member 22,CYP4A22,Homo sapiens (Human),455,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..32; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,A5PL05,A5PL05_HUMAN,CYP4A22 protein,CYP4A22,Homo sapiens (Human),357,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..32; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,Q5TCH5,Q5TCH5_HUMAN,"Cytochrome P450 family 4 subfamily A member 22 (Cytochrome P450, family 4, subfamily A, polypeptide 22)",CYP4A22 RP1-18D14.1-003,Homo sapiens (Human),421,,intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020],"intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..32; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
5,,A5PKT5,A5PKT5_HUMAN,CYP4A22 protein,CYP4A22,Homo sapiens (Human),455,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 12..32; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""UGT2B17"")",O75795,UDB17_HUMAN,UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (UGT2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT),UGT2B17,Homo sapiens (Human),530,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; steroid metabolic process [GO:0008202]; xenobiotic metabolic process [GO:0006805],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 495..515; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:23288867}; Single-pass membrane protein {ECO:0000255}.,
1,,A0A804HJ67,A0A804HJ67_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT2B17,Homo sapiens (Human),173,,membrane [GO:0016020],membrane [GO:0016020]; UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|RuleBase:RU362059}.,
0,"(gene:""CYP4B1"")",P13584,CP4B1_HUMAN,Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450-HP),CYP4B1,Homo sapiens (Human),511,biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; heterocyclic compound binding [GO:1901363]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825]; biphenyl metabolic process [GO:0018879]; fatty acid metabolic process [GO:0006631],aromatase activity [GO:0070330]; heme binding [GO:0020037]; heterocyclic compound binding [GO:1901363]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxygen binding [GO:0019825],,,SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.,
1,,E9PML0,E9PML0_HUMAN,Cytochrome P450 family 4 subfamily B member 1,CYP4B1,Homo sapiens (Human),325,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 13..34; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
2,,Q8IZB0,Q8IZB0_HUMAN,Cytochrome P450 family 4 subfamily B member 1 (Pulmonary cytochrome P450 4B1 variant),CYP4B1,Homo sapiens (Human),497,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 13..34; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,E9PL36,E9PL36_HUMAN,Cytochrome P450 family 4 subfamily B member 1,CYP4B1,Homo sapiens (Human),87,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 13..34; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,F5H1Q8,F5H1Q8_HUMAN,Cytochrome P450 family 4 subfamily B member 1,CYP4B1,Homo sapiens (Human),70,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
5,,F5H5Q6,F5H5Q6_HUMAN,Cytochrome P450 family 4 subfamily B member 1,CYP4B1,Homo sapiens (Human),138,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 13..34; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
6,,Q8WWV1,Q8WWV1_HUMAN,"Cytochrome P450, family 4, subfamily B, polypeptide 1, isoform CRA_b (Truncated cytochrome P450)",CYP4B1 hCG_22100,Homo sapiens (Human),295,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 13..34; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
0,"(gene:""UGT2B4"")",P06133,UD2B4_HUMAN,UDP-glucuronosyltransferase 2B4 (UDPGT 2B4) (UGT2B4) (EC 2.4.1.17) (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1),UGT2B4 UGT2B11,Homo sapiens (Human),528,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],endoplasmic reticulum membrane [GO:0005789],endoplasmic reticulum membrane [GO:0005789]; glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 493..509; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000305|PubMed:8333863}; Single-pass membrane protein {ECO:0000255}.,
1,,D6RGY0,D6RGY0_HUMAN,UDP glucuronosyltransferase family 2 member B4,UGT2B4,Homo sapiens (Human),54,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
0,"(gene:""CYP4F11"")",Q9HBI6,CP4FB_HUMAN,Cytochrome P450 4F11 (CYPIVF11) (EC 1.14.14.1) (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80) (Phylloquinone omega-hydroxylase CYP4F11) (EC 1.14.14.78),CYP4F11,Homo sapiens (Human),524,arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; cytochrome metabolic process [GO:1903604]; fatty acid metabolic process [GO:0006631]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; aromatase activity [GO:0070330]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; cytochrome metabolic process [GO:1903604]; fatty acid metabolic process [GO:0006631]; menaquinone catabolic process [GO:0042361]; omega-hydroxylase P450 pathway [GO:0097267]; oxylipin biosynthetic process [GO:0031408]; phylloquinone catabolic process [GO:0042376]; vitamin K catabolic process [GO:0042377]","aromatase activity [GO:0070330]; fatty acid binding [GO:0005504]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",,"TRANSMEM 15..37; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:18065749}; Single-pass membrane protein {ECO:0000305}. Microsome membrane {ECO:0000269|PubMed:18065749}; Single-pass membrane protein {ECO:0000305}.,
1,,F8W978,F8W978_HUMAN,Cytochrome P450 family 4 subfamily F member 11,CYP4F11,Homo sapiens (Human),454,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,V9GYP6,V9GYP6_HUMAN,Cytochrome P450 family 4 subfamily F member 11,CYP4F11,Homo sapiens (Human),199,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""UGT2B7"")",P16662,UD2B7_HUMAN,"UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (UGT2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2)",UGT2B7 UGTB2B9,Homo sapiens (Human),529,androgen metabolic process [GO:0008209]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020]; androgen metabolic process [GO:0008209]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210]; lipid metabolic process [GO:0006629]; xenobiotic metabolic process [GO:0006805],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 493..509; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10702251}; Single-pass membrane protein {ECO:0000255}.,
1,,D6RH08,D6RH08_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT2B7,Homo sapiens (Human),156,,membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|RuleBase:RU362059}.,
2,,Q5QKR3,Q5QKR3_HUMAN,glucuronosyltransferase (EC 2.4.1.17),UGT2B7,Homo sapiens (Human),240,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],,glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],,,,
3,,Q9HCT7,Q9HCT7_HUMAN,glucuronosyltransferase (EC 2.4.1.17),UGT2B7,Homo sapiens (Human),215,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],,glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],,,,
4,,A0A087X084,A0A087X084_HUMAN,glucuronosyltransferase (EC 2.4.1.17),UGT2B7,Homo sapiens (Human),335,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
5,,E9PBP8,E9PBP8_HUMAN,glucuronosyltransferase (EC 2.4.1.17),UGT2B7,Homo sapiens (Human),369,,,UDP-glycosyltransferase activity [GO:0008194],UDP-glycosyltransferase activity [GO:0008194],,,,
6,,Q99912,Q99912_HUMAN,glucuronosyltransferase (EC 2.4.1.17),UGT2B7,Homo sapiens (Human),149,cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],,glucuronosyltransferase activity [GO:0015020]; cellular glucuronidation [GO:0052695]; estrogen metabolic process [GO:0008210],glucuronosyltransferase activity [GO:0015020],,,,
0,"(gene:""CYP4F12"")",Q9HCS2,CP4FC_HUMAN,Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12),CYP4F12 UNQ568/PRO1129,Homo sapiens (Human),524,arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; phylloquinone catabolic process [GO:0042376]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; xenobiotic metabolic process [GO:0006805],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497]; arachidonic acid metabolic process [GO:0019369]; epoxygenase P450 pathway [GO:0019373]; fatty acid metabolic process [GO:0006631]; leukotriene B4 catabolic process [GO:0036101]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; phylloquinone catabolic process [GO:0042376]; pressure natriuresis [GO:0003095]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; xenobiotic metabolic process [GO:0006805],alkane 1-monooxygenase activity [GO:0018685]; arachidonic acid epoxygenase activity [GO:0008392]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; monooxygenase activity [GO:0004497],,"TRANSMEM 19..39; /note=""Helical""; /evidence=""ECO:0000255""; TRANSMEM 87..107; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q9HBI6}. Microsome membrane {ECO:0000250|UniProtKB:Q9HBI6}.,
1,,F8VR75,F8VR75_HUMAN,Cytochrome P450 family 4 subfamily F member 12,CYP4F12,Homo sapiens (Human),104,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 20..42; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
2,,F8VU50,F8VU50_HUMAN,Cytochrome P450 family 4 subfamily F member 12,CYP4F12,Homo sapiens (Human),70,,,,,,,,
3,,F8VZP1,F8VZP1_HUMAN,Cytochrome P450 family 4 subfamily F member 12,CYP4F12,Homo sapiens (Human),79,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 20..42; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,Q6QF45,Q6QF45_HUMAN,Cytochrome P450 4F12,CYP4f12,Homo sapiens (Human),9,,,,,,,,
5,,Q8IV39,Q8IV39_HUMAN,"Cytochrome P450, family 4, subfamily F, polypeptide 12",CYP4F12,Homo sapiens (Human),524,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
0,"(gene:""UGT3A1"")",Q6NUS8,UD3A1_HUMAN,UDP-glucuronosyltransferase 3A1 (UDPGT 3A1) (EC 2.4.1.17),UGT3A1,Homo sapiens (Human),523,,UDP-N-acetylglucosamine transferase complex [GO:0043541],UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194],glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194],"TOPO_DOM 23..483; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 505..523; /note=""Cytoplasmic""; /evidence=""ECO:0000255""","TRANSMEM 484..504; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,
1,,A8K444,A8K444_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT3A1 hCG_1777941,Homo sapiens (Human),523,,membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,"TRANSMEM 488..514; /note=""Helical""; /evidence=""ECO:0000256|RuleBase:RU362059""",SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|RuleBase:RU362059}.,
2,,B7Z8Q8,B7Z8Q8_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT3A1,Homo sapiens (Human),436,,membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|RuleBase:RU362059}.,
3,,E9PD17,E9PD17_HUMAN,UDP-glucuronosyltransferase (EC 2.4.1.17),UGT3A1,Homo sapiens (Human),402,,membrane [GO:0016020],membrane [GO:0016020]; glucuronosyltransferase activity [GO:0015020],glucuronosyltransferase activity [GO:0015020],,,SUBCELLULAR LOCATION: Membrane {ECO:0000256|RuleBase:RU362059}; Single-pass membrane protein {ECO:0000256|RuleBase:RU362059}.,
4,,D6RHV6,D6RHV6_HUMAN,UDP glycosyltransferase family 3 member A1,UGT3A1,Homo sapiens (Human),57,,,,,,,,
0,"(gene:""CYP4F2"")",P78329,CP4F2_HUMAN,Cytochrome P450 4F2 (EC 1.14.14.1) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450-LTB-omega) (Docosahexaenoic acid omega-hydroxylase) (EC 1.14.14.79) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.14.94) (Phylloquinone omega-hydroxylase CYP4F2) (EC 1.14.14.78),CYP4F2,Homo sapiens (Human),520,arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805],apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231]; 20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]; arachidonic acid metabolic process [GO:0019369]; blood coagulation [GO:0007596]; epoxygenase P450 pathway [GO:0019373]; fatty acid omega-oxidation [GO:0010430]; icosanoid metabolic process [GO:0006690]; leukotriene B4 catabolic process [GO:0036101]; leukotriene metabolic process [GO:0006691]; long-chain fatty acid metabolic process [GO:0001676]; menaquinone catabolic process [GO:0042361]; negative regulation of icosanoid secretion [GO:0032304]; omega-hydroxylase P450 pathway [GO:0097267]; phylloquinone catabolic process [GO:0042376]; positive regulation of icosanoid secretion [GO:0032305]; pressure natriuresis [GO:0003095]; regulation of blood pressure [GO:0008217]; renal water homeostasis [GO:0003091]; sodium ion homeostasis [GO:0055078]; very long-chain fatty acid metabolic process [GO:0000038]; vitamin E metabolic process [GO:0042360]; vitamin K catabolic process [GO:0042377]; xenobiotic metabolic process [GO:0006805]","20-aldehyde-leukotriene B4 20-monooxygenase activity [GO:0097259]; 20-hydroxy-leukotriene B4 omega oxidase activity [GO:0097258]; alkane 1-monooxygenase activity [GO:0018685]; alpha-tocopherol omega-hydroxylase activity [GO:0052871]; arachidonic acid epoxygenase activity [GO:0008392]; arachidonic acid omega-hydroxylase activity [GO:0052869]; aromatase activity [GO:0070330]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; leukotriene-B4 20-monooxygenase activity [GO:0050051]; long-chain fatty acid omega-hydroxylase activity [GO:0102033]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO:0016709]",,,"SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:19297519, ECO:0000269|PubMed:24138531, ECO:0000269|PubMed:8026587}; Peripheral membrane protein {ECO:0000305}. Endoplasmic reticulum membrane {ECO:0000269|PubMed:20861217}; Peripheral membrane protein {ECO:0000305}.",
1,,A0A0A0MQR0,A0A0A0MQR0_HUMAN,"Cytochrome P450 family 4 subfamily F member 2 (Cytochrome P450, family 4, subfamily F, polypeptide 2, isoform CRA_a)",CYP4F2 hCG_1788543,Homo sapiens (Human),520,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
2,,K7EK90,K7EK90_HUMAN,Cytochrome P450 family 4 subfamily F member 2,CYP4F2,Homo sapiens (Human),153,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..42; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
3,,K7EPM0,K7EPM0_HUMAN,Cytochrome P450 family 4 subfamily F member 2,CYP4F2,Homo sapiens (Human),89,,membrane [GO:0016020],membrane [GO:0016020],,,"TRANSMEM 20..42; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
4,,K7EQI8,K7EQI8_HUMAN,Cytochrome P450 family 4 subfamily F member 2,CYP4F2,Homo sapiens (Human),74,,,"heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,,,
5,,O95743,O95743_HUMAN,Cytochrome P450,CYP4F2,Homo sapiens (Human),48,,,,,,,,
0,"(gene:""UGT3A2"")",Q3SY77,UD3A2_HUMAN,UDP-glucuronosyltransferase 3A2 (UDPGT 3A2) (EC 2.4.1.17),UGT3A2 PSEC0073 UNQ842/PRO1780,Homo sapiens (Human),523,cellular response to genistein [GO:0071412],UDP-N-acetylglucosamine transferase complex [GO:0043541],UDP-N-acetylglucosamine transferase complex [GO:0043541]; glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194]; cellular response to genistein [GO:0071412],glucuronosyltransferase activity [GO:0015020]; UDP-glycosyltransferase activity [GO:0008194],"TOPO_DOM 23..483; /note=""Extracellular""; /evidence=""ECO:0000255""; TOPO_DOM 505..523; /note=""Cytoplasmic""; /evidence=""ECO:0000255""","TRANSMEM 484..504; /note=""Helical""; /evidence=""ECO:0000255""",SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,
1,,D6RDU1,D6RDU1_HUMAN,UDP glycosyltransferase family 3 member A2,UGT3A2,Homo sapiens (Human),138,,,,,,,,
2,,D6RHY1,D6RHY1_HUMAN,UDP glycosyltransferase family 3 member A2,UGT3A2,Homo sapiens (Human),120,,,,,,,,
0,"(gene:""CYP4F22"")",Q6NT55,CP4FN_HUMAN,Ultra-long-chain fatty acid omega-hydroxylase (EC 1.14.14.177) (Cytochrome P450 4F22),CYP4F22,Homo sapiens (Human),531,ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690],endoplasmic reticulum membrane [GO:0005789],"endoplasmic reticulum membrane [GO:0005789]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]; ceramide biosynthetic process [GO:0046513]; icosanoid metabolic process [GO:0006690]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","TOPO_DOM 1..22; /note=""Lumenal""; /evidence=""ECO:0000305|PubMed:26056268""; TOPO_DOM 44..531; /note=""Cytoplasmic""; /evidence=""ECO:0000305|PubMed:26056268""","TRANSMEM 23..43; /note=""Helical""; /evidence=""ECO:0000255, ECO:0000305|PubMed:26056268""",SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:26056268}; Single-pass type I membrane protein {ECO:0000269|PubMed:26056268}. Microsome membrane {ECO:0000269|PubMed:26056268}; Single-pass type I membrane protein {ECO:0000269|PubMed:26056268}.,
1,,A0A1B1SMS2,A0A1B1SMS2_HUMAN,Cytochrome P450 4F22,CYP4F22,Homo sapiens (Human),531,,membrane [GO:0016020],"membrane [GO:0016020]; heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]","heme binding [GO:0020037]; iron ion binding [GO:0005506]; monooxygenase activity [GO:0004497]; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO:0016705]",,"TRANSMEM 20..40; /note=""Helical""; /evidence=""ECO:0000256|SAM:Phobius""",,
